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Abstract
The coordination chemistry of the cyclopropyl-substituted alkenes, bicyclopropylidene
(BCP) and methylenecyclopropane (MCP), with platinum was explored. A
range of complexes with η2-alkene ligands were synthesised by the displacement
of a ligand, typically ethene, from a precursor complex. These complexes are
[Pt(L)(P—P)] (L = BCP, MCP; P—P = Ph2P(CH2)3PPh2, Cy2P(CH2)2PCy2,
tBu2P(CH2)2P
tBu2,
tBu2PCH2(o-C6H4)CH2P
tBu2), [Pt(L)(P—S)] (L = BCP, MCP;
P—S = tBu2PCH2(o-C6H4)CH2S
tBu), [Pt(C2H4)(L)(PR3)] (L = BCP, MCP; PR3 =
PPh3, PCy3), [Pt(MCP)2(PR3)] (PR3 = PPh3, PCy3) and [PtCl2(L)(L
′)] (L = BCP,
MCP; L′ = Py, DMSO). These were the first examples of platinum complexes with
η2-BCP ligands, and the first bis-MCP Pt complexes.
BCP underwent ring-opening reactions with both Pt(0) and Pt(II) complexes to form
the 1,3-diene allylidenecyclopropane (ACP). The first transition metal complexes of ACP
[Pt(ACP)(P—P)] (P—P = Ph2P(CH2)3PPh2, Cy2P(CH2)2PCy2,
tBu2P(CH2)2P
tBu2)
were synthesised. Some of these complexes rearranged to form η2:σ2-metallacyclopentene
complexes, the first instances of the formation of η2:σ2-metallacyclopentene complexes
from η2:pi-diene complexes. With MCP, the ring-opening reaction only occurred with
[PtEt2(COD)], as a result of the anti-Markovnikov addition of Pt–H, generated by the
β-hydride elimination of an Et group, across the double-bond. The major products of
this reaction were the 1-methylcyclopropyl complexes [Pt(C(CH2)2CH3)Et(COD)] and
[Pt(C(CH2)2CH3)2(COD)], the first examples of such complexes.
Protonation of [Pt(L)(P—P)] resulted in a ring-opening reaction to form
both the 2-substituted and 1-methyl allyl complexes, [Pt(η3-CH2CRCH2)(P—P)]
+
ii
(R = cPr, Me; P—P = Ph2P(CH2)3PPh2,
tBu2PCH2(o-C6H4)CH2P
tBu2)
and [Pt(η3-CR2CHCHMe)(P—P)]
+ (R = cPr, Me; P—P = Ph2P(CH2)3PPh2,
tBu2PCH2(o-C6H4)CH2P
tBu2). The analogous 1-methyl complexes were also formed
from [Pt(L)(P—S)], wherein the alkene reacted with a hydride formed by the ortho-
metallation of the P—S ligand. Computational models were used to investigate the
formation of the allyl structures and it was found that the activation energy had a more
significant effect than complex stability on product distributions.
Complexes with β-chloroalkyl ligands [Pt(C(CH2)2CR2Cl)Cl(L)2] (R = CH2, H, L
= SEt2, NC
tBu, Py) were formed by the addition of Pt–Cl across the alkene double
bond. Phosphine complexes were formed by the displacement of a ligand from cis–
[Pt(C(CH2)2CR2Cl)Cl(Py)2] (R = CH2, H). These are the first examples of stable Pt(II)
β-haloalkyl complexes. It was found using computational models that the presence of
cyclopropyl rings had a stabilising effect on these complexes.
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Chapter 1
Introduction
1.1 Transition Metal Chemistry of Alkenes
1.1.1 Introduction
Alkene complexes of transition metals, particularly platinum, are among the most
extensively studied organometallic compounds.1 The first transition metal-alkene complex
was K[PtCl3(C2H4)].H2O, or Zeise’s salt, which was synthesised in 1830.
2 Alkene
complexes are common intermediates in catalytic cycles, and several model complexes
have been synthesised over the years in order to lend insight into the processes that occur
during catalysis.1
1.1.2 Bonding
When the X-ray crystal structure of Zeise’s salt was solved in 1953, it was found that the
alkene ligand was bound to the metal via the pi electrons, rather than by a σ-bond to just
one of the carbon atoms, an arrangement now known to be typical of transition metal-
alkene complexes.3 The currently accepted model for the bonding between alkene ligands
and transition metal complexes is the Dewar-Chatt-Duncanson model. This was first
proposed by Dewar in relation to silver-ethene complexes4 and later applied to platinum-
ethene complexes by Chatt and Duncanson.5 In this model, there is a synergistic bond
between the metal and the ligand, involving the donation of electron density from the
3
highest occupied molecular orbital (HOMO) of the ligand, the pi-orbital, into an empty
metal orbital with σ-type symmetry, coupled with the back-donation from a filled pi-type
metal d-orbital into the lowest unoccupied molecular orbital (LUMO) of the ligand, the
pi*-orbital (Figure 1.1).5–8 As a result of the back-donation, the double-bond is weakened
and lengthened, and there is a partial rehybridisation of the carbon centres, with the sp2
carbon atoms becoming more sp3-like.8 With the change in hybridisation, the substituents
on the double-bond carbon atoms are bent away from the bond, with the angle increasing
with the degree of back-bonding.8 The effect of back-donation can be seen in the infrared
spectra of the complexes, with the coordinated alkene having a C=C bond stretch at
lower wavenumber.5
C
C
M
Figure 1.1. Schematic of the synergistic bonding between a metal atom and an alkene
ligand.5–8
In general, the attenuation of the bond strength, and therefore the increase in bond
length is correlated to the extent of back-bonding. In the case of a weak pi-base, such as
the Pt(II) in Zeise’s salt, the back-bonding is minimal. The ethene C=C bond length is
similar to that in free ethene, and it can therefore be described as a simple pi-complex.
This is typical of alkene complexes with the metal in a high oxidation state.8 Conversely,
when an electron-deficient alkene is coordinated to a strongly pi-basic metal, as in the
formally Pt(0) complex [Pt(C2(CN)4)(PPh3)2], the back-bonding is maximised. The
alkene double-bond is significantly lengthened, and the complex can best be described
as a metallacyclopropane species.8 Most transition metal-alkene complexes fall between
the above extremes.
4
As late transition metals have more filled orbitals than the earlier ones, the ability
of the alkene ligand to act as a pi-acceptor determines the strength of the binding to the
metal, and stronger complexes are therefore formed with electron-deficient alkenes.8–10
Early transition metals, on the other hand, tend to have more empty orbitals, so it is the
ability of the ligand to act as a σ-donor that predominantly affects the binding strength,
and stronger complexes are formed with electron-rich alkenes.8,11–13 In general, alkenes
are weak σ-donors but very good pi-acceptors.8
The high pi-accepting ability of alkene ligands mean that they have a strong trans-
effect.2 Electron deficient alkenes, which have lower LUMOs, have stronger trans-effects.8
The trans-influence of the alkene ligand, however, is highly dependent on the nature of
the ligand trans to the alkene.2
The coordination strength of an alkene ligand is not just dependent on the electronic
properties of the ligand. The structure of the alkene also plays a significant role in
determining the stability of a complex. In general, the stability decreases with the number
of substituents on the alkene, and cis isomers tend to be more tightly bound than the
corresponding trans isomer.8,9,14,15 Ring strain is also a very important factor in complex
stability. Strained alkenes such as norbornene (nb) form particularly stable complexes
as coordination and the subsequent rehybridisation of the carbon atoms alleviates the
strain.8,15 Strained alkenes also have a lower pi*-molecular orbital and a higher pi-orbital
than unstrained alkenes, which leads to a more favourable overlap with metal d-orbitals
and therefore more stable complexes.16
1.1.3 Group 10 Alkene Complexes
By far the most common class of alkene complexes are those of the Group 10 metals
nickel, palladium and platinum. These range from monoalkene complexes with a variety
of auxiliary ligands, to complexes with three alkene ligands. There are several ways of
synthesising Group 10 alkene complexes. Complexes with the metal in the +2 oxidation
state can be made either by reacting a metal salt directly with an alkene (Scheme 1.1
(i)),17 or by displacing a ligand such as another alkene (Scheme 1.1 (ii)).2,18 Complexes
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(i)
Pt
Cl
Cl
Cl
Cl
NH2
(NH4)2
Pt
Cl
Cl
NH2
+
(ii)
+Pt
Cl
Cl
O
PhN
Pt
Cl
Cl
O
N
Ph
(iii)
Pt
Ph3P
Ph3P Ph
+Pt
PPh3
PPh3
Cl
Cl
Ph
Ph
Ph
N2H4
(iv)
Pd
Ph3P
Ph3P COOEt
+Pd
PPh3
PPh3
PPh3
Ph3P
EtOOC
COOEt
EtOOC
(v)
Pt Pt+ 2
Scheme 1.1. Synthesis of alkene-transition metal complexes.17–21
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with the metal in the zero oxidation state can be synthesised by the reduction of a M(II)
complex in the presence of an alkene (Scheme 1.1 (iii)),19 or by the displacement of other
ligands such as phosphines or other alkenes (Scheme 1.1 (iv) and (v)).2,20,21
The first complexes containing purely alkene ligands were made with nickel,
[Ni(cycloocta-1,5-diene)2] and [Ni(trans,trans,trans–cyclododeca-1,5,9-triene)].
16 Pure
alkene complexes of platinum and palladium have also been synthesised. These are
commonly used as precursors in the synthesis of other complexes, as alkenes are relatively
easily displaced by other ligands. They are also used as catalysts and pre-catalysts.
The orientation of the coordinated alkene ligands is dependent on the oxidation state
of the metal. In M(II) complexes, the alkene ligand usually sits perpendicular to the
metal coordination plane (Figure 1.2 (i)),2,22 while in M(0) complexes, the alkene usually
lies parallel to the coordination plane (Figure 1.2 (ii)).2,23 In cases where the ligands
are constrained, the geometry of the complex differs from the ideal. The coordination
geometry means that a maximum of three monoalkenes can coordinate to the metal in pure
alkene complexes, although it is possible for four individual double-bonds to coordinate.16
Bis(cycloocta-1,5-diene)platinum, for example, has four coordinated double-bonds and a
Pt(0) metal centre, and is almost tetrahedral at the metal.24
1.2 Methylenecyclopropane
1.2.1 Synthesis and Properties
Methylenecyclopropane (MCP) (Figure 1.3) is a four-carbon molecule that contains a
cyclopropane ring with an external double-bond. It is a gas at room temperature, with
a boiling point of 10 ◦C. As cyclopropane rings have some analogous reactivities to
double-bonds,25 MCP can be considered analogous to allene. Methylenecyclopropane
was first synthesised in 1952 from 3-chloro-2-(chloromethyl)-1-propene using magnesium
(Scheme 1.2 (i)).26 In this synthesis, the 3-chloro-2-(chloromethyl)-1-propene first had to
be prepared by the chlorination of 3-chloro-2-methyl-1-propene (methallyl chloride). A
second synthetic method enabled the transformation of methallyl chloride directly into
7
(i)
(ii)
(iii)
Figure 1.2. X-ray crystal structures of some metal-alkene complexes: (i)
[PtCl2(C2H4)2],
22 (ii) [Ni(C2H4)(
tBu2P(C2H4)P
tBu2)]
23 and (iii) [Pt(nb)3].
16
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MCP using potassium amide (Scheme 1.2 (ii)).27 The equivalent reaction with sodium
amide produced 1-methylcyclopropene, which means that the choice of base is important.
This method was further modified to use a KOtBu/NaNH2 base system.
28
Cl Cl
Cl
Mg
(i)
Cl
NaNH2
or KNH2
KOtBu/NaNH2
(ii)
Scheme 1.2. Methods of synthesising methylenecyclopropane.26,27
Figure 1.3. Methylenecyclopropane.29
While a crystal structure of MCP has not been obtained, the structural properties have
been calculated from the microwave spectrum.29 The length of the double-bond (1.332 Å)
is comparable to that of ethene (1.330 Å)30 and 2-methylpropene (1.330 Å).29 The
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proximal (C2–C3) bond lengths (1.457 Å) are shortened relative to the ideal cyclopropane
bond lengths of 1.514 Å,29 while the distal bond length (1.542 Å) is lengthened. The
proximal bond shortening is due to the fact that the bonding is between formally sp3
and sp2 carbon atoms, which typically means a shorter bond length than that of a bond
between two sp3 carbon atoms.29 This trend can also be observed in 2-methylpropene
and cyclopropanone, with proximal bonds shortened to 1.507 and 1.475 Å respectively,
while in methylcyclopropane the bond lengths are 1.517 Å, closer to the ideal.29,31 The
C3–C2–C3′ angle is larger than that of cyclopropane (60◦)32 at 63.9◦, while the remaining
angles in the cPr ring are 58.0◦.29
The first ionisation energy of methylenecyclopropane is 9.6 eV, similar to
2-methylpropene (9.2 eV), but significantly less than ethene (10.5 eV).33 MCP shows
a strong C=C stretch at 1742 cm−1 in the infrared spectrum, which is at a higher
wavenumber than that of ethene, 1623 cm−1.34,35 In the NMR spectra, there are three
different carbon and two proton environments.28,36 The double-bond methylene carbon
has a proton resonance at 5.35 ppm and a carbon resonance at 103.0 ppm, while the ring
methylenes have resonances at 1.00 and 2.6 ppm in the 1H NMR and 13C NMR spectra
respectively (CDCl3). The ring sp
2 carbon has a signal at 130.7 ppm. The 13C–1H
coupling constant of the ring carbons, 162 Hz, is indicative of the long-range effect of the
increased s-character of the double-bond relative to cyclopropane, which has a coupling
constant of 160.3 Hz.36,37
1.2.2 Organometallic Chemistry
1.2.2.1 Transition Metal-Catalysed Reactions
The transition metal chemistry of methylenecyclopropane and its derivatives has been
explored since the 1970s. There are four different ways that MCPs react with transition
metal species (Scheme 1.3).38 When the metal reacts with the cyclopropane ring, there
can be insertion into either the distal (Scheme 1.3 (i)) or the proximal bonds (Scheme
1.3 (ii)) of the ring. When the double-bond reacts with an organotransition metal species
(R–MLn), this can yield either the Markovnikov product (Scheme 1.3 (iii)), with the metal
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bound to the cPr carbon atom, or the anti-Markovnikov product (Scheme 1.3 (iv)), with
the metal bound to the methylene carbon atom.
M
M
LnM R
R MLn
"M"
"M"
R-MLn
R-MLn
(i)
(ii)
(iv)
(iii)
Scheme 1.3. The four reaction modes of methylenecyclopropanes with transition
metals.38
The transition metal-catalysed reactions of MCPs which have been previously
studied can be divided into four types, which involve at least one of the above
transformations: Transition metal-catalysed [3+2] cycloadditions, Heck-type reactions
with organopalladium species, additions of metal hydrides (M–H) and pronucleophiles
(Nu–H), and the addition of bis-metallic species.38
1.2.2.2 Transition Metal-Catalysed [3+2] Cycloadditions
Methylenecyclopropane can act as a three-carbon unit in transition metal catalysed [3+2]
cycloadditions.38–40 These reactions always involve the cleavage of one of the bonds in the
cPr ring. In the case of distal bond cleavage (Scheme 1.4), the reaction proceeds via the
formation of a metallacyclobutane species, followed by the insertion of an X=Y multiple
bonded species. This forms a 5-membered carbo- or hetero-cycle, depending on the nature
of X=Y.38,41
Alternatively, in the case of proximal bond cleavage, the reaction can proceed via one
11
MX=Y
Y
X
M
YM
X
X
Y
Scheme 1.4. TM catalysed [3+2] cycloaddition of MCP involving distal bond
cleavage.38
of two routes. (Scheme 1.5). The first, the direct attack of the catalyst on the proximal
bond, is similar to distal bond cleavage, involving a metallacyclobutane intermediate.
In the second route, a metallacyclopentane species is formed, incorporating X=Y. This
then undergoes a cyclopropyl to homoallyl rearrangement, yielding 5-membered carbo-
or hetero-cycles with different regiochemistry to the distal bond cleavage product. The
mode of ring opening is catalyst dependent.38,41
M
X=Y
YX
M
M
X
Y
or M
X
Y
X
Y
Scheme 1.5. TM catalysed [3+2] cycloaddition of MCP involving proximal bond
cleavage.38
There are several species that can behave as X=Y in these [3+2] cycloadditions.
Reactions where X=Y is a carbon-carbon multiple bond have been extensively inves-
tigated, particularly for nickel- and palladium-catalysed reactions.38–40 A variety of MCP
derivatives have been utilised as the three-carbon component, and the reaction has been
extended to intramolecular versions.42–44
Reactions with carbon-heteroatom bonds have been successful with heterocumulenes
such as carbon dioxide and ketenimines, producing lactones and pyrrolidine derivatives
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respectively.41,45 MCPs can also be reacted with aldehydes to produce substituted
tetrahydrofurans,46 and with imines to produce 3-methylenepyrrolidine derivatives.47
These reactions are reasonably high yielding, ranging from 38% to 94%, depending on
the nature of both the MCP derivative and the carbon-heteroatom species.38
1.2.2.3 Heck-Type Reactions
Methylenecyclopropanes can undergo palladium-catalysed Heck-type reactions with alkyl
or aryl halides (Scheme 1.6).38 These reactions predominantly involve the cleavage of one
of the proximal bonds of the cPr ring.38,48,49 Initially, a previously formed R–Pd–X species
adds across the double-bond in an anti-Markovnikov fashion. The proximal bond is then
cleaved in a cyclopropyl to homoallyl rearrangement, generating a homoallylpalladium
species. When this undergoes β-hydride elimination, the product is a 2-alkylated
1,3-diene. However, in some cases the homoallylpalladium species rearranges to a pi-
allylpalladium intermediate, which can then be trapped by an appropriate nucleophile.38
R-PdX
R
PdX
R
R
PdX
XPd R
R
Nu
R
Nu
+
Nu
Scheme 1.6. Palladium-catalysed Heck-type reaction with MCP.38
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1.2.2.4 Addition of Metal Hydrides and Pronucleophiles
The palladium-catalysed reactions of methylenecyclopropanes with either metal hydrides
(M–H) or pronucleophiles (Nu–H) are of considerable use, as this can introduce a
functional group into unsaturated molecules in an atom-economical manner.38 These
reactions involve the cleavage of one of the cPr bonds. The type of bond cleaved is
dependent upon the substrate.38 In the reaction with metal hydrides such as stannyl
hydrides (HSnR3) and hydrosilanes (HSiR3), it is usually one of the proximal bonds
that is cleaved.38,50 First, the palladium atom inserts into the M–H bond, and then, as
with the Heck-type reactions, the resulting H–Pd–M species undergoes anti-Markovnikov
addition across the MCP double-bond. The proximal bond is cleaved, forming a
homoallylpalladium species. The product is formed by reductive elimination from the
palladium (Scheme 1.7). Proximal bond cleavage also occurs in the addition of a boron-
boron bond.38
M-Pd-H
H
M
MPd H
H
PdM
M = Sn, Si
Scheme 1.7. Palladium-catalysed addition of metal hydrides to MCP.38
In the reaction with pronucleophiles such as carbo-pronucleophiles (HC(EWG)nR3−n),
amines (HNR2) and alcohols (HOR), it is mainly the distal bond that is cleaved.
38 There
are two mechanistic possibilities in this reaction. The palladium atom could first insert
into the Nu–H bond, generating a H–Pd–Nu species, which then adds across the double-
bond in a Markovnikov fashion. The cyclopropylpalladium species undergoes β-carbon
palladium elimination to give a pi-allylpalladium intermediate that is attacked by the
nucleophile to yield the product (Scheme 1.8). Alternatively, the Pd can insert into the
distal cPr bond, forming a metallacyclobutane. This then reacts with the pronuclophile
14
to give the same pi-allylpalladium species as before.
H PdNu
Pd
H
PdNu
H Nu
H-Pd-Nu
Pd(0)
Scheme 1.8. Palladium-catalysed addition of pronucleophiles to MCP.38
1.2.2.5 Bismetallation
Catalytic bismetallation is an attractive methodology to introduce two metal atoms into
a carbon framework by directly adding the metals across a carbon-carbon multiple bond.
This chemistry has previously been demonstrated using alkenes, alkynes, 1,3-dienes and
allenes. More recently, methylenecyclopropanes have been used as acceptors as they
impart unique structural properties to the products.38
The palladium- and nickel-catalysed bismetallation of substituted MCPs has been
achieved using trimethylsilyl cyanide.51 This can be done either with retention of the
ring, or with cleavage of the distal bond. Unsubstituted MCP has been bismetallated
by a diborane using a platinum catalyst, with cleavage of the proximal ring bond to
yield a ring-opened product.52 Most extensively studied has been the palladium- and
platinum-catalysed silaboration of MCPs.53 These reactions can involve either distal or
proximal bond cleavage. The mechanism of the silaboration reaction has not been fully
explored, and there are several possible reaction pathways (Scheme 1.9).38,53 Firstly,
there is the possibility that it proceeds similar to the Heck type reactions and Nu–H
additions, with the addition of a R2B–M–SiR
′
3 species across the double-bond, followed
by a rearrangement to yield a homoallyl product. However, this does not completely
explain the product distribution. An alternative mechanism is possible, with the oxidative
15
addition of the proximal bond onto the metal forming a metallacyclobutane, followed by
reductive elimination of the borane and the double-bonded carbon atom to generate the
same homoallyl species. The metallacyclobutane mechanism can also be applied to the
case of distal bond cleavage.
MR'3Si BR2
M
SiR'3R2B
+
M
SiR'3
BR2
BR2
SiR'3
SiR'3
BR2
R2B-M-SiR'3
Scheme 1.9. Possible mechanisms for the metal-catalysed silaboration of MCP.38,53
1.2.2.6 Transition Metal Complexes
The transition metal chemistry of methylenecyclopropane is dominated by ring opening re-
actions, which has somewhat limited the isolation of η2-methylenecyclopropane complexes.
A common occurrence upon the coordination of MCP is the ring-opening of the distal cPr
bond to form η4-trimethylenemethane complexes. Complexes of this ligand formed from
MCP have been isolated for molybdenum,54 iron,39 nickel39,55 and palladium.56,57 Despite
this propensity to ring-open, there are several instances of transition metal-catalysed
reactions of MCP in which the ring is retained, and as such there have been a few η2-
methylenecyclopropane complexes isolated. As MCP has a high HOMO compared to
other alkenes such as ethene, and is highly strained, it should be able to both effectively
donate electron density into empty metal orbitals and accept back donation.58,59 Due
to the sensitivity of MCP to ring-opening reactions, the precursor complexes and the
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ancillary ligands need to be carefully chosen. Complexes of nickel and platinum with
phosphine ligands have been successfully synthesised by starting from the equivalent
ethene complexes. In the presence of an excess of MCP, the ethene is displaced to yield
[Ni(η2-MCP)(PPh3)2]
60 and [Pt(η2-MCP)(PPh3)2].
61 (Scheme 1.10).
M
Ph3P
Ph3P
C6H6
RT
M
Ph3P
Ph3P
M = Ni, Pt
Scheme 1.10. Synthesis of Ni and Pt complexes of MCP.60,61
A rhodium-bis-MCP complex has also been isolated by the displacement of ethene
from [Rh(acac)(C2H4)2].
61 The variable temperature NMR data of this complex shows
that the MCP ligands undergo rapid propeller rotation at room temperature.61 Also, the
NMR data showed that coupling to 103Rh only occurs to the olefinic carbon atoms and
protons, not to those in the cPr ring. This is also the case for the above Pt complex. An
X-ray crystal structure of [Rh(acac)(MCP)2] was obtained (Figure 1.4).
61 This shows that
the coordination geometry of the rhodium atom is almost perfectly square planar. The two
MCP ligands are anti-parallel to each other, and perpendicular to the metal coordination
plane. The double-bond ring carbon is closer to the metal than the double-bond methylene
carbon atom carbon atom (2.07 and 2.13 Å respectively), and the coordination plane
intersects the double-bond closer to the ring carbon atom. This can also be inferred from
the 103Rh–13C coupling constants, with that of the ring carbon atom larger than that of
the methylene carbon atom (20 Hz vs. 14 Hz). The plane of the cPr ring is bent away
from that of the double-bond by 23◦, indicative of back bonding from the metal. The
double-bond itself is at an angle of 80◦ relative to the metal plane. This distortion is
similar to that observed in allene complexes.61,62
MCP complexes can be synthesised by methods other than the displacement of an
ethene ligand. The above nickel-phosphine complex ([Ni(MCP)(PPh3)2]) can also be
synthesised from [Ni(acac)], Et2Al(OEt), PPh3 and MCP.
60 A cobalt complex has been
synthesised by reductive complexation from a chloro complex. The Co(II) complex
17
Figure 1.4. X-ray crystal structure of [Rh(acac)(MCP)2].
61
((2-(di-tert-butylphosphanyl)-P-ethyl)cyclopentadienyl)chlorocobalt(II) ([CoCl(Cp#)])
was treated with sodium amalgam and MCP at −50 ◦C to yield [Co(Cp#)(MCP)]
(Scheme 1.11).58,59
Co
P
Co Cl
P
Na/Hg
-50 to 20°C
83% tBu2tBu2
Scheme 1.11. Synthesis of a Co-MCP complex.58,59
1.3 Bicyclopropylidene
1.3.1 Synthesis of Bicyclopropylidene
Bicyclopropylidene (BCP) is a unique tetra-substituted alkene, consisting of two cy-
clopropylidene units joined by a common double-bond. It was originally conceived
18
MeO2C
CO2Me
CH2I2, Zn/Cu
~2-5%
FVP
520-530 °C
0.1 Torr
~4%
Scheme 1.12. First syntheses of bicyclopropylidene.63
by two independent groups as a molecule of mainly theoretical interest.37 The first
syntheses (Scheme 1.12), either a Simmons-Smith-type monocyclopropanation of the
terminal double-bond in ethenylidenecyclopropane64 or a retro-Diels-Alder cleavage
of dispiro[cyclopropane-1,2′-bicyclo[2.2.2]octa[5,7]diene-3′,1′′-cyclopropane]-5′,6′-dimethyl
ester,65 did not yield enough compound to perform a full structural and spectroscopic
characterisation. Later syntheses were higher yielding, but still too convoluted to be
synthetically useful.63 It was not until the Kulinkovich reaction enabled the transformation
of an ester to a cyclopropanol group using an ethylmagnesium bromide/titanium tetraiso-
propoxide reagent that BCP could be easily made in useful quantities.63 This enabled
the transformation of methyl cyclopropanecarboxylate to 1-cyclopropylcyclopropanol
quantitatively, which could then be simply converted to the bromide followed by
dehydrobromination to form the double-bond (Scheme 1.13).66,67 This efficient synthesis
method allowed the properties and chemistry of BCP to be studied extensively.
CO2Me
OH
Br
99%
EtMgBr
Ti(OiPr)4
PPh3, Br2
Py
78%
81%
KOtBu
DMSO
Scheme 1.13. Highest yielding synthesis of bicyclopropylidene.66,67
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1.3.2 Properties of Bicyclopropylidene
1.3.2.1 Structural Properties
Bicyclopropylidene can be thought of as comprising two joined methylenecyclopropane
units. The double-bond has increased s-character due to the presence of the cPr rings and
the carbon atoms are therefore close to sp-hybridised.29,32,68 As a result of this, in the X-
ray crystal structure the length of the double-bond is 1.304 Å (Figure 1.5),30 shorter than
the double-bonds in ethene (1.330 Å)30 and MCP (1.332 Å).29 It is noteworthy that the
presence of one terminal cPr on a double-bond does not make much of a difference to the
bond length, as in the case of MCP, while the presence of two significantly shortens the
bond. The double-bond in BCP is comparable to the central bond in butatriene, and has
properties approaching those of an acetylenic triple bond.63 The length of the bonds in the
cPr rings, 1.472 and 1.549 Å for proximal (C1–C2, C1–C3) and distal (C2–C3) respectively,
are comparative to the equivalent bonds in MCP, 1.457 and 1.542 Å, although the BCP
proximal bond is somewhat longer.30 As with MCP, the shortening of the proximal bonds
relative to the bonds in cyclopropane (1.541 Å)29 has been attributed to the fact that
these bonds are nominally sp2-sp3, which tend to be shorter than sp3-sp3 bonds.29
Figure 1.5. X-ray crystal structure of BCP at 173 K.30
The C2–C1–C3 angle is 63.1◦,30 approximately the same as that in MCP (63.9◦)29 and
larger than that in cyclopropane (60◦).32 Correspondingly, the C1–C2–C3 and C1–C3–C2
angles are smaller than those in cyclopropane at 58.4◦. The two cPr rings are coplanar
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with the double-bond to within 0.002◦.30
1.3.2.2 Spectroscopic and Electronic Properties
There have been several IR and Raman spectra of bicyclopropylidene reported by different
groups, and not all are in agreement.37 The most relevant vibrational mode with respect
to its bonding properties is the double-bond stretch, a weak band at 1836 cm−1 in the
Raman.37 The NMR data show a peak at 1.16 ppm in the 1H NMR spectrum and peaks at
2.9 and 110.2 ppm in the 13C NMR spectrum (CDCl3).
67 The 13C–1H coupling constant,
162.3 Hz, is indicative of a slightly increased s character of the C–H bonds relative to
those in cyclopropane, which has a coupling constant of 160.3 Hz.37 Bicyclopropylidene
has a relatively high-lying HOMO, 0.64 eV higher than that of MCP.37 While the first
ionisation energy of BCP (8.93 eV)68 is higher than that of tetramethylethene (8.27 eV),69
BCP is significantly more reactive towards additions across the double-bond.63 This is in
part due to the decreased steric bulk of the cPr rings relative to the methyl groups, but
mostly due to the difference in hybridisation of the double-bond carbon atoms.63 There is
significant electronic interaction between the two cPr rings, which can be approximated as
double-bonds,70 meaning that BCP has been described as a ‘bishomobutatriene’.37 This,
and the high HOMO mean that BCP has a uniquely enhanced reactivity towards a wide
range of electrophiles and cycloaddends.37
1.3.2.3 Reactivity
BCP is reactive towards cycloadditions and additions across the double-bond. Due to
the high HOMO, BCP is nucleophilic.32 While most monoalkenes are limited in their
cycloadditions, the uniqueness of BCP is evident in the fact that it undergoes a wider
range of reactions towards cycloaddends, comparable to cross-conjugated polyenes.71 For
example, thermal cyclodimerisations of monoalkenes are rare, but BCP dimerises at high
temperatures.64 Some of the chemistry of BCP is similar to that of cumulenes, namely that
it undergoes high temperature dimerisations and [2+2] cycloadditions with conjugated
dienes.32 This is to be expected from the fact that it is a ‘bishomobutatriene’.
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BCP can be deprotonated easily, leading to the formation of a wide range of substituted
bicyclopropylidenes.37,63 This enhanced kinetic acidity is due not so much to the polarity
of the C–H bond, but rather to the stabilisation of the carbanion.37 BCP can also undergo
reactions in which either the proximal or distal bonds of the cPr rings are cleaved.37,63
1.3.3 Organometallic Chemistry
1.3.3.1 Transition Metal-Catalysed Reactions
Bicyclopropylidene is active in several transition metal-catalysed reactions. These tend
to be analogous to the transition metal-catalysed reactions of methylenecyclopropanes.
To date, the bulk of the catalysis has involved the use of a palladium catalyst, although
there are some examples of nickel-catalysis.37,63
1.3.3.2 Transition Metal-Catalysed Cycloadditions
As with other methylenecyclopropanes, BCP can undergo palladium-catalysed [3+2] cy-
cloadditions as the C3-building block.
72 When reacted with electron-deficient alkenes such
as those in Scheme 1.14, two regioisomers that possess the 4-methylenespiro[2.4]heptane
skeleton are produced.
+
R
CO2Me
[Pd(dba)2]
PiPr2tBu
110 °C, 3 h
MeO2C R R CO2Me
+
(i) (ii)
R Yield % (i):(ii)
H 54 74:26
Me 58 90:10
Ph 81 89:11
Scheme 1.14. Pd-catalysed reactions of BCP with electron-deficient alkenes.72
22
+
EtO2C
CO2Et
[Pd(dba)2]
PiPr2tBu
110 °C, 3 h
EtO2C CO2Et
EtO2C CO2Et
[RhCl(PPh3)3]
2-Butyne
AgOTf
110 °C, 3 h
CO2EtEtO2CCO2EtEtO2C
pyrolysis 
600 °C
[RhCl(PPh3)3]
toluene
110 °C, 5 d
Scheme 1.15. Pd-catalysed reactions of BCP with diethyl fumarate.72
These reactions are regioselective, both with respect to BCP, in that only methylene-
spiro[2.4]heptane derivatives are produced, and with respect to the positioning of the
carboxylate relative to the cPr ring in the product, with 75–90% of the products having
the carboxylate group in the γ-position (Scheme 1.14 (i)). In equivalent reactions with
isopropylidene- and cyclopentylidene cyclopropane, the alkylidene group is retained, while
Pd(0) catalysed reactions of 2-(1-trimethylsilyl-1-cyclopropyl)alkyl pivalate with electron
deficient alkenes give a solvent-dependent distribution of products. Calculations involving
MCP and ethene73 predict that the regioisomers with the carboxylate in the β-position
(Scheme 1.14 (ii)) should be the sole products.72 However, these are the minor products,
with the γ-carboxylate products being favoured. While the mechanism for the product
formation is not completely understood, Scheme 1.16 shows the proposed mechanisms.72
Alternatively, a ‘(trimethylenemethane)palladium’ intermediate with charge separation
could account for the observed regiochemistry.72
In the case of the reaction of BCP with diethyl fumarate (Scheme 1.15), there is
only one possible isomer formed. Several further reactions of this product have been
explored, and the rhodium-catalysed cocyclisation with an alkyne yielding a further seven-
membered ring, the first intermolecular case of this reaction, may have applications in
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M PR"3
R'
CO2R
M
RO2C PR"3
R'
M
CO2R
PR"3R'
CO2RR'
R' CO2R
Scheme 1.16. Mechanisms for the formation of [3+2] cycloaddition products of BCP.72
terpene total synthesis.72
BCP can also undergo palladium(0)-catalysed [3+2] cycloadditions with strained
alkenes such as norbornene and norbornadiene to give products similar to those in
Scheme 1.14 in good yields (Scheme 1.17).72 In the case of nb, there are also a number
of 2:1 nb:BCP cotrimers formed. As BCP is itself a strained alkene, it can also can also
undergo a [3+2] cycloaddition to form a dimer.74 This involves the cleavage of a distal
ring bond (Scheme 1.18).
When a nickel(0) rather than a palladium(0) catalyst is used, the reaction is no
longer a simple [3+2] cycloaddition. When BCP was reacted with diethyl fumarate
under Ni(0)-catalysis conditions, there were three products formed (Scheme 1.19).72
The major product was the [2+2] cycloaddition product (Scheme 1.19 (i)), in 23-46%
yield, depending on the proportion of phosphine used in the catalyst mixture.72 The
[3+2] addition product (Scheme 1.19 (ii)), resulting from distal bond cleavage, was still
produced in 10-25% yield, and a cotrimer, generated by the [3+2] cycloaddition of two
molecules of diethyl fumarate onto the two cPr rings of BCP, with proximal cleavage
(Scheme 1.19 (iii)) was also produced. Nickel(0) can also catalyse the [2+2] cycloaddition
between cyclobutene and BCP to give dispiro[cyclopropane-1,2′-bicyclo[2.2.0]hexane-3′,1′′-
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[Pd(dba)2]
PiPr2tBu
110 °C, 0.5 h
[Pd(dba)2]
PiPr2tBu
110 °C, 0.5 h
+
Scheme 1.17. Pd(0)-catalysed cyclodimerisation of BCP with norbornene and
norbornadiene.72
[Pd(dba)2]
PiPr3
110 °C, 4 h PdLn
Scheme 1.18. Pd(0)-catalysed cyclodimerisation of bicyclopropylidene.74
+
EtO2C
CO2Et
[Ni(COD)2]
P(OC6H42-Ph)3 (1-3 eq.)
110 °C, 0.5 h
CO2Et
CO2Et(i)
EtO2C CO2Et
+ +
CO2Et
EtO2C CO2Et
CO2Et
(ii) (iii)
Scheme 1.19. Ni(0)-catalysed cycloaddition of bicyclopropylidene with diethyl
fumarate.74
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cyclopropane] (Scheme 1.20).37,75 This reaction also produces cycloocta-1,5-diene via the
dimerisation of cyclobutene and subsequent rearrangement.
+ +
[Ni(COD)2], PPh3, C6H6 
20 °C, 0.5 h
Scheme 1.20. Ni(0)-catalysed [2+2] cycloaddition of BCP with cyclobutene.37,75
1.3.3.3 Heck-Type Reactions
BCP undergoes reactions with Heck-type reagents in a similar fashion to methylenecy-
clopropanes. First an organopalladium species adds across the BCP double-bond, after
which one of the cPr rings opens up to a homoallylpalladium species. This then undergoes
β-hydride elimination to yield a cross-conjugated diene (Scheme 1.21).74 While the
resulting diene can be isolated, it is more often used in further reactions, usually Diels-
Alder reactions with a dieneophile.44,74,76 This can lead to a series of domino Heck-Diels-
Alder reactions, creating a range of spiro[2.5]octane derivatives. (Scheme 1.22).63,74 These
reactions tend to be high yielding, and the reactions have been carried out on a robotic
system to generate several small-molecule libraries of compounds.74
RPdX
R
PdX
R R
PdX
Scheme 1.21. The reaction of BCP with Heck-type reagents.74
The domino reaction can be extended to create a variety of carbon skeletons containing
a cyclopropane ring. In the case of the reaction with iodoethene, the cross-conjugated
triene product can undergo two sequential Diels-Alder reactions to give a tricyclic product
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+ ArI +
R1
R2
MeCN, Et4NCl, K2CO3
80 °C, 20 h
Ar R1
R2
[Pd(OAc)2] (5 mol%)
PPh3 (15 mol%)
Ar R1 R2 Yield %
Ph H CO2Me 100
Ph H CO2
tBu 87
Ph CO2Me CO2Me 97
4-Tol CO2Me CO2Me
4-Py H CO2
tBu 81
4-Py CO2Me CO2Me 60
Scheme 1.22. Domino Heck-Diels-Alder reactions of BCP.63,74
(Scheme 1.23).74 When the reaction involves oligoiodoarenes, there is the possibility of
creating up to 12 new C–C bonds in a single synthetic operation in at least 47% yield
(Scheme 1.24).74
+ +
R
[Pd(OAc)2]
PPh3
R1
CO2Me
I
R
CO2MeR
CO2Me
R = H, CO2Me
+
MeO2C
NEt3, DMF
80 °C, 4 h
Scheme 1.23. Domino Heck-Diels-Alder reaction of BCP with iodoethene and
dienophiles.37,75
An alternative sequence of reactions is observed when, instead of undergoing β-hydride
elimination after the formation of the homoallylpalladium species, the intermediate
rearranges to form a pi-allylpalladium species.74 This is favoured by the use of electron-
rich ligands such as trifurylphosphine (TFP), which is known to retard β-hydride
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IIR
1 R2
R2
R1
R2
R1
R1 R2
I
II
R2
R1
R2
R1
R2
R1
H CO2Me
I
II
I
MeO2C CO2Me
CO2MeMeO2C
A,
A,
A,
R1 R2
CO2Me H
CO2
tBu H
CO2Me CO2Me
A = [Pd(OAc)
2
], PPh
3
, MeCN, Et
4
NCl, K
2
CO
3
, 80 ◦C, 2–3 d
Scheme 1.24. Multicomponent domino reactions of BCP.74
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elimination.63 The pi-allylpalladium species can then undergo either inter- or intra-
molecular attack by a nucleophile (Schemes 1.25 and 1.26, c.f. Scheme 1.6).63
+
PdX
PdXXPd
I
+ NuH
Pd(OAc)2, TFP
NEt3, DMSO
80 °C, 24 h
Nu
NuH
Scheme 1.25. Domino reaction of BCP involving a homoallyl- to pi-allyl palladium
rearrangement with an intermolecular nucleophile.63
When BCP is reacted with a Heck catalyst in the absence of another activated alkene,
it undergoes Pd-catalysed isomerisation to form allylidenecyclopropane (Scheme 1.21,
R = H). This then slowly reacts further to form several different dimeric species
(Scheme 1.27).74
1.3.3.4 Bismetallation
As is the case with methylenecyclopropane, bicyclopropylidene can undergo palladium
catalysed bismetallations. In particular, the additions of silyl-containing species, such
as disilanes, silylboranes and silylstannanes, have been studied.77 Disilanes, both
intra- and inter-molecular, can be added across the bond with retention of both
cPr rings (Scheme 1.28).77 The retention of both rings has also been achieved with
silylstannanes (Scheme 1.29).77 Tributyl(trimethylsilyl)stannane adds directly across the
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+I
OH
O
+
[Pd(OAc)2], TFP
NEt3, DMSO
80 °C, 24 h
PdX
PdXXPdHO
OH OH
Scheme 1.26. Domino reaction of BCP involving a homoallyl- to pi-allyl palladium
rearrangement with an intramolecular nucleophile.63
+
+ +
[Pd(OAc)2], PPh3 
C6D6, 80 °C, 20 h
Scheme 1.27. Palladium-catalysed isomerisation of BCP.74
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double-bond to give tributyl[1′-(trimethylsilyl)[1,1′-bicyclopropyl]-1-yl]-stannane. How-
ever, trimethyl(trimethylsilyl)stannane underwent Pd-catalysed disproportionation to
form disilanes and distannanes, and the distannane subsequently added across the double-
bond.77
SiR3
SiMe3
R = Me, Ph
+
SiMe3
R3Si
[Pd(OAc)2]
1,1,3,3-tetramethylbutylisonitrile
Toluene, 70 °C, 3 d
Si
Me2
O SiMe3
R3Si
SiMe2
O
[Pd(OAc)2]
1,1,3,3-tetramethylbutylisonitrile
C6H6, 70 °C, 3 d
Scheme 1.28. Inter- and intra-molecular examples of the addition of a disilane to BCP
with retention of both cPr rings.77
A 
Bu3Sn-SiMe3
SiMe3
Bu3Sn
SnBu3
SnBu3
+
A 
Me3Sn-SiMe3
SnMe3
Me3Sn
SiMe3
SiMe3
+
A = [Pd(OAc)2], 1,1,3,3-tetramethylbutylisonitrile, pentane, 50 °C, 7 d
Scheme 1.29. Pd-catalysed addition of silylstannanes to BCP.77
Bismetallation reactions which involve the cleavage of one of the cPr bonds can also
occur.77 This occurs with disilanes for which at least one of the silanes is halogenated,
as well as for silylboranes and silylstannanes. The reaction seems to initially proceed
by the insertion of a palladium atom into the silyl-metal bond, then by the addition of
this silylpalladium species across the BCP double-bond. In the case where the cPr rings
are retained, the next step is reductive elimination to form the bicyclopropyl products.
However, in most cases, instead of a reductive elimination there is a rearrangement to
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generate a homoallylpalladium intermediate. This intermediate then undergoes reductive
elimination to generate the ring-opened products (Scheme 1.30). It is thought that the
deciding factor as to whether the product is the ring-opened or ring-retained product is the
electrophilicity of the organopalladium species formed by the addition of the silylpalladium
species across the double-bond (Scheme 1.30 (i)), with more electrophilic species favouring
the ring-opened product.77
SiMe2R
X
+
SiMe2R
PdLnX
RMe2Si
PdLnX
SiMe3
X
RMe2Si
X
X = SiR3, SnR3 X = SiR3, SnR3, B(OR)2, CN
PdLn
50-130 °C
12 hr-14 d
R = F, Cl, Me, Ph
(i)
Scheme 1.30. Mechanism for the Pd catalysed bismetallation of BCP.77
1.3.3.5 Transition Metal Complexes
To date, there have been only two isolated transition metal complexes which have
bicyclopropylidene as a ligand in η2-coordination.58 Most of the organometallic research
involving BCP thus far has been focused on its behaviour in metal-catalysed reactions,
rather than on the organometallic intermediates themselves. BCP has the potential to be
a good ligand towards transition metals for a number of reasons. The high-lying HOMO
means that it should be able to effectively donate electron density into the empty metal
orbitals. Also, as it is a highly strained system, it should be able to accept back-bonding,
stabilising the system by alleviating ring strain upon complexation.
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The first transition metal complex of BCP was made from a bis(cyclopentadienyl)-
bis(trimethylphosphine)titanium(II) precursor by reaction with BCP in pentane
(Scheme 1.31).58 The product with ligated BCP was obtained as a green solid in
79% yield. The precursor complex was chosen because titanocene complexes with alkene
ligands are known 16-electron species. As such, if a BCP ligand was prone to ring-opening
by oxidative addition, it would be likely to happen in this complex.58 The isolation of
this BCP complex shows that this does not happen with titanium.
Ti
Cp
Cp
Ti
Cp
Cp
PMe3
PMe3
Pentane
-18°C
79%
Scheme 1.31. Synthesis of the first Ti complex of BCP.58
The second BCP complex was made by reacting ((2-(di-tert-butylphosphanyl)-P-
ethyl)cyclopentadienyl)chlorocobalt(II) ([CoCl(Cp#)]) with sodium amalgam and BCP
(Scheme 1.32).58,59 The Cp# ligand prevents potential oligomerisation reactions because
the phosphine arm wins competition for the coordination site, preventing the complexation
of another ligand and therefore reaction with the existing BCP ligand.58
Co
P
Co Cl
P
Na/Hg
-50 to 20 °C
83%tBu2 tBu2
Scheme 1.32. Synthesis of the first Co complex of BCP.58,59
The X-ray crystal structure of the [Co(Cp#)(BCP)] complex (Figure 1.6)58 shows
that the cPr rings of the BCP ligand are bent away from the double-bond by 40◦. This
and the increase of the length of the double-bond to 1.401 Å indicate that there is a high
degree of back bonding, as predicted. The percentage change in the bond length upon
complexation is greater in the case of BCP (7.4%) than for free ethene (5.0%), implying
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a greater degree of back bonding to BCP.78 As the character of the double-bond carbon
atoms has become more sp3-like, the proximal bonds in the two cPr rings have shortened
from 1.544 to 1.499 Å.
Figure 1.6. X-ray crystal structure of [Co(Cp#)(BCP)].58
These two complexes show that BCP is a good ligand toward transition metals. As
such, there is much potential for the synthesis of complexes containing this ligand with
other transition metals. As there is a dearth of isolated η2-alkene complexes of both BCP
and MCP, the initial focus of this project was on the synthesis of platinum complexes
with these ligands. The reactivity of these complexes was then investigated. During the
exploration of the reactivity of BCP and MCP towards platinum, a range of reactivity
patterns were observed. Complexes with ligands derived from these reactions were also
synthesised.
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Chapter 2
Platinum(0) Phosphine Complexes
The reactions of methylenecyclopropane and bicyclopropylidene with Pt(0) alkene
complexes produced η2-MCP and BCP complexes. Complexes with both mono- and
di-phosphine auxillary ligands were synthesised. BCP underwent a ring-opening reaction
to form the 1,3-diene allylidenecyclopropane, and the coordination chemistry of ACP was
explored.79
2.1 [Pt(L)(P—P)] Complexes
A range of Pt(0) complexes containing chelating diphosphines as auxiliary ligands
were chosen as precursors. These complexes were chosen because chelating phosphines
not only stabilise transition metal complexes, particularly those in low oxidation
states, but also allow the coordination of only one alkene ligand, thus preventing
possible oligomerisation reactions. The diphosphines used in this research were
1,3-bis(diphenylphosphino)propane (dppp), 1,2-bis(dicyclopentylphosphino)ethane
(dcyppe), 1,2-bis(di-tert-butylphosphino)ethane (dbpe) and 1,2-bis[(di-tert-
butylphosphino)methyl]benzene (dbpx), representing a variety of electronic properties
and backbone sizes (Figure 2.1).
As discussed in Section 1.1.3, one of the ways of synthesising alkene complexes is
by the displacement of another ligand such as another alkene. Ethene complexes were
chosen as suitable precursors due to the ease of displacement of the ethene ligand as well
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P P
P P
P
P
P
P
dppp dcyppe
dbpe dbpx
Phosphine θ (◦) ν (cm−1)
dppp 127 2067 (PPh2Et)
dcyppe * *
dbpe 11580 2058 (PEttBu2)
dbpx 13881 2060 (P(o-tol)tBu2)
θ = Tolman cone angle. Calculated from the cone formed between the metal and the outer
hydrogens of the ligand with an M–P bond length of 2.28 Å.82
ν = Tolman electronic parameter. Calculated from the C−−O stretching frequency in
[Ni(CO3)(L)].
82
* No data available.
Figure 2.1. Structures and properties of diphosphine ligands.82
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as the simplicity of the NMR spectra of both the free and the coordinated alkene, which
facilitated the monitoring of the reactions. Free ethene is observed at δH 5.2 and δC
123 ppm, while the resonances of coordinated ethene occur at approximately δH 2–3 ppm
and δC 20–30 ppm.
A range of methods were used to synthesise the various ethene complexes, with the
choice of method dictated by the diphosphine ligand. The complexes [Pt(C2H4)(dbpe)]
and [Pt(C2H4)(dbpx)] were synthesised by adding adding the appropriate diphosphine
to [Pt(C2H4)3], generated in situ from [Pt(COD)2].
83 This method was unsuitable for
the synthesis of [Pt(C2H4)(dppp)], as the coordination of a second dppp ligand to form
[Pt(dppp)2] is very facile. Instead, the ethene complex was generated by the reduction of
[PtCl2(dppp)] under an ethene atmosphere using NaBH4.
While the reaction of dcyppe with [Pt(C2H4)3] yielded [Pt(C2H4)(dcyppe)], problems
with purification meant that this was not a viable synthetic method. Reduction
with NaBH4 was attempted, but was not successful. Instead, [Pt(C2H4)(dcyppe)] was
synthesised by the reduction of [PtCl2(dcyppe)] using sodium amalgam. Complexes of 1,2-
bis(diphenylphosphino)ethane (dppe) were considered, as these would have made a good
comparison for the dppp complexes. However, [Pt(C2H4)(dppe)] could not be synthesised
from [Pt(C2H4)3] due to the facile formation of [Pt(dppe)2], while reduction methods
yielded only [Pt3H3(dppe)3]
+. [Pt3H3(dppe)3]
+ forms because the intermediate hydride
complex in the reduction reaction is dimeric for dppe, rather than monomeric as for
dppp.84,85 While the synthesis of [Pt(C2H4)(dppe)] using sodium naphthalenide has been
reported,86 this method did not involve the isolation of the pure ethene complex, which
meant that this synthesis was not suitable for the NMR-scale studies undertake here.
Methylenecyclopropane was made by the reaction of methallyl chloride with sodium
amide and potassium tert-butoxide (Scheme 1.2 (ii)),28 while the synthesis of bicyclo-
propylidene made use of the Kulinkovich reaction to produce cyclopropylcyclopropanol
from methyl cyclopropanecarboxylate, which was then converted to the bromide followed
by dehydrobromination to produce the alkene (Scheme 1.13).67 Whereas BCP is an easily
handled liquid, MCP is a gas at room temperature, with a boiling point of 10 ◦C. For this
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research, it was generally deemed most practical to use MCP by cooling a glass syringe in
the freezer and then rapidly inject a small amount of the liquid alkene into the reaction
vessel. However, standard solutions in both C6D6 and CDCl3 were occasionally used.
Carbon-13 enriched bicyclopropylidene was synthesised in order to increase the
sensitivity of the double-bond carbons toward 13C NMR spectroscopy (Scheme 2.1).
First, cyclopropanecarboxylic acid was synthesised using a Grignard reagent formed from
cyclopropyl bromide and CO2 generated from BaCO3 (70%
13C). This was then converted
to methyl cyclopropanecarboxylate using methyl iodide and DBU.87 The cPrCOOMe was
then diluted with the carbon-12 variant to 12% enrichment of carbon-13, and the BCP
synthesis continued as previously. The overall yield of this process was 0.8% based on
BaCO3. This was both due to the small scale of the
cPrCOOMe to BCP synthesis (the
yield of this stage was 7%, compared to 27% for larger scale) and to difficulties in the
cPrCOOH synthesis. While the literature method reported yields of 82% for the synthesis
of cPrCOOH, it was not possible to obtain yields of greater than 30%.88
Br
i) Mg, THF
ii) Ba13CO3
H2SO4 OH
O
13 MeI
C6D6
DBU
19%
OMe
O
13
63%
13
7%
Scheme 2.1. Synthesis of carbon-13 enriched bicyclopropylidene.
BCP and MCP complexes were synthesised via the displacement of the ethene ligand
from the precursor complexes. This was done by dissolving the ethene complex in either
toluene or d6-benzene and adding an excess of the appropriate alkene, producing the
diphosphine complexes [Pt(BCP)(P—P)] (P—P = dppp (1a), dcyppe (1b), dbpe (1c)
and dbpx (1d)) and [Pt(MCP)(P—P)] (P—P = dppp (2a), dcyppe (2b), dbpe (2c) and
dbpx (2d)) (Scheme 2.2).
The formation rates of the complexes were found to depend on both the size of the
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P
P
Pt
P
P
P-P = dppp
       = dcyppe
       = dbpe
       = dbpx
C6D6
5 min, RT
12 hr, RT
7 d, 60 °C
6 d, 60 °C
1
1a
1b
1c
1d
Pt
P
P
Pt
P
P
P-P = dppp
       = dcyppe
       = dbpe
       = dbpx
5 min, RT
12 hr, RT
12 hr, 40 °C
12 hr, 60 °C
C6D6
2
2a
2b
2c
2d
Scheme 2.2. Synthesis of [Pt(BCP)(P—P)] (1) and [Pt(MCP)(P—P)] (2).
alkene and the size of the diphosphine ligand. MCP, with only one cPr ring, coordinated
more rapidly than BCP, with two rings. The steric bulk of the substituents on the
phosphine ligands had a more significant effect on the formation rates. Complexes of dppp
formed most rapidly, with the reaction occurring almost instantly at room temperature.
Complexes of dcyppe reacted more slowly, forming overnight at room temperature. Both
of the tBu phosphine complexes required heating, at 40 and 60 ◦C overnight for 2c and
2d, respectively, and for up to 7 days for 1c and 1d. The dependence of reaction rate on
steric bulk points to an associative rather than dissociative exchange mechanism.
X-ray quality crystals of 1a were grown by recrystallisation from hot toluene, and
an X-ray crystal structure was obtained (Figure 2.2, Table 2.1). The BCP C=C bond
length increased from 1.304(2) Å in the free alkene to 1.427(3) Å in 1a, an increase of
9.4%.30 This was greater than the 7.4% increase observed for [Co(Cp#)(BCP)], which
had a C=C bond length of 1.401(5) Å.59 The bond length of 1a was closer to that of
the comparable C–C bond in bicyclopropyl (1.487(4) Å, differing from 1a by 0.06 Å)
than to the C=C bond length of free BCP (differing from 1a by 0.123 Å).89 The two cPr
rings in 1a were bent by 36.02◦ and 37.14◦ away from the plane of the double-bond. The
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corresponding angles in the cobalt complex were 39.33◦ and 41.04◦, while in bicyclopropyl
the rings were at 54.72◦ to the central C–C bond. There was a decrease in the cPr
ring angle centered on the double-bond carbon atom from 63.3(1)◦ to 61.40(14)◦ and
61.37(15)◦ upon coordination and a concomitant shortening of the distal ring bond from
1.539(2) Å to 1.516(3) and 1.519(3) Å. This effect was greater in the Co complex, with
angles and distal bond lengths of 61.15◦ and 1.499(12) Å, respectively. The increase in the
C=C bond length, the out-of-plane bend of the cPr rings, and the shortening of the ring
bond and angle were all indicative of the large degree of back-donation and subsequent
rehybridisation of the double-bond carbon atoms upon coordination.8,59
Figure 2.2. ORTEP diagram of [Pt(BCP)(dppp)] (1a) showing 50% probability
thermal ellipsoids. H atoms have been omitted for clarity.
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Table 2.1. Crystallographic Data for [Pt(BCP)(dppp)] (1a).
Chemical formula C33H34P2Pt
Formula weight 687.63
a, Å 16.8042(6)
b, Å 9.6338(3)
c, Å 17.7241(6)
α, deg 90.00
β, deg 106.904(2)
γ, deg 90.00
V, Å3 2745.35(16)
Z 4
Space group P21/n
T, K 119.0
λ, Å 0.71073
Dcalcd, g cm−3 1.664
µ, mm−1 5.248
R1, [I> 2σ(I)]a 0.0252
wR2 (all data)a 0.0502
a Definition of R indices: R1
= Σ||Fo|−|Fc||/Σ|Fo|; wR2 =
[Σw(Fo
2
−Fc
2)2/Σw(Fo
2)2]
1/2
.
The dppp backbone adopted a chair conformation, with a P–Pt–P angle of 96.762(19)◦.
A search of the Cambridge Crystallographic Database in March 2011 showed that of 81
dppp complexes with one or two platinum atoms, 86% adopted a chair and 9% adopted a
boat conformation, while 5% were not sufficiently resolved to determine the conformation.
Four of the 81 complexes were Pt(0) species, and of the four, three were trigonal planar
complexes. All four Pt(0) complexes had dppp in a chair conformation.90–92 These
complexes had P–Pt–P angles of 90.99–97.76◦, with that of 1a falling at the top end
of the range.
2.1.1 NMR Characterisation
For representative NMR spectra, see Figures A.1–A.11. The magnitude of the platinum–
phosphorus 1JPt–P coupling constants in the 31P{1H} NMR spectra of 1 and 2 showed that
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the alkenes were in η2-coordination. In the BCP complexes, 1JPt–Pvalues were between
2731 and 2983 Hz (Table 2.2), ∼450 Hz less than those in the parent ethene complex. The
31P{1H} NMR spectra of 2 had second-order ABX (A, B = 31P, X = 195Pt) peak patterns
due to the unsymmetrical alkene and the rigid coordination geometry (Figure 2.3 (i)).
The 1JPt–Pvalues could be used to distinguish the P trans to the cPr group from that of
the P trans to the methylene in the MCP complexes, as the two coupling constants were
comparable to those of 1 and the parent ethene complexes, respectively.
The 13C{1H} NMR spectra also clearly showed that the alkenes were in η2-
coordination. The cyclopropyl double-bond carbons showed large 1JPt–C values,
410–456 Hz for 1 and 455–538 Hz for 2 (Table 2.2), while the methylene carbon in
2 had 1JPt–C several hundred Hz less (164–173 Hz). There was also a large upfield shift
of the cPr double-bond carbon resonances upon coordination, from 110.6 to 29–34 ppm
for 1 and from 131.0 to 33–43 ppm for 2. The methylene carbon was typically ∼15 ppm
upfield of the cPr carbon, expect for in 2d, where the difference was only 5.8 ppm. For
comparison, the methylene chemical shift differed from that of the parent ethene ligand
by 0.6–6.6 ppm. A stronger Pt–C bond is formed to the cyclopropyl carbons in 1 and 2
than to the methylene carbons in 2 and the parent ethene complexes. This is evidenced
by the lower 1JPt–P of the P trans to the cyclopropyl carbons and the higher 1JPt–C
coupling constants of these carbons and is a result of the decrease in strain energy of the
cPr rings by rehybridisation upon coordination.8,93–97
For the double-bond carbons in 1, the line shape was characteristic of a “false AA′X”
spin system (A, A′ = 31P, X = 13C) with 195Pt satellites due to both the magnetic
inequivalence of the two chemically equivalent carbons when one was 13C and to the two
31P atoms having the same chemical shift (Figure 2.3).98,99 The double-bond carbons in
2, however were ABX systems with 195Pt satellites, as the two 31P atoms were in different
chemical environments.99 These 13C NMR peaks, and the 31P NMR spectra of 2, indicate
that the alkene ligands do not rotate at room temperature when coordinated, as rotation
would result in the two 31P atoms becoming equivalent.
The endo/exo geometry of the cPr protons in 1a and 2a (Figure 2.4) was assigned
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(i)
(ii)
Figure 2.3. (i) 31P{1H} NMR spectrum of [Pt(MCP)(dppp)] (2a) (125 MHz, RT,
40 mg/mL, C6D6). (ii)
13C{1H} NMR spectrum of [Pt(BCP)(dppp)] (1a) (150 MHz,
RT, 40 mg/mL, C6D6). * signifies peaks belonging to other species.
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Table 2.2. Selected NMR Data of [Pt(L)(P—P)].a
Compound δP
1
JPt–P
2
JPt–P
cPr =CHR =CR
2
δH JPt–H δC JPt–C δH
2
JPt–H δC
1
JPt–C δC
1
JPt–C
BCP 1.18 3.3 110.6
MCP 0.90 2.9 5.46 103.5 131.1
ACP 0.93 2.6 6.53 136.9 129.3
0.85 2.3
[Pt(BCP)(dppp)] 1a 9.3 2932 1.29 66.0 8.8 23.1 34.3 410.8
1.18 37.7
[Pt(BCP)(dcyppe)] 1b 70.8 2731 1.5–1.4 b 10.4 23.1 33.8 424.6
[Pt(BCP)(dbpe)] 1c 97.4 2798 1.57 b 9.9 23.7 31.8 428.9
1.31 b
[Pt(BCP)(dbpx)] 1d 43.3 2983 1.34 61.2 9.9 22.5 29.3 456.3
0.99 32.0
[Pt(BCP)(P—S)] 8 54.9 3383 b b 9.0 trans P 28.1 579.0
8.7 trans S 25.2 656.6
[Pt(MCP)(dppp)] 2a 11.7 3275 42 trans =CH
2
1.65 33.0 10.1 25.9 2.63 65.3 25.3 173.4 42.7 455.4
11.4 2975 trans =CR
2
1.32 82.5
[Pt(MCP)(dcyppe)] 2b 75.0 2751 63 trans =CR
2
1.95 b 12.3 23.0 2.40 60.5 22.4 169.0 38.3 501.0
70.8 3107 trans =CH
2
1.80 b
[Pt(MCP)(dbpe)] 2c 100.8 2807 66 trans =CR
2
1.89 33.6 11.8 24.5 2.39 60.6 23.5 171.6 36.8 511.4
99.2 3167 trans =CH
2
1.79 60.0
[Pt(MCP)(dbpx)] 2d 49.3 3362 30 trans =CH
2
1.60 b 11.4 25.0 2.12 56.2 27.8 164.2 33.6 537.6
43.7 3025 trans =CR
2
1.60 b
[Pt(MCP)(P—S)] 9a 58.8 3870 trans =CH
2
1.45 b 10.5 30.1 2.05 52.7 26.3 145.1 b b
1.37 b
[Pt(MCP)(P—S)] 9b 55.3 3483 trans =CR
2
1.59 10.0 24.8 2.38 82.1 25.7 270.6 b b
1.50
[Pt(ACP)(dppp)] 3a 10.3 3293 39 trans =CHR 1.3–0.8 b b b 3.78 67.8 b b b b
9.7 3003 trans =CR
2
[Pt(ACP)(dcyppe)] 3b 70.0 3153 −59 trans =CHR b b b b 3.41 62.1 b b b b
68.6 2771 trans =CR
2
[Pt(ACP)(dbpe)] 3c 96.4 2848 62 trans =CR
2
1.5 b 10.6 17.7 3.43 62.0 44.7 165.5 41.4 533.1
96.4 3196 trans =CHR 1.0 b 9.5 15.5
[Pt(C
2
H
4
)(dppp)] 13.8 3340 2.68 60.0 31.9 216.0
[Pt(C
2
H
4
)(dcyppe)] 75.4 3170 2.38 58.0 23.2 227.4
[Pt(C
2
H
4
)(dbpe)] 102.5 3230 2.41 59.4 25.0 229.0
[P(C
2
H
4
)(dbpx)] 50.1 3493 2.20 57.3 27.2 217.0
a δ values are given in ppm and J values in Hz. All spectra were measured in C
6
D
6
at room temperature with 40 mg/mL sample. b NMR data
could not be obtained.
44
using 1D NOESY correlations. When each proton resonance was selectively excited, those
due to the endo protons showed correlations to the o-C6H5 protons on the phosphine
substituents, as well as to the other cPr protons, while the exo protons only correlated to
the cPr protons. It was also found that the endo protons had significantly higher JPt–H
couplings (∼60 vs. ∼30 Hz), allowing the geometry of other complexes to be assigned by
analogy.
Pt
P
P
Hexo
Hendo
Hexo
Hendo
Figure 2.4. Geometry of the endo/exo protons in [Pt(BCP)(P—P)] (1).
Due to the complex nature of the 31P NMR spectra of 2 and the 13C NMR resonances
of the double-bond carbons of 1, the NMR modelling program gNMR was used to obtain
chemical shift and coupling constant data reported in Table 2.2.
2.2 Allylidenecyclopropane
It was found that when BCP reacted with [Pt(C2H4)3], a ring-opening reaction occurred
to form the 1,3-diene, allylidenecyclopropane (ACP) (Scheme 2.3). This reaction also
occurred with [Pt(COD)2], [Pt(nb)3], [PtMe2(1,5-hexadiene)] and [PtEt2(COD)]. One
previous instance of the formation of ACP from BCP has been reported, occurring in the
reaction of BCP with [Pd(OAc)2] and PPh3.
74 The proposed mechanism for this reaction
involved the addition of a palladium hydride across the BCP double-bond, followed by a
cyclopropylmethyl to homoallyl rearrangement and terminated by β-hydride elimination.
Under the reported conditions, ACP went on to react with another molecule of BCP to
form various oligomers (see Scheme 1.21, R = H). However, no oligomerisation reactions
were observed with the above Pt complexes, even after several days at 60 ◦C.
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[Pt]
Scheme 2.3. Synthesis of allylidenecyclopropane from bicyclopropylidene.
As there were no published reports of any transition metal chemistry with ACP,
the formation of Pt-diphosphine complexes containing ACP ligands was investigated.
A solution of ACP was produced for these reactions by dissolving a few crystals of
[PtMe2(1,5-hexadiene)] in either CDCl3 or C6D6 under inert atmosphere and adding a
small amount of BCP. The reaction could then be monitored by NMR spectroscopy for
completion, typically reaching ∼95% after 5 days. The solution was then used without
further purification.
The first transition metal complexes of allylidenecyclopropane (3a and 3b) formed
immediately upon addition of the ACP solution to the parent ethene complex
[Pt(C2H4)(P—P)] (P—P = dppp, dcyppe) (Scheme 2.4). ACP could also be generated
in situ from small amounts of [Pt(COD)2], and the addition of BCP and [Pt(COD)2] to
solutions of [Pt(C2H4)(dbpe)], followed by heating at 40
◦C, was used to synthesise 3c
(Scheme 2.5). With 10% [Pt(COD)2] present, the reaction reached 97% completion
after heating overnight. The formation of 3c still occurred when no detectable
[Pt(COD)2] was present; however, this reaction only reached 88% completion after
13 days. [Pt(ACP)(dbpx)] could not be synthesised, likely due to the steric bulk of the
phosphine ligand making coordination of the alkene unfavourable.
Pt
P
P
Pt
P
P
P-P = dppp
       = dcyppe
C6D6
RT, 5 min
3
3a
3b
Scheme 2.4. Synthesis of [Pt(ACP)(P—P)] (3).
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Pt Pt[Pt(COD)2]
C6D6
12 hr, 40°C
P
P
P
P
tBu2
tBu2
tBu2
tBu2
3c
Scheme 2.5. Synthesis of [Pt(ACP)(dbpe)] (3c).
It was found that when both ACP and BCP were present in the reaction mixture,
ACP complexes formed initially. However, the ACP ligand in 3a was slowly displaced
by BCP over several hours at room temperature to form 1a. For the dbpe complexes,
3c was the only product at 40 ◦C, while at 60 ◦C, 3c formed initially, before continued
heating over several days produced 1c. It was unclear whether this would also happen
for the dcyppe complexes, as 3b underwent a rearrangement that reached completion too
rapidly for displacement to occur (see below), although it is considered likely. From this
we infer that the complexes of the less bulky ACP were the kinetic products, while the
BCP complexes, which had a degree of extra stabilisation afforded by alleviation of strain
in the second cyclopropyl ring, were the thermodynamic products.
Complexes 3a and 3b were unstable in solution, undergoing a rearrangement to form
the metallacyclic complexes 4a and 4b (Scheme 2.6). The rearrangement proceeded more
rapidly for the dcyppe complex 3b, with significant amounts of 4b present within 5 min
of addition of the ACP solution and the reaction proceeding to completion after 3 hr. For
the dppp complex 3a, the metallacycle appeared in the 31P{1H} NMR spectroscopy after
3 hr, reaching 96% completion after 7 days.
The formation of metallacyclo-3-pentenes from 1,3-dienes is well established. There are
two possible binding modes for these ligands: the η4:σ2,pi mode, where the double-bond
is also coordinated to the metal, common for early transition and actinide metals,100–102
and the planar η2:σ2 mode. Planar metallacyclopentene complexes are considered to be
intermediates in ring-flipping mechanisms of η4-diene complexes,103 and complexes with
η2:σ2-metallacyclopentene ligands formed from various 1,3-dienes have been reported for
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Pt
P
P
P-P = dppp
       = dcyppe
P-P = dppp
       = dcyppe
C6D6
RT
3 hr
7 d
3
3a
3b
4
4a
4b
Scheme 2.6. Rearrangement of [Pt(ACP)(P—P)] (3a) to form metallocyclopentene
complexes
Fe,104,105 Co,106 Mo107 W,107 Rh,103,108–110 Ir,111–114 Pt,103,115 Ge,116 and Mg.117
The rearrangements of 3 to 4 appear to be the first instances of the formation of
η2:σ2-metallacyclopentene complexes from η2:pi-diene complexes. Previously reported
η2:σ2-metallacyclopentenes were formed either directly upon addition of the 1,3-diene
to a metal precursor103–105,108–110,115–117 or by rearrangement of an η4:pi-diene complex,
generally initiated by the addition of a species such as a Lewis base.106,107,113,114
2.2.1 NMR Characterisation
2.2.1.1 Allylidenecyclopropane Complexes
All ACP complexes exhibited second-order ABX 31P{1H} NMR spectra similar to the
corresponding MCP complexes, with 1JPt–P couplings for both phosphine environments
within 40 Hz of those in 2 (Table 2.2). The 1H NMR signal of the internal double-
bond proton showed a large upfield shift from 6.6 ppm in free ACP to 3.4–3.8 ppm in 3
(Table 2.3). The magnitudes of the 2JPt–H coupling constants of these protons, 62–68 Hz,
were typical of coordination through this bond. The protons of the terminal double-bond
have chemical shifts much closer to those in the free alkene. Both the 1H and the 31P
NMR data indicated that ACP was coordinated via the internal rather than the terminal
double-bond. This is to be expected given the stabilisation afforded by the alleviation of
ring strain in the cPr upon coordination.
The 1JPt–C coupling constants of the internal double-bond carbons of 3c further
indicated that the alkene had coordinated via this bond. The coupling constant for
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Table 2.3. 1H and 13C{1H} NMR Data of [Pt(ACP)(P—P)].a
Compound
δH δC
cPr =CH
2
terminal =CHR internal =CHR cPr =CH
2
terminal =CHR internal =CHR =CR
2
ACP 0.93 5.18 6.49 6.58 2.6 115.2 120.2 136.9 129.3
0.85 5.05 2.3
[Pt(ACP)(dppp)] 3a 1.3–0.8 5.04 6.47 3.78 b b b b b
4.69 2JPt–H = 67.8 Hz
[Pt(ACP)(dcyppe)] 3b b 4.85 6.11 3.41 b b b b b
4.37 2JPt–H = 62.1 Hz
[Pt(ACP)(dbpe)] 3c 1.5 4.98 6.20 3.43 10.6 102.7 147.5 44.7 41.4
4.64 2JPt–H = 62.0 Hz 9.5
a δ values are given in ppm and J values in Hz. All spectra were measured in C
6
D
6
at room temperature with 40 mg/mL sample. b NMR
data could not be obtained.
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the cyclopropyl carbon was 533 Hz, while that of the methyne was 166 Hz, both of which
were within 20 Hz of the corresponding value for 2c (Table 2.2). The chemical shifts of
the carbons of the terminal double-bond were also much closer to those of the free alkene
than the internal double-bond carbons (Table 2.3). In 3c, the double-bond carbons had
an AA′X coupling pattern with 195Pt satellites similar to those of the BCP complexes.
This was due to the two phosphorus atoms in this complex coincidentally having the
same chemical shift.99 The effect could be seen throughout the carbon spectrum, with
all of the resonances of the ACP ligands in 3a and 3b would have ABX spectra (with
195Pt satellites) similar to the corresponding MCP complexes, as the phosphorus atoms
have different chemical shifts. However, due to the short lifetimes of these complexes, 13C
NMR data could not be obtained.
2.2.1.2 Metallocyclopentene Complexes
For representative NMR spectra, see FIgures A.12–A.15. The NMR data of 4 were consis-
tent with a planar η2:σ2-metallocyclopentene structure. The 1JPt–P coupling constants of
4 (1784–1856 Hz) were comparable to those of [Pt(CH2CPh−CCHC−CMe2)(dppe)] (1818
and 1842 Hz), which showed that there were Pt–C σ-bonds in 4.103 In the previously
reported Pt metallacycles, the CH2 groups directly bonded to the metal had δH at
2.8–3.2 ppm with 2JPt–H = 68–92 Hz and δC at 31–41 ppm with 1JPt–C = 603–787 Hz,103,115
while the Ir metallacycles had 2.4–3.0 and −2–13 ppm for δH and δC, respectively.113 The
NMR data of both the Pt–CH2 groups (δH = 2.9–3.2 ppm,
2JPt–H = 62–73 Hz, δC =
29–39 ppm, 1JPt–C = 297–450 Hz) and the Pt–CR3 groups (δC = 32-33 ppm,
1JPt–C =
959 Hz for 4b) in 4 agree well with the literature. The NMR data of the double-bond
carbons and their attached protons (δH = 5.3–6.4 and δC = 131–154 ppm) also compared
favourably to the literature values (δH = 5.0–5.6 and δC = 135.9–151.3 ppm).103,113,115
2.3 [Pt(L)2(PR3)] Complexes
Precursor complexes containing two ethene ligands and one phosphine ligand were also
investigated. Bis-ethene complexes were chosen due to the possibility that oligomerisation
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or isomerisation reactions similar to the formation of ACP from BCP might occur.
Complexes of the type [M(L)(BCP)(PR3)] (M = Ni, Pd, L = electron-deficient alkene, PR3
= tert-butyldiisopropylphosphine, tris(o-phenylphenyl)phosphite) have been proposed as
intermediates in the palladium- and nickel catalysed [3+2] co-cyclisation of BCP with
various alkenes, but were not isolated (see Scheme 1.16).72 Bis-BCP complexes have also
been postulated to be intermediates in nickel-catalysed [3+2+2] co-cyclisations.118
Bis-ethene precursor complexes [Pt(C2H4)2(PR3)] (PR3 = PPh3, PCy3) were synthe-
sised by addition of the appropriate phosphine (Figure 2.5) to [Pt(C2H4)3].
119 When BCP
was added to [Pt(C2H4)2(PR3)], the product was [Pt(C2H4)(BCP)(PR3)] (PR3 = PPh3
(5a), PCy3 (5b)) (Scheme 2.8). For the bulkier PCy3, complex 5b was stable with an
excess of BCP. However, 5a was stable in solution only when 1 equiv. of BCP was used.
When more than 1 equiv. was used, [Pt(BCP)(PPh3)2] began to form after 40 min and
was the only phosphine-containing product after 24 hr. No other platinum-containing
species were identified. The formation of a bis-BCP complex did not occur with either of
the phosphines used in this work. This was likely due to the steric constraints of having
the two alkenes in a planar coordination geometry as occurs with platinum(0).2
PtR3P PtR3P PtR3P+
= PPh3  
= PCy3 
PR3= PPh3  
= PCy3 
PR3
C6D6
5 min, RT
6
6a
6b
7
7a
7b
Scheme 2.7. Synthesis of [Pt(MCP)(C2H4)(PR3)] (6) and [Pt(MCP)2(PR3)] (7).
Despite the large excesses of MCP used, both the mixed alkene [Pt(C2H4)(MCP)(PR3)]
(PR3 = PPh3 (6a), PCy3 (6b)) and the bis-MCP complexes [Pt(MCP)2(PR3)] (PR3 =
PPh3 (7a), PCy3 (7b)) were always formed in a closed system (Scheme 2.7). The bis-
MCP complexes 7 are the first examples of Pt-MCP complexes with more than one MCP
ligand. When PPh3 was used, the product ratio was 80:20 bis-MCP:mixed alkene. The
ratio changed to 30:70 in favour of the mixed complex when PCy3 was used, with the
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PP
PPh3 PCy3
Phosphine θ (◦) ν (cm−1)
PPh3 145 2069
PCy3 170 2056
θ = Tolman cone angle. Calculated from the cone formed between the metal and the outer
hydrogens of the ligand with an M–P bond length of 2.28 Å.82
ν = Tolman electronic parameter. Calculated from the C−−O stretching frequency in
[Ni(CO3)(L)].
82
Figure 2.5. Structures and properties of monophosphine ligands.82
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PtR3P PtR3P
(5a)
Pt
Ph3P
Ph3P
= PPh3  
= PCy3 
PR3
C6D6
5 min, RT
24 hr 0.5
5
5a
5b
Scheme 2.8. Synthesis of [Pt(BCP)(C2H4)(PR3)] (5).
bulkier phosphine hindering but not preventing the coordination of the second MCP
ligand. When ethene was allowed to diffuse out of the reaction, complex 7a was formed
in 90% yield. Yields could be improved and complex 7b formed selectively when inert
gas was bubbled through the reaction mixture. The mixed alkene complexes 6 became
the major products when ethene was bubbled through the solution. However, the mixed
alkene complexes were much less stable than the bis-MCP complexes, as large amounts of
ethene regenerated the bis-ethene complexes, while in the presence of free MCP, 7 formed.
Figure 2.6. ORTEP diagram of [Pt(MCP)2(PPh3)] (6a) showing 50% probability
thermal ellipsoids. H atoms have been omitted for clarity.
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X-ray quality crystals of 7a were grown from cold hexane (Figure 2.6, Table 2.4).
The MCP carbon–carbon double-bond length was increased by 5.7% upon coordination,
from 1.332(1) Å in free MCP to 1.408(5) Å in 7a.29 In [Rh(acac)(MCP)2], the only
other MCP complex characterized by X-ray diffraction, the bond lengths were 1.405(19)
and 1.440(19) Å, representing increases of 5.4% and 8.1%, respectively. The increase
in MCP bond length upon coordination was much greater than the 1.5% increase in
ethene C=C bond length in the related complex [Pt(C2H4)(C2F4)(PCy3)], the only
other [Pt(alkene)2(PR3)] complex with an X-ray crystal structure.
120,121 The C2F4 bond
increased by 10.0% upon coordination.122 The cyclopropyl rings in 7a were bent by 35.49◦
and 35.86◦ away from the plane of the double-bond, a greater angle than those in the Rh
complex (26.48◦ and 27.79◦). Given the strain of the cPr ring, it would be expected that
there was a stronger bond from the platinum to the ring double-bond carbon than to the
methylene carbon. This was evidenced by the shorter Pt–C distance to the cPr carbon
(2.087(3) and 2.093(3) Å) than to the methylene (2.130(3) and 2.123(3) Å). The Pt–P
bond length was 2.3028(7) Å, shorter than that in [Pt(C2H4)(C2F4)(PCy3)], which had a
Pt–P distance of 2.343(2) Å.
2.3.1 NMR Characterisation
For representative NMR spectra, see Figures A.20–A.25. The double-bond carbons of the
BCP ligands in 5 had similar chemical shifts (29–30 ppm) and 1JPt–C (431–483 Hz) to
those in 1, indicating that the ligands were in η2-coordination (Table 2.5). The 1JPt–P
coupling constants in both mixed alkene complexes were ∼330 Hz lower than those of the
parent bis-ethene complexes, showing the same decrease in 1JPt–P upon coordination of
BCP as was seen for the diphosphine complexes.
The mixed ethene–MCP complexes 6 had 1JPt–P couplings within 10 Hz of the ethene–
BCP complexes 5 (Table 2.5). 13C NMR data could not be obtained for these complexes
due to their instability. However, their 1H NMR spectra showed similar chemical shifts
and 2JPt–H for the ethene ligands to 5. The bis-MCP complexes 7 had 1JPt–P several
hundred Hz lower than the parent ethene complexes and more than 150 Hz lower than
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Table 2.4. Crystallographic Data for [Pt(MCP)2(PPh3)] (6a).
Chemical formula C26H27PPt
Formula weight 565.54
a, Å 10.4179(4)
b, Å 10.7385(4)
c, Å 11.3770(4)
α, deg 66.647(2)
β, deg 71.772(2)
γ, deg 70.542(2)
V, Å3 1077.48(7)
Z 2
Space group P−1
T, K 119.0
λ, Å 0.71073
Dcalcd, g cm−3 1.743
µ, mm−1 6.594
R1, [I> 2σ(I)]a 0.0250
wR2 (all data)a 0.0601
a Definition of R indices: R1
= Σ||Fo|−|Fc||/Σ|Fo|; wR2 =
[Σw(Fo
2
−Fc
2)2/Σw(Fo
2)2]
1/2
.
the mixed alkene complex (Table 2.5). The MCP methylene resonances in the 1H NMR
were also at lower chemical shifts than in the mixed complex and had lower 2JPt–H (50-
55 Hz), closer to those of the ethene rather than the MCP ligand in 6. Both the carbon
and proton NMR data showed that the two MCP ligands were in the same chemical
environment on the NMR time scale. While this could be due to rotation of the ligands,
it was considered more likely that the ligands were arranged either head-to-head or tail-
to-tail. The X-ray crystal structure of 7a showed that in the solid state the two MCP
ligands were tail-to-tail
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Table 2.5. Selected NMR Data of [Pt(L)2(PR3)].
a
Compound δP
1
JPt–P
cPr MCP =CH
2
C
2
H
4
=CH
2
=CR
2
δH JPt–H δC JPt–C δH
2
JPt–H δC
1
JPt–C δH
2
JPt–H δC
1
JPt–C δC
1
JPt–C
[Pt(BCP)(C
2
H
4
)(PPh
3
)] 5a 23.2 3094 1.2–0.8 b 9.2–6.8 b 2.71 51.0 54.8 102.2 30.2 431.5
[Pt(BCP)(C
2
H
4
)(PCy
3
)] 5b 25.3 2976 1.17–1.05 b 8.3 23.8 2.68 50.0 50.7 101.8 29.1 482.9
[Pt(MCP)(C
2
H
4
)(PPh
3
)] 6a 23.6 3085 1.64 60.0 b b 2.58 61.5 b b 2.61 56.0 b b b b
1.55 34.0
[Pt(MCP)(C
2
H
4
)(PCy
3
)] 6b 28.0 2978 1.5–0.9 b b b 2.52 61.2 b b 2.49 48.1 b b b b
[Pt(MCP)
2
(PPh
3
)] 7a 22.3 2932 1.31 b 7.8 24.5 2.39 55.0 38.9 100.3 54.1 352.9
[Pt(MCP)
2
(PCy
3
)] 7b 23.2 2695 1.47–1.29 b 7.2 25.0 2.27 50.0 32.0 b 48.5 385.6
[Pt(MCP)
2
(P—S)] 10 40.6 2661 b b 7.2 25.4 2.49 48.1 35.7 100.6 48.7 381.9
[Pt(C
2
H
4
)
2
(PPh
3
)] 24.6 3426 2.82 57.8 42.3 146
[Pt(C
2
H
4
)
2
(PCy
3
)] 29.2 3296 2.72 56.7 36.9 146
a δ values are given in ppm and J values in Hz. All spectra were measured in C
6
D
6
at room temperature with 40 mg/mL sample. b NMR data could not be
obtained.
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Chapter 3
Phosphine-Thioether and Allyl
Complexes
Phosphine-thioether (P—S) Pt(0) complexes with η2-methylenecyclopropane and bicyclo-
propylidene ligands were synthesised by the displacement of the norbornene ligand from
[Pt(nb)(P—S)]. These complexes rearranged to form allyl complexes through metallation
of the P—S backbone. Analogous allyl complexes were also synthesised by the protonation
of diphosphine MCP and BCP complexes.
3.1 [Pt(L)(P—S)] Complexes
The novel complex [Pt(nb)(P—S)] (nb = norbornene, P—S = tBu2PCH2(o-
C6H4)CH2S
tBu),123 was used as a precursor complex because the P—S ligand is
an analogue of 1,2-bis[(di-tert-butylphosphino)methyl]benzene (dbpx). Dbpx is used
in a number of catalytic systems, including the commercial synthesis of methyl
methacrylate.124–128 The replacement of one of the phosphine groups with a thioether has
the potential to affect the reactivity of complexes in catalysis, particularly as the sulfur is
potentially hemilabile.129–132 The synthesis of BCP and MCP complexes was undertaken
to give insight into the effect of the different donor atoms, as well as to compare the P—S
ligand to dbpx (see Section 2.1 for dbpx complexes).
[Pt(BCP)(P—S)] (8) was synthesised by the addition of a stoichiometric amount
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of BCP to [Pt(nb)(P—S)] (Scheme 3.1). The formation of 8 was complete after one
hour at room temperature. In the analogous reaction with MCP, two isomers of
[Pt(MCP)(P—S)] formed over an hour at room temperature. In this case, two isomers
were formed. The major isomer (9a), which formed in a 62:38 ratio relative to the
minor isomer, had the cyclopropyl ring trans to the sulfur, while the minor isomer (9b)
had the cyclopropyl ring trans to the phosphorus (Scheme 3.2). When one equivalent
of MCP was added to [Pt(nb)(P—S)], 9 formed in only 80% yield by 31P{1H} NMR.
However, the [Pt(nb)(P—S)] continued to react slowly, until it had reacted completely
(see Section 3.2.1). When a large excess of MCP was used, all of the nb complex reacted
immediately, and 9a, 9b as well as a new complex 10 formed, initially in a 40:24:36 ratio.
This new complex (10) was determined to be [Pt(MCP)2(P—S)] (Scheme 3.3).
S
Pt
P
S
Pt
P
tBu2tBu2
tButBu
C6D6
1 hr, RT
8
Scheme 3.1. Synthesis of [Pt(BCP)(tBu2PCH2(o-C6H4)CH2S
tBu)] (8).
S
Pt
P
S
Pt
P
tBu2
tBu2
S
Pt
P
tBu2
62%
38%
+
tBu
tBu
tBu
C6D6
1 hr, RT
9a
9b
Scheme 3.2. Synthesis of [Pt(MCP)(tBu2PCH2(o-C6H4)CH2S
tBu)] (9).
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Scheme 3.3. Reaction of [Pt(nb)(tBu2PCH2(o-C6H4)CH2S
tBu)] with an excess of
MCP.
3.1.1 NMR Characterisation
The η2-BCP complex 8 formed from [Pt(nb)(P—S)] had the highest 1JPt–P coupling
constant of the BCP complexes synthesised in this study by a significant margin (3383
compared to 2983 Hz for [Pt(BCP)(dbpx)] (1d)); this was due to the nature of the
P—S ligand, rather than the BCP ligand (Table 2.2). The nb starting material had a
significantly higher 1JPt–P coupling (3868 Hz) than both the ethene precursors used in
Section 2.1 (∼3300 Hz) and [Pt(nb)(dbpx)] (3331 Hz).133 The change in 1JPt–P upon
coordination of BCP was 485 Hz, similar to the average change of ∼450 Hz for 1, and
therefore consistent with the formation of a BCP complex.
The two different isomers of [Pt(MCP)(P—S)] could be easily distinguished by their
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1JPt–P coupling constants. For 9a 1JPt–P was 3870 Hz, while for 9b 1JPt–P was 3483 Hz.
These coupling constants were both higher than those in 2d (3362 Hz for P trans to
methylene, 3025 Hz for P trans to cPr). However, the relative changes in 1JPt–P upon
coordination were similar enough to be consistent with the formation of MCP complexes
(2 and 385 Hz for 9, ∼70 and ∼425 Hz for 2), particularly given that nb complexes
tend to have lower 1JPt–P than ethene complexes (3331 Hz for [Pt(nb)(dbpx)] vs. 3493 Hz
for [Pt(C2H4)(dbpx)]). As with 2, the P trans to the
cPr carbon had a lower coupling
constant due to the higher trans-influence of the sp2 carbon of the cyclopropyl ring.
The 13C{1H} NMR data for 8, 9a and 9b confirmed the formation of η2-BCP and η2-
MCP complexes. In particular, the values of the 1JPt–C coupling constants were consistent
with those of 1 and 2 (Table 2.2). These coupling constants showed the differing trans-
influences of the two donor atoms of the P—S ligand. For 8, the carbon atom trans
to P had a 1JPt–C of 579.0 Hz, while that trans to S had a 1JPt–C of 656.6 Hz. In 9,
when the methylene was trans to P, 1JPt–C was 145.1 Hz, while the 1JPt–C trans to S was
270.6 Hz. The peak due to the cPr carbon in 9 could not be found due to its low intensity.
The higher 1JPt–C coupling constant for the carbons trans to S demonstrates the weaker
trans-influence of sulfur relative to phosphorus, resulting in a stronger Pt−C bond trans
to S.93 This effect was also evident in the 1H NMR spectra in the relative sizes of the
2JPt–H coupling constants of the methylene resonances in 9. For the methylene trans to
the P, 2JPt–H was 52.7 Hz, slightly lower than those in 2 (∼60 Hz). The 2JPt–H of the
methylene trans to S was significantly larger at 82.1 Hz.
The NMR data for 10 were consistent with the other bis-MCP complexes 7 (Table 2.5).
The 1JPt–P coupling constant (2661 Hz) was closer to that of [Pt(MCP)2(PCy3)] (7b)
(2695 Hz) than [Pt(MCP)2(PPh3)] (7a) (2932 Hz). This could be rationalised by the fact
that the phosphine of the P—S ligand was more similar both sterically and electronically
to PCy3 than PPh3.
82 For PCy3, the cone angle θ is 170
◦ and the Tolman electronic
parameter ν is 2056 cm−1, while for PPh3, θ is 145
◦ and ν is 2069 cm−1. The cone
angle of the P—S ligand was calculated to be 180◦ when in monodentate coordination
through the P in trans–[PtH2(P—S)],
123 while the P(o-tol)tBu2 (ν = 2060 cm
−1) is a
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close analogue for the electronic parameter. These show more similarity to PCy3 than to
PPh3.
The 13C{1H} NMR data for the MCP ligands of 10 were very similar to those of 7,
particularly 7b. The double-bond carbons had chemical shifts of 48.7 and 35.7 ppm and
1JPt–C of 381.9 and 100.6 Hz for cPr and methylene respectively, compared to 48.5–54.1
and 32.0–38.9 ppm, and 352.9–385.6 and 100.3 Hz for 7. The cyclopropyl methylene
carbons appeared at 7.18 ppm with JPt–C coupling of 25.4 Hz, compared to 7.20–7.70 ppm
and 24.5–25.0 Hz for 7. The 1H NMR data of 10 was also in agreement with 7, with the
methylene protons of 10 appearing at 2.49 ppm with a 2JPt–H of 48.1 Hz, compared to
2.27–2.39 ppm and 50.0–55.0 Hz for 7.
3.2 Allyl Complexes
3.2.1 Complexes Formed By Hydride Transfer
Both [Pt(BCP)(P—S)] (8) and the two isomers of [Pt(MCP)(P—S)] (9a and 9b) (P—S =
tBu2PCH2(o-C6H4)CH2S
tBu) proved to be unstable in solution. In the case of 8, two new
complexes (11a and 11b) began to form after one hour. The formation of these complexes
was 99% complete by 31P NMR spectroscopy after eight days at room temperature. For
9a and 9b, two new complexes (12a and 12b) began to form overnight, reaching 91–95%
completion after three weeks. When 1 eq. of MCP was used, 20% [Pt(nb)(P—S)] was
still present initially, as well as 9a, 9b and free MCP. The [Pt(nb)(P—S)] was the slowest
of the three alkene species to react, and the conversion to 12a and 12b reached 95%
completion after 21 days. When [Pt(MCP)2(P—S)] (10) was present (excess of MCP
used), all three MCP complexes rearranged to form 12a and 12b. Complex 10 reacted
more rapidly than 9a or 9b due to the sulfur already being displaced. The ratio of 9 to
10 changed from 64:36 to 78:22 after 10 days, all 10 had reacted after 13 days, and the
reaction reached 91% completion after 21 days at room temperature.
The new complexes 11a, 11b, 12a and 12b were determined to be allyl complexes
wherein the alkene ligand had undergone a reaction with a hydride, resulting in proximal
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Scheme 3.4. Formation of allyl complexes from [Pt(BCP)(P—S)] (8).
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Scheme 3.5. Formation of allyl complexes from [Pt(MCP)(P—S)] (9).
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bond cleavage of one of the cyclopropyl rings (Schemes 3.4 and 3.5). The hydride was
generated by ortho-metallation of the P—S ligand, producing a P—C chelate ring. The
formation of allyl complexes from coordinated MCP has been observed previously in
the reaction of MCP with trans-[PtH(NO3)(L)2] (L = PEt3, PMe2Ph, PPh3)
134,135 and
with [PdCl2(NCPh)2].
136 The product of the reaction with trans-[PtH(NO3)(L)2] was
dependent on the phosphine ligand. When L = PEt3 or PMe2Ph, the product was
entirely the 1-methylallyl complex. When L = PPh3, an approximately 1:1 mixture of
the 1-methylallyl and 2-methylallyl complexes was produced. With [PdCl2(NCPh)2], the
product was the 1-methylallyl complex, with a Cl at the 2-position. Allyl complexes are
also intermediates in several of the transition metal catalysed reactions of both MCP and
BCP, most notably in Heck-type reactions (see Schemes 1.6 and 1.21).38,72,74,137,138
The proposed mechanism for the formation of the 1-methyl allyl complexes involves the
anti-Markovnikov addition of Pt–H across the double-bond, with the H attaching to the
cPr carbon. This was followed by the cleavage of the proximal ring bond to form an alkyl
ligand, β-hydride elimination, then hydride attack at the methylene end of the coordinated
double-bond (Scheme 3.6). This was supported by studies using trans-[PtD(NO3)(L)2]
and the reaction with [PdCl2(NCPh)2], with, respectively, the deuterium or the chloride
ending up in the 2-position. The proposed mechanism for the formation of the 2-methyl
allyl complexes also began with the addition of Pt–H across the double-bond, except
that in this case the H attached to the methylene carbon. The cleavage of the ring then
occurred at the distal rather than the proximal bond, leading to the direct formation of
the 2-methylallyl complex (Scheme 3.6). When trans-[PtD(NO3)(PPh3)2] was used, the
deuterium ended up on the methyl carbon in the 2-substituted product.134
The P—S complexes in this work formed exclusively 1-methylallyls. Due to the lack
of symmetry in both the allyl and the P—C ligand, in each case there were two possible
isomers. The isomer which had the least substituted carbon trans to the C of the P—C
ring formed in the largest amounts (11a and 12a). For 11, there was a pronounced
difference in the proportions of the two isomers, 85:15 11a to 11b. The isomer with
the cPr ring trans to the C was disfavoured due to the high trans-influences of both the
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Scheme 3.6. Mechanism for the formation of allyl complexes from MCP.135
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σ-bonded carbon and the cPr ring.93,139 The difference between the two isomers of 12 was
less significant, 63:37 12a:12b. In this case, the proportions were more equal due to the
steric and electronic similarity of the methylene to the CHMe group.140
The methyl groups in 11 and 12 were determined to be in the anti position based on
1H NMR coupling constants (Section 3.2.1.1). In other systems, anti methyl groups were
the kinetic products, while syn methyl groups were the thermodynamically stable isomer
(Figure 3.1).141,142 No rearrangement to the syn-methyl isomer was observed for 11 and
12, even when the complexes were placed in d6-acetone, which was found to facilitate the
rearrangment of other allyl systems (Section 3.2.2).
H
H R
RPt
H
H
R
RPt
anti syn
Figure 3.1. Geometry of allyl systems with anti and syn methyl groups.
3.2.1.1 NMR Characterisation
For representative NMR spectra, see Figures A.26–Figure A.35. As with other complexes
(see Table 2.2), it was possible to distinguish between the two isomers of 11 based on
their 1JPt–P coupling constants (Table 3.1). The isomer with the P trans to the cPr ring,
11a, had a 1JPt–P of 3141 Hz, while 11b, with P trans to the CHMe, had a 1JPt–P of
3893 Hz. The two isomers of 12 had very similar coupling constants; 3560 and 3590 Hz
for 12a and 12b respectively.
The orientation of the allyl relative to the P—C chelate ring had an effect on the
13C{1H} NMR spectra. The most pronounced differences were in the resonances of the
carbons of the allylic system (Table 3.2). The allyl carbon trans to the phosphorus donor
had 1JPt–C and JP–C couplings typical of other alkene/allyl complexes (see Table 2.2).143
In 11a, the quaternary cPr carbon had a large trans JP–C coupling constant (76.3 Hz),
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Table 3.1. Selected 31P{1H} and 1H NMR Data of Allyl Complexes.a
Compound δP
1JPt–P
cPr CH
2
CH CHMe CH
3
δH δH
2JPt–H δH
2JPt–H δH
2JPt–H δH
[Pt(η3-C(CH
2
)
2
CHCHMe)(P—C)] b 11a 82.0 3141 1.56 4.54 39.0 4.85 13.0 1.63
1.26
[Pt(η3-C(CH
2
)
2
CHCHMe)(P—C)] b 11b 80.1 3893 1.38 4.82 41.6 4.57 c 1.65
1.26
1.1
[Pt(η3-CH
2
CHCHMe)(P—C)] b 12a 84.1 3560 3.57 (syn) 4.61 (13.3, 7.7) 41.9 4.34 1.39
2.27 38.1 (anti)
[Pt(η3-CH
2
CHCHMe)(P—C)] b 12b 82.0 3590 3.6 (syn) 4.61 (13.3, 7.7) 41.9 4.39 1.29
2.92 (anti)
[Pt(η3-C(CH
2
)
2
CHCHMe)(dppp)]+ 13a 1.4 3852 1.21 5.40 (8.2) 54.0 4.93 0.88
−2.8 3259 0.86
0.37
[Pt(η3-C(CH
2
)
2
CHCHMe)(dppp)]+ 13b 1.0 4042 1.22 5.39 (12.5) 51.0 4.14 1.38
−0.4 3267 0.65
0.39
0.14
[Pt(η3-CH
2
CHCHMe)(dppp)]+ 16a −1.2 3569 3.94 (syn) 5.32 (14.1, 7.6) 53.4 4.62 0.80
−1.2 3625 2.99 (anti)
[Pt(η3-CH
2
CHCHMe)(dppp)]+ 16b 1.4 3670 3.59 (syn) 5.23 (12.7, 7.3) 51.5 3.68 1.29
−1.8 3693 2.54 (12.7, 10.0, 2.7) (anti)
[Pt(η3-CH
2
CHCHMe)(dbpx)]+ 18b 36.9 3844 4.53 (syn) 5.04 (12.2, 7.5) 51.9 6.28 c
2.86 (11.1, 10.0, 2.2) 34.4 (anti)
[Pt(η3-CH
2
CcPrCH
2
)(dbpx)]+ 17 33.9 3632 0.93 4.81 (syn)
32.1 3647 0.87 2.74 (8.1) 41.3 (anti)
[Pt(η3-CH
2
CMeCH
2
)(dppp)]+ 15 0.1 3521 3.56 (syn) 1.96
2.95 (8.5) 32.0 (anti)
[Pt(η3-CH
2
CMeCH
2
)(dbpx)]+ 18a 33.9 3572 4.88 (syn) c
32.4 3641 2.80 (8.4) 39.4(anti)
a δ values are given in ppm and J values in Hz. Values in parentheses are JH–H couplings. All spectra were measured in d6-acetone at room
temperature with 40 mg/mL sample unless noted. b Spectra collected in C
6
D
6
. c NMR data could not be obtained.
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Table 3.2. Selected 13C{1H} NMR Data of Allyl Complexes.a
Compound
Pt−C cPr CR
2
CH CHMe CH
3
δC
1
JPt–C δC JPt–C δC
1
JPt–C δC
1
JPt–C δC
1
JPt–C δC
2
JPt–C
[Pt(η3-C(CH
2
)
2
CHCHMe)(P—C)] b 11a 152.9 (2.4) 1192.1 7.7 (4.3) 25.9 53.5 (76.3) 447.4 98.6 (4.3) 21.1 74.1 32.6 17.3 27.9
3.7 18.0
[Pt(η3-C(CH
2
)
2
CHCHMe)(P—C)] b 11b 159.9 (2.8) 1043.3 9.0 15.0 48.1 202.3 102.8 7.1 84.3 (30.1) 130.6 16.8 (4.6) 41.6
6.6
[Pt(η3-CH
2
CHCHMe)(P—C)] b 12a 158.4 (2.3) 1142.7 42.5 52.0 108.2 8.4 73.4 (37.0) 173.4 15.3 (5.2) 39.9
[Pt(η3-CH
2
CHCHMe)(P—C)] b 12b 155.5 (2.4) 1132.8 53.1 (40.4) 182.6 108.7 11.0 62.5 48.6 15.6 26.6
[Pt(η3-C(CH
2
)
2
CHCHMe)(dppp)]+ 13a 8.2 (4.0) 16.8 66.7 (54.4) 252.6 104.2 (3.4, 1.7) 91.2 (22.6) 65.9 15.5 (4.1) 33.2
4.4 15.6
[Pt(η3-C(CH
2
)
2
CHCHMe)(dppp)]+ 13b 8.6 (4.0) 20.8 67.1 (53.2) 269.3 111.6 (4.1, 1.8) 92.6 (21.9) 29.0 15.9 (2.4)
5.7
[Pt(η3-CH
2
CHCHMe)(dppp)]+ 16a 60.2 88.0 113.9 (3.2) 16.5 83.4 83.7 14.1 (2.8, 1.1) 23.1
[Pt(η3-CH
2
CHCHMe)(dppp)]+ 16b 62.3 100.1 119.3 (3.5) 26.6 84.3 54.4 15.9 (2.9) 3.8
[Pt(η3-CH
2
CHCHMe)(dbpx)]+ 18b 51.7 106.9 106.8 84.6 63.7 16.5 14.5
[Pt(η3-CH
2
CcPrCH
2
)(dbpx)]+ 17 8.9 59.1 (30.2, −2.1) 79.8 126.4 44.5
[Pt(η3-CH
2
CMeCH
2
)(dppp)]+ 15 66.4 85.0 135.9 (3.2) 24.8 24.8 30.0
[Pt(η3-CH
2
CMeCH
2
)(dbpx)]+ 18a 63.3 127.1 56.7 21.6 28.4
a δ values are given in ppm and J values in Hz. Values in parenthesis are JP–C. All spectra were measured in d6-acetone at room temperature with 40 mg/mL sample unless
noted. b Spectra collected in C
6
D
6
.
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and a 1JPt–C of 447.4 Hz, similar to those in the alkene complexes 1 and 2. For the allyl
carbon attached to the methyl, when trans to the P in 11b and 12a 1JPt–C was 130.6
and 173.4 Hz, while JP–C was 30.1 and 37.0 Hz respectively. The methylene in 12b had
a 1JPt–C of 182.6 Hz and a JP–C of 40.4 Hz.
The 1JPt–C coupling constants for the allyl carbons dramatically decreased when trans
to the carbon donor. For 11b, the 1JPt–C coupling of the quaternary cPr carbon was less
than half that of 11a at 202.3 Hz. The carbons attached to the methyls in 11a and 12b
had couplings of 32.6 and 48.6 Hz respectively, 98–125 Hz less than their counterparts. In
12a, the methylene carbon also had a significant decrease in 1JPt–C from 12b, decreasing
by 130 Hz to become 52.0 Hz. The effect on the central carbon of the allyl was less
significant, but was still evident. In 11b and 12a, which had the methyls trans to the
phosphorus, 1JPt–C was 7.1 and 8.4 Hz respectively, while in 11a and 12b 1JPt–C was
21.1 and 11.0 Hz respectively. There was also a decrease in the 2JPt–C coupling constants
of the methyl carbons when they were trans to the C, from 41.6 and 39.9 Hz in 11b
and 12a (trans P) to 27.9 and 26.6 in 11a and 12b (trans C). The low JPt–C coupling
constants for the carbons trans to the C of the P—C chelate was due to the high trans-
influence of the σ-bonded carbon.93 This lowering of 1JPt–C trans to a σ-bonded carbon
has been reported for a range of η3-allyl complexes, both with P—C chelate rings and for
[Pt(η3-C3H5)Me(PPh3)] complexes.
144
The orientation of the allyl also had an effect on the chemical shift of the carbon
resonances. There was some variation in the absolute chemical shift; when a particular
carbon environment was trans to the phosphorus it had a shift 10.2–10.9 ppm higher than
when it was trans to the carbon. The exceptions to this were the central allyl carbons,
which did not sit trans to either donor and had differences of 0.5–4.2 ppm, and the cPr
CH2 carbons, which again did not sit directly trans , only differed by 5.5 ppm.
The metallation of the aromatic ring was evident in the high chemical shift
(152.9–159.9 ppm) and high 1JPt–C coupling constant (1043.3–1192.1 Hz) of one of the
ring carbon atoms. The complex with the cPr ring trans to the carbon, 11b, had a 1JPt–C
100 Hz lower than the other complexes, signifying that the strong Pt−cPr bond caused
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a weakening of the Pt−C σ-bond. The shifts of both of the S−tBu carbons were very
similar to those of the free ligand, and showed no platinum or phosphorus coupling, unlike
in 8 and 9. This was consistent with the S no longer being coordinated.
The 1H NMR spectra of 11a–12b were typical of allyl complexes.141,142,144,145 It was
possible to assign the syn and anti protons of the methylenes of 12a and 12b both from
the chemical shift and from the JH–H couplings. The anti protons had lower chemical shifts
(2.27 and 2.97 ppm) than the syn (3.57 and 3.6 ppm), while the JH–H coupling of the anti
protons to the central allyl protons was higher (∼13 vs. ∼8 Hz). It was also possible to
determine the geometry at the CHMe carbon of 11 and 12 using JH–H couplings. The
peak belonging to the central allyl proton in 11a was a doublet with coupling of 8.0 Hz,
while that of 11b was a doublet with coupling of 7.5 Hz, corresponding to couplings to a
proton in the syn position. The methyl groups were therefore in the anti position. In both
12a and 12b, the central allyl proton was a doublet of triplets, with a doublet coupling of
13.3 Hz and a triplet coupling of 7.7 Hz, indicating one proton in the anti position (from
the CH2) and two in the syn position (from the CH2 and the CHMe). Again, the methyl
groups were therefore in the anti position.
3.2.2 Complexes Formed By Protonation
The reactivity of a selection of η2-alkene P—P complexes [Pt(BCP)(P—P)] (P—P =
dppp (1a), dbpx (1d)) and [Pt(MCP)(P—P)] (P—P = dppp (2a), dbpx (2d)) with
acids was explored. The acid predominantely used for these studies was H2C(SO2CF3)2
(pK a = 2.4 in DMSO).146 The reactions with dppp complexes were also performed
using HCPh(SO2CF3)2 (pK a = 2.0 in DMSO)
146 and HBF4 (pK a = 1.2 in 1,2-
dichloroethane),147 with no difference in product distributions observed.
When H2C(SO2CF3)2 was added to a suspension of 1a in d6-acetone, a reaction
occurred immediately, resulting in the formation of two species in a approx. 75:25 ratio.
The major product 13a proved to be a 1-methylallyl complex similar to 11, with the
methyl in the anti position, formed by cleavage of the proximal ring bond, while the
structure of the minor product (14a) could not be assigned. Overnight, 13a began to
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convert into the syn-methyl complex, 13b. The conversion continued slowly, eventually
stabilising at 27:73 anti :syn after two months at room temperature.
Pt
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Ph2
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Ph2
+
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d6-acetone
5 min, RT
27:73 anti:syn
30 d, RT
13a 13b
1a
Scheme 3.7. Formation of allyl complexes by protonation of [Pt(BCP)(dppp)] (1a).
In the equivalent reactions with 2a, there were two products formed initially (15 and
16a), in a 68:32 ratio (Scheme 3.8). In this case, the major product 15 was a 2-methylallyl
complex, formed by the cleavage of the distal ring bond (Scheme 3.6). This complex had
been synthesised previously by the addition of dppp to [Pt(CH2CMeCH2)(acetone)2]
+.148
The minor product 16a was a 1-methylallyl complex with the methyl in the anti position.
As with 13, the conversion to the syn-methyl complex (16b) was evident within 12 hr,
with the ratios stabilising at 16:84 anti :syn after 8 days. When the protonation reaction
was done in CD2Cl2 rather than d6-acetone, the ratio of 15 to 16a was much higher
in favour of the 2-methyl complex at 84:16. There was also no conversion of the anti
1-methyl complex into the syn form. This was ascribed to the ability of d6-acetone to
coordinate to the metal, filling a vacant coordination site while the allyl converted from
η3 (anti) to η1 to η3 (syn), which was not possible in non-coordinating CD2Cl2.
The reactivity of the dbpx complexes differed from that of the dppp complexes. The
products of the reactions were again allyl complexes, but different isomers were favoured.
In the reaction of 1d with H2C(SO2CF3)2, the only species produced (17) was an allyl
substituted in the 2-position with a cyclopropyl ring (Scheme 3.9). This species was not
observed with 1a, though the analogous 2-methylallyl complex was the major product
with 2a. The 2-methyl complex (18a) was also formed in the reaction with 2d, as well
as the 1-methylallyl complex with the methyl in the anti position (18b) (Scheme 3.10).
Unlike the dppp complexes, in this case it was the 1-methylallyl complex that was the
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Scheme 3.8. Formation of allyl complexes by protonation of [Pt(MCP)(dppp)] (2a).
major isomer, with a ratio of 58:42 18a:18b. The dbpx complexes further differed from
the dppp complexes with no rearrangement of the anti -methyl 18b to the syn-methyl
complex.
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P
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tBu2
P
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P
tBu2
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+
H
H2C(SO2CF3)2
d6-acetone
5 min, RT
17
1d
Scheme 3.9. Formation of an allyl complex by protonation of [Pt(BCP)(dbpx)] (1d).
3.2.2.1 NMR Characterisation
For representative NMR spectra see Figures A.36–A.70. The 1H NMR resonances of
the 1-methylallyl complexes as well as 1D NOESY correlations were used to assign the
geometries of the allyl ligand. In 16a and 18b, the peak due to the central allyl proton
was a doublet of triplets with couplings of 14.1 and 7.6 Hz for 16a and 12.2 and 7.5 Hz
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Scheme 3.10. Formation of allyl complexes by protonation of [Pt(MCP)(dbpx)] (1d).
for 18b. This showed that there were two protons in the syn positions (from the CHMe
and the CH2), and one in the anti (from the CH2), and that the methyl was therefore
in the anti position (Figure 3.2).141,142,144,145 The peak due to the central allyl proton in
16b, however, was a triplet of doublets with couplings of 12.7 and 7.3 Hz, showing that
there were now two anti protons, and the methyl was therefore syn. The central allyl
protons in 13a and 13b were also used to assign the allyl geometries. In 13a, the peak
had a JH–H coupling of 8.2 Hz to the CHMe proton, indicating that it was in the syn
position, with the methyl group in the anti. The JH–H coupling in 13a was 12.5 Hz, and
the methyl group was therefore syn.
There were several other differences between the anti - and syn-methyl allyl complexes
in the NMR spectra (Tables 3.1 and 3.2). In the 1H NMR spectrum, the chemical shifts
for the methyl protons appeared at lower chemical shifts for the anti methyl groups (0.80
and 0.88 ppm) than for the syn (1.29 and 1.38 ppm). This differed from the other protons,
with the chemical shifts of the protons in the syn-methyl allyl lower than the equivalent
anti -methyl allyl. The 2JPt–H couplings on the central proton were also slightly larger for
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HPt
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Figure 3.2. 1H NMR resonances of the central allyl proton in
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] 16a[PhC(SO2CF3)2] (anti) and
16b[PhC(SO2CF3)2] (syn).
73
the anti form (53.4 and 54.0 Hz) than for the syn form (51.0–51.9 Hz).
In the 13C{1H} NMR spectrum (Table 3.2), the differences in chemical shift had the
opposite trend, with those of the anti isomers typically being at lower ppm than the syn
isomer, by 0.4–7.4 ppm. Most of the JPt–C coupling constants were also lower in the anti
isomer by 10–17 Hz. The exception to this was the CHMe carbons, where the 1JPt–C
coupling constants were higher in the anti case by 36.9 Hz for 13 and 29.3 Hz for 16. As
with other complexes, the carbon with the cyclopropyl ring attached had a significantly
higher 1JPt–C than the equivalent methylene carbon due to the higher trans-influence of
the cPr ring, 252.6 and 269.3 vs. 88.0–106.9 Hz. However, the coupling constants of
the cPr allyl carbons in 13 were lower by ∼150 Hz than those in 1. This decrease was
consistent with the metal in the allyl complexes being Pt(II) rather than Pt(0), with less
electron-density being available and therefore weaker bonds to the allyl system than to
the alkene ligands.140,149–151 In 11a, which was also Pt(II) with the cPr ring trans to P,
the 1JPt–C of the cPr allyl carbon (447.4 Hz) was also larger than for 13, though that
of 11b, with the cPr trans to C, was lower (202.3 Hz). However, the P—P complexes
had a positive charge, again leading to a lower electron density. As well as this, the allyl
system in the P—C complexes would be affected by the significantly different strengths
of the Pt–P and Pt–C bonds, leading to a comparatively stronger bond trans to the P.
The lower 1JPt–C coupling constants of the CHMe carbon compared to the CH2 carbon
in 16 and 18b indicated that there was a greater interaction with the metal for the CH2
group than for the CHMe, both in the P—P and the P—C complexes.93 The differences
varied between 3.4 Hz when trans to C in 12 and 45.7 Hz for 16b.
In the 31P{1H} NMR spectra of 13, there was a large difference between 1JPt–P
coupling constants, with that of the phosphorus trans to the cPr ring significantly lower
than the that of the P trans to CHMe at 3260 Hz. There was a nearly 200 Hz difference in
the 1JPt–P of the P trans to the CHMe group between the anti - and syn-methyl complexes,
3852 and 4042 Hz respectively. As with 11, the P trans to the CHMe had a significantly
higher 1JPt–P in the complexes derived from BCP than from MCP. In 16, the 1JPt–P of
the P trans to CHMe (3625 and 3695 Hz) were within 60 Hz of the 1JPt–P of the P trans
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to CH2 (3569 and 3670 Hz).
The 2-substituted allyl complexes with dbpx (17 and 18a) both had NMR spectra that
varied with temperature. At room temperature, the 31P NMR spectra of both complexes
showed two very broad peaks of uneven intensity, with the major peaks at 32.1 and
32.4 ppm with 1JPt–P of 3647 and 3572 Hz and the minor peaks at 33.9 and 33.9 ppm
with 1JPt–P of 3632 and 3641 Hz for 17 and 18a respectively (Figure 3.4). When NMR
spectra were run at higher temperatures, the peaks coalesced into a sharp singlet (17 δP
= 33.4 ppm, 1JPt–P = 3640 Hz, 18a δP = 32.3 ppm, 1JPt–P = 3598 Hz), beginning at
30 ◦C. This fluxional behaviour was due to flipping of the dbpx backbone.152,153 When
the temperature of 17 was decreased, the two broad peaks became four sharp peaks,
beginning at 0 ◦C (δP = 34.2, 33.0, 31.0 and 30.7 ppm, 1JPt–P = 3650, 3651, 3639 and
3642 Hz, with 8:34:12:46 intensity). This was ascribed to a combination of flipping of the
dbpx backbone and different orientations of the cyclopropyl substituent, prevented from
free rotation due to the large steric bulk of the tBu substituents (Figure 3.3).
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Figure 3.3. Possible conformations of [Pt(η3-CH2C
cPrCH2)(dbpx)]
+ (17).
The coalescence temperature for the 1H NMR of 17 was slightly lower than for the 31P
NMR, between 0 and−10 ◦C. (Figures 3.5 and 3.6). The room temperature proton spectra
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Figure 3.4. Temperature-dependent 31P{1H} NMR spectra of
[Pt(η3-CH2C
cPrCH2)(dbpx)]
+ (17) (125 MHz, 40 mg/mL, C6D6). * signifies peaks
belonging to other species
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Figure 3.5. Temperature-dependent 1H NMR spectra of [Pt(η3-CH2C
cPrCH2)(dbpx)]
+
(17) (300 MHz, 40 mg/mL, C6D6).
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H
Figure 3.6. Temperature-dependent 1H NMR spectra of the anti methylene proton of
[Pt(η3-CH2C
cPrCH2)(dbpx)]
+ (17) (300 MHz, 40 mg/mL, C6D6).
78
of the three 2-substituted allyl complexes 15, 17 and 18a showed good agreement. All
three showed a broad singlet peak due to the syn CH2 allyl peaks between 3.56–4.88 ppm,
with only 0.07 ppm difference between the two dbpx complexes. The anti CH2 allyl peaks
appeared between 2.74–2.95 ppm, with 2JPt–H between 32.0–41.3 Hz. Due to the presence
of the large tBu peaks, the methyl protons for 18a could not be found, with those of 15
appearing at 1.96 ppm, higher than for the 1-methyl allyl complexes.
The room temperature 13C{1H} NMR spectra of 17 and 18a showed the same
broadness as the 31P NMR spectra, although there was only one set of peaks. The
central allyl carbon peak appeared at higher chemical shifts (126.4–135.9 ppm) than the
corresponding carbon in the 1-methyl allyl complexes (98.59–119.33 ppm). The peak due
to the methylene carbon appeared at similar chemical shifts to the 1-methyl methylene
carbons (51.7–66.4 ppm), with the methylene in the 2-methyl complex at higher shifts
than in the 1-methyl complex with the same phosphine backbone. The methyl carbons
also appeared at higher ppm than in the 1-methyl complexes, at 21.6 and 24.8 ppm. The
1JPt–C coupling constants of the 2-methyl complexes showed the same trends, with that of
the methylene carbon of similar magnitude (79.8–85.0 c.f. 88.0–100.1 Hz) and that of the
methyl carbon higher (28.4–30.0 c.f. 3.8–23.1 Hz) than for the 1-methyl allyl complexes.
The structure of the minor product in the protonation reaction of 1a could not be
fully determined. The complex formed initially (14a) converted into a second complex
overnight (14b), and remained unchanged over several months. The same complexes
formed in the same ratios when either H2C(SO2CF3)3, HCPh(SO2CF3)3 or HBF4 was
used. From the 1JPt–P coupling constants, 3439 and 3520 Hz for 14a, 3512 and 3592 Hz for
14b, both complexes had unsymmetrical allyl ligands, therefore were not the 2-substituted
allyl similar to 17. The similar size of the coupling constants indicated that the end of
the allyl was not substituted with a cyclopropyl ring, as with 11 and 16.
The 13C{1H} NMR data for 14b suggested that it was a 2-substituted allyl, evidenced
by the presence of a peak at 135.8 ppm, comparable to 15, 17 and 18a. There were
peaks at 84.7 and 76.3 ppm with 1JPt–C of 123.7 and 56.6 Hz respectively. When carbon-
13 enriched BCP (enriched at the double-bond carbons) was used, it was the peak at
79
84 ppm which was enhanced, as well as the peak at 135 ppm. The peak at 76 ppm
was at a much higher chemical shift and had a much smaller 1JPt–C coupling constant
than the methylene resonances in the other allyl complexes (Table 3.2). Three other
carbon resonances were identified, at 12.5, 27.4 and 30.6 ppm. None of these were in
good agreement with the methyl peaks in either the 2-methyl (21.6 and 24.8 ppm) or
1-methyl (14.1–17.3 ppm) allyls. The presence of two phosphorus and three allyl carbon
environments precludes a structure similar to 17. A structure similar to that of 11 and
16 with the methyl in the 2-position was ruled out due to the similarities of the 1JPt–P
coupling constants and the small size of the allyl 1JPt–C couplings compared to those of
the cPr allyl carbons. While it was evident that the second cyclopropyl ring had opened,
there was no sign of a double-bond, which which would result from the ring-opening when
the number of protons was conserved. The possibility of ring-opening with the gain of
deuterium from the NMR solvent (d6-acetone) was considered, but was deemed unlikely
due to the lack of coupling to deuterium on any of the 13C NMR peaks.
3.2.3 Computational Studies
Complexes with three allyl structural motifs were observed experimentally, with the
proportions of these dependent on both the phosphine backbone and the solvent used.
These were the allyl substituted in the 2-position, the 1-methyl allyl with the methyl in
the anti position and the 1-methyl allyl with the methyl in the syn position. When formed
from BCP, the 1-methyl allyls had a cyclopropyl ring in the 3-position. Computational
models were used to investigate the formation of the allyl complexes. All structures
were optimised and frequencies calculated using density functional theory calculations
(B3LYP),154–157 optimised using the def2-TZVP basis set,158 of triple ζ quality.
Structures with a range of allyl systems were optimised for each of the three
phosphine backbones used. The three phosphine backbones were the ortho-metallated
phosphine-thioether ligand C6H3-o-CH2P
tBu2-m-CH2S
tBu (P—C), dppp and dbpx.
Six allyl complexes were used for both dppp and dbpx (Figures 3.9, 3.10, 3.11
and 3.12). These were the 2-substituted allyl complexes [Pt(η3-CH2C
cPrCH2)(P—P)]
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(P—P = dppp (19), dbpx (17)) and [Pt(η3-CH2CMeCH2)(P—P)] (P—P = dppp
(15), dbpx (18a)), the 1-methyl allyl complexes with the the methyl in the anti
position [Pt(η3-C(CH2)2CHCHMe)(P—P)] (P—P = dppp (13a), dbpx (20a)) and
[Pt(η3-CH2CHCHMe)(P—P)] (P—P = dppp (16a), dbpx (18b)), and the 1-methyl
complex with the methyl in the syn position [Pt(η3-C(CH2)2CHCHMe)(P—P)] (P—P
= dppp (13b), dbpx (20b)) and [Pt(η3-CH2CHCHMe)(P—P)] (P—P = dppp (16a),
dbpx (18c)).
Due to the unsymmetrical phosphine ligand in the P—C complexes, there were 10
possible allyl structures (Figures 3.7 and 3.8). The 2-substituted complexes were
[Pt(η3-CH2C
cPrCH2)(P—C)] (21) and [Pt(η
3-CH2CMeCH2)(P—C)] (22). There
were four 1-methyl allyl complexes with the methyl group in the anti position,
[Pt(η3-C(CH2)2CHCHMe)(P—C)] (Me trans C (11a), Me trans P (11b)) and
[Pt(η3-CH2CHCHMe)(P—C)] (Me trans P (12a), Me trans C (12b)), and four 1-
methyl complexes with the methyl in the syn position, [Pt(η3-C(CH2)2CHCHMe)(P—C)]
(Me trans C (23a), Me trans P (23b)) and [Pt(η3-CH2CHCHMe)(P—C)] (Me trans P
(24a), Me trans C (24b)). Structures for the parent alkene complexes [Pt(BCP)(P—P)]
(P—P = dppp (1a), dbpx (1d)), [Pt(MCP)(P—P)] (P—P = dppp (2a), dbpx (2d)),
[Pt(BCP)(P—S)] (8), [Pt(MCP)(P—S)] (cPr trans S (9a), cPr trans P (9b)), the acid
used in the protonation reactions (H2C(SO2CF3)2) and its counter ion (HC(SO2CF3)
–
2)
were also optimised.
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Figure 3.7. Allyl structural motifs derived from [Pt(BCP)(P—S)] (8).
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Figure 3.8. Allyl structural motifs derived from [Pt(MCP)(P—S)] (9).
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Figure 3.9. Allyl structural motifs derived from [Pt(BCP)(dppp)] (1a).
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Figure 3.10. Allyl structural motifs derived from [Pt(MCP)(dppp)] (2a).
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Figure 3.11. Allyl structural motifs derived from [Pt(BCP)(dbpx)] (1d).
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Figure 3.12. Allyl structural motifs derived from [Pt(MCP)(dbpx)] (2d).
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The reaction ∆H values for the formation of the allyl complexes from the appropriate
η2-alkene complexes were calculated (Tables 3.3 and 3.4, Figures 3.13, 3.14 and 3.15). The
reaction used for the P—C complexes was the rearrangement of the parent [Pt(L)(P—S)]
complex to form the allyl complex (Scheme 3.11), with the isomers of [Pt(MCP)(P—S)]
leading to two reaction possibilities. For the diphosphine complexes, the reaction used
was the addition of H2C(SO2CF3)2 to [Pt(L)(P—P)], forming [Pt(allyl)(P—P)]
+ and
HC(SO2CF3)
–
2 (Scheme 3.12). The species used in the calculations were isolated molecules
in the gas phase, so the absolute values of ∆H thus obtained were not necessarily those for
the experimental systems. However, the calculated values of reaction ∆H were considered
to be accurate indicators of the trends in stability of the complexes, within the limits of
the theoretical description. Transition state structures were not calculated, so no kinetic
information was obtained.
In all systems, the reaction ∆H for the formation of the 2-substituted allyl complexes
had the lowest value. The 2-cyclopropyl complexes with P—C (21) and dppp (19) (∆H
= −172.6 and 46.7 kJ mol−1 respectively) were not observed experimentally, despite the
lower ∆H value indicating that these complexes were more stable than the corresponding
1-methyl complexes. The difference between ∆H for the 2-substituted and 1-methyl
complexes was similar for both backbones (39.1–48.1 kJ mol−1). The formation of the
2-substituted allyl complexes occurs via a different mechanism than for the formation of
the 1-methyl allyls (Scheme 3.6). It is therefore likely that there was a larger activation
energy for the formation of the 2-substituted complexes, leading to the formation of the 1-
methyl complexes being favoured kinetically. The 2-cyclopropyl complex 17 was the only
protonated product observed experimentally with dbpx. In this case, ∆H (56.3 kJ mol−1)
was significantly lower than for the 1-methyl complexes, with differences of 79.8 and
81.3 kJ mol−1 between the anti and syn methyl complexes respectively, nearly twice that
of the P—C and dppp systems.
The 2-methyl substituted complexes 15, 18a and 22 also had lower reaction∆H values
than for the 1-methyl allyls, 69.0, 97.9, −141.5 and −145.4 kJ mol−1 respectively. In this
case, there were smaller differences between the 2-substituted and 1-methyl complexes
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Scheme 3.11. Formation of P—C allyl complexes from [Pt(L)(P—S)].
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Scheme 3.12. Formation of P—P allyl complexes from [Pt(L)(P—P)].
Table 3.3. Reaction ∆H for the Formation of Allyl Complexes from η2-BCP
Complexes.
Compound ∆H (kJ mol−1)
[Pt(η3-CH2C
cPrCH2)(P—C)] 21 −172.6
[Pt(η3-C(CH2)2CHCHMe)(P—C)] Me trans C anti 11a −126.9
[Pt(η3-C(CH2)2CHCHMe)(P—C)] Me trans C syn 23a −133.6
[Pt(η3-C(CH2)2CHCHMe)(P—C)] Me trans P anti 11b −124.6
[Pt(η3-C(CH2)2CHCHMe)(P—C)] Me trans P syn 23b −124.5
[Pt(η3-CH2C
cPrCH2)(dppp)]
+ 19 46.7
[Pt(η3-C(CH2)2CHCHMe)(dppp)]
+ anti 13a 93.0
[Pt(η3-C(CH2)2CHCHMe)(dppp)]
+ syn 13b 86.2
[Pt(η3-CH2C
cPrCH2)(dbpx)]
+ 17 56.2
[Pt(η3-C(CH2)2CHCHMe)(dbpx)]
+ anti 20a 136.0
[Pt(η3-C(CH2)2CHCHMe)(dbpx)]
+ syn 20b 137.4
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Table 3.4. Reaction ∆H for the Formation of Allyl Complexes from η2-MCP
Complexes.
Compound
∆H (kJ mol−1)
From 9a From 9b From 2
[Pt(η3-CH2CMeCH2)(P—C)] 22 −141.5 −145.4
[Pt(η3-CH2CHCHMe)(P—C)] Me trans P anti 12a −124.9 −128.7
[Pt(η3-CH2CHCHMe)(P—C)] Me trans P syn 24a −125.3 −129.2
[Pt(η3-CH2CHCHMe)(P—C)] Me trans C anti 12b −119.7 −123.6
[Pt(η3-CH2CHCHMe)(P—C)] Me trans C syn 24b −125.4 −129.3
[Pt(η3-CH2CMeCH2)(dppp)]
+ 15 69.0
[Pt(η3-CH2CHCHMe)(dppp)]
+ anti 16a 86.0
[Pt(η3-CH2CHCHMe)(dppp)]
+ syn 16b 81.5
[Pt(η3-CH2CMeCH2)(dbpx)]
+ 18a 97.9
[Pt(η3-CH2CHCHMe)(dbpx)]
+ anti 18b 115.5
[Pt(η3-CH2CHCHMe)(dbpx)]
+ syn 18c 118.7
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Figure 3.13. Reaction ∆H for the formation of allyl complexes from [Pt(L)(P—S)].
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(12.6–21.8 kJ mol−1). Again, it was likely that the size of the activation barrier played
a part in determining which isomers were formed. While the differences in ∆H for the
P—C complexes (16.1–21.8 kJ mol−1) was similar to those of the diphosphine complexes,
22 was not observed experimentally. A significantly larger proportion of 15 (68%) was
produced than 18a (42%), despite the similarity in the differences of ∆H (12.6–17.1 and
17.6–20.9 kJ mol−1 respectively). It was found experimentally that the solvent used in
the reaction had a large effect on the proportion of 15 formed, with 68% 15 formed in
d6-acetone and 84% 15 formed in CD2Cl2 (Section 3.2.2), indicating that more factors
affected the reaction outcome than were considered in this computational study.
The majority of the 1-methyl complexes with the methyl group in the anti position
had enthalpy values higher than the corresponding complexes with the methyl group in
the syn position, indicating that the syn isomer was thermodynamically more stable. The
dbpx complexes and the P—C cyclopropyl allyl complexes with the methyl group trans
to the P (11b and 23b), which had lower values for the anti isomer, were the exception
to this. The complexes of dppp (∆H = 93.0, 86.0, 86.0 and 81.5 kJ mol−1 for 13a, 13b,
16a and 16b respectively) and P—C with the methyl group trans to C (∆H = −126.9 for
11a, −133.6 for 23a, −119.7 and −125.4 for 12b, and −123.6 and −129.3 kJ mol−1 for
24b) had the largest differences between the anti and syn isomers, 4.5–6.8 kJ mol−1 in
favour of the syn isomer. The P—C complexes with the methyl group trans to P had only
small differences between the isomers; ∆H was −124.9 and −128.7 kJ mol−1 for 12a and
−125.3 and −129.2 kJ mol−1 for 24a, 0.5 kJ mol−1 in favour of the syn isomer, −124.6
and −124.5 kJ mol−1 for 11b and 23b, 0.1 kJ mol−1 in favour of the anti isomer. The
dbpx complexes (∆H = 136.0, 137.4, 115.5 and 118.7 kJ mol−1 for 20a, 20b, 18b and
18c respectively) had differences of 1.5 and 3.2 kJ mol−1, in favour of the anti isomer.
Experimentally, it was the anti isomer that was formed initially, for all cases except
for the protonation of [Pt(BCP)(dbpx)] (1d), where only the 2-substitiuted allyl 17 was
observed. While this was consistent with the lower anti reaction ∆H values for the
dbpx complexes and 11b/23b, for the other reactions it was the syn isomer which was
thermodynamically the more stable. The anti isomer would therefore be the kinetic
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isomer, with a lower activation energy for formation (not calculated in this study).
Rearrangement to the syn isomer was observed for the dppp complexes, with anti :syn
ratios stabilising at 27:73 for 13 and 58:42 for 16. Other allyl systems showed similar
reactivity, with the anti methyl isomers formed initially, followed by rearrangement to
the syn isomer.141,142 No rearrangement was observed for the P—C complexes, indicating
that the energy barrier for rearrangement was higher in these systems.
In order to determine whether the atomic charges on the double-bond atoms had
an effect on the site of protonation, NBO calculations were performed on the starting
complexes (Table 3.5). For the P—S/P—C complexes, the reaction was with an internal
hydride formed by the ortho-metallation of the backbone aromatic ring, rather than a
proton. Structures of the likely intermediate complexes [PtH(L)(P—C)] were optimised,
and the atomic charges calculated. A number of structures were possible due to the
unsymmetrical backbone and the perpendicular coordination of the alkene (Figure 3.16),
favoured in platinum(II) complexes.2,22 Two isomers of [PtH(BCP)(P—C)] were used,
with H trans to P (25a) and with H trans to C (25b). There were four isomers of
[PtH(MCP)(P—C)] used, H trans to P with the cPr ring up according to the coordination
plane as drawn (26a), H trans to P with the cPr ring down (26b), H trans to C with the
cPr ring down (26c) and H trans to C with the cPr ring down (26d).
The atomic charges on the double-bond carbons in the dppp complexes (−0.20 e for
1a, −0.22 (=CR2) and −0.55 e (=CH2) for 2a) were found to be the same as for the dbpx
complexes (−0.20 e for 1d, −0.22 (=CR2) and −0.55 e (=CH2) for 2d). The double-bond
carbons trans to P in the P—S complexes had charges 0.2 e lower (more negative) than for
the P—P complexes, −0.22 e for 8, −0.24 e (=CR2) for 9b and −0.58 e (=CH2) for 9a.
When trans to S, the carbons had charges higher (more positive) by 0.6 e than when trans
to P, −0.16 e for 8, −0.18 e (=CR2) for 9a and −0.52 e (=CH2) for 9b. For the hydride
complexes, the atoms trans to P had higher charges. This difference was small for the
double-bond carbons, 0.01–0.04 e, but larger for the hydride, 0.08–0.09 e. The methylene
end of the MCP double-bond had a higher charge than the cyclopropyl end, −0.6 vs.
−0.2 e, which indicated that protonation of the =CH2 would be more likely. According
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Figure 3.16. Structures of [PtH(L)(P—C)] complexes.
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Table 3.5. Atomic Charges on the Double-Bond and Hydride Atoms of Alkene
Complexes.
Compound
Charge (e, 1.602×10−19 C)
=CR2 =CH2 H
[Pt(BCP)(P—S)] 8 −0.22 (trans P)
−0.16 (trans S)
[PtH(BCP)(P—C)] 25a H trans P −0.04 (up) −0.05
−0.06 (down)
[PtH(BCP)(P—C)] 25b H trans C −0.03 (up) −0.14
−0.03 (down)
[Pt(BCP)(dppp)] 1a −0.20
−0.20
[Pt(BCP)(dbpx)] 1d −0.20
−0.20
[Pt(MCP)(P—S)] 9a cPr trans S −0.18 −0.58
[Pt(MCP)(P—S)] 9b cPr trans P −0.24 −0.52
[PtH(MCP)(P—C)] 26a H trans P −0.05 (up) −0.41 (down) −0.07
[PtH(MCP)(P—C)] 26b H trans P −0.04 (down) −0.42 (up) −0.06
[PtH(MCP)(P—C)] 26c H trans C −0.03 (up) −0.38 (down) −0.15
[PtH(MCP)(P—C)] 26d H trans C −0.03 (down) −0.38 (up) −0.15
[Pt(MCP)(dppp)] 2a −0.22 −0.55
[Pt(MCP)(dbpx)] 2d −0.22 −0.55
to the literature mechanism for the allyl formation (Scheme 3.6), attack on the methylene
carbon results in the formation of 2-methyl allyl complexes. While these isomers were
observed experimentally, the fact that the dbpx complex, which formed 42% 18a, had the
same atomic charges as for the dppp complex, which formed 68% 15, indicated that the
factors affecting the product distribution were not simply electronic.
This is supported by the Tolman electronic parameters ν of the phosphines both in this
study and in the reaction of trans-[PtH(NO3)(L)2] (L = PEt3 (ν = 2062 cm
−1), PMe2Ph
(ν = 2067 cm−1), PPh3 (ν = 2069 cm
−1)) with MCP.82,134,135 While there was no data
available for dppp and dbpx, PPh2Et (ν = 2067 cm
−1) and P(o-tol)tBu2 (ν = 2060 cm
−1)
were reasonable approximations.82 The electronic properties of the P—C ligand were more
complicated. No 2-substituted allyl complex was observed with PEt3 or PMe2Ph, which
were on the low and high end respectively of the range of electronic parameters. With
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PPh3, dppp and dbpx, 42–100% of the products were 2-substituted, with the ν values
again at both ends of the range. There was therefore no correlation between the value of
ν and the product distribution.
There was a stronger correlation between the product distribution and the cone angle
of the phosphine ligand. In the reaction of trans-[PtH(NO3)(L)2] with MCP, when the
cone angle was small (PEt3 θ = 132
◦, PMe2Ph θ = 122
◦), only 1-methyl allyl complexes
were formed.82 With PPh3, which had a larger cone angle of 145
◦, the products were
50:50 1-methyl to 2-methyl allyls. A similar trend was seen in the protonation of the
BCP complexes of dppp (θ = 127◦) and dbpx (θ = 138◦),81,82 where no 2-substituted
complex was observed for dppp, and 100% 2-substituted was observed for dbpx. These
trends indicated that steric factors had a significant effect on product distributions.
The protonation of the MCP complexes did not fit this trend, with more 2-substituted
complexes observed with dppp than with dbpx. This suggested that the factors affecting
product distribution were more complicated than those discussed here, and it was likely
that both steric and electronic factors played a part.
In summary, the reaction ∆H values indicated that the 2-substituted complexes were
more stable than the corresponding 1-methyl substituted complexes. In most cases, the
1-methyl complex with the methyl in the syn position was more stable than the anti
isomer, although it was the anti isomer that was formed initially experimentally. This
indicated that the activation energy had a significant effect on complex formation.
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Chapter 4
Platinum(II) Chemistry
4.1 Introduction
Three different types of reactivity were observed when bicyclopropylidene and
methylenecyclopropane were reacted with platinum(II) complexes. These were (i)
ring-opening reactions to form 1,3-dienes, (ii) the coordination of an alkene to form an
η2-alkene complex, and (iii) the formation of a β-chloroalkyl complex.
4.2 1,3-Dienes
Allylidenecyclopropane (ACP) is a 1,3-diene which has a cyclopropyl ring at the end
of one of the double-bonds, and can be produced when bicyclopropylidene undergoes
a single ring-opening reaction. As mentioned previously (Section 2.2), there has been
one report of the formation of ACP from BCP, occurring in the reaction of BCP with
[Pd(OAc)2] and PPh3.
74 The proposed mechanism for this reaction involved the addition
of a palladium hydride across the BCP double-bond, followed by a cyclopropylmethyl to
homoallyl rearrangement and termination by β-hydride elimination. Under the reported
conditions, ACP went on to react with another molecule of BCP to form various oligomers
(see Scheme 1.27).
In the reactions of BCP with the alkyl complexes [PtMe2(1,5-hexadiene)] and
[PtEt2(COD)], ACP was produced (Scheme 4.1). This reaction was also observed with the
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Pt(0) complexes [Pt(C2H4)3], [Pt(COD)2] and [Pt(nb)3] (Section 2.2). With [PtMe2(1,5-
hexadiene)] the reaction was catalytic, converting a ∼1000 fold excess of BCP into ACP
in three days at room temperature, although the [PtMe2(1,5-hexadiene)] was largely
unreacted. Only two equivalents of BCP were converted to ACP in the reaction with
[PtEt2(COD)]. This occurred over one day at room temperature, with the reaction mixture
unchanged over several weeks. While approximately half of the [PtEt2(COD)] reacted with
BCP, no platinum-containing products could be characterised.
[PtR2(L)]
R = Me
= Et
L = 1,5-hexadiene
= COD
Scheme 4.1. Formation of allylidenecyclopropane from Pt(II) alkyl complexes.
The analogous ring-opening reaction of MCP would produce 1,3-butadiene. When
MCP was combined with [PtMe2(1,5-hexadiene)] at room temperature no reaction
occurred. With [PtEt2(COD)], there was a small amount of 1,3-butadiene formed
(10% relative to the amount of [PtEt2(COD)]). However, this was not the major
product. After one day, two new complexes [PtEt(C(CH2)2CH3)(COD)] (27a) and
[Pt(C(CH2)2CH3)2(COD)] (27b) formed in an approximately 2:1 ratio (Scheme 4.2), with
about a third of the [PtEt2(COD)] still unreacted. All of the [PtEt2(COD)] had reacted
after 2 days. The mono-ethyl complex 27a also continued to react with MCP, reaching a
15:85 27a:27b ratio after 30 days, even when 11 eq. of MCP was used.
PtPt Pt
C6D6
2 d, RT
C6D6
30 d, RT
27a 27b
Scheme 4.2. Reaction of [PtEt2(COD)] with MCP.
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While the cyclopropylmethyl motif is fairly common (see Sections 2.2 and 4.4 for
examples from this work), these complexes are the first examples of complexes with stable,
unsubstituted cyclopropylmethyl ligands. The ligands were formed by the Markovnikov
addition of Pt–H across the MCP double-bond, with 27a formed from one equivalent of
MCP, and 27b formed from two equivalents (Scheme 4.2). The Pt–H was generated by
the β-hydride elimination of an ethyl group, as evidenced by the presence of ethene in the
reaction mixture.159 The small amount of butadiene resulted from the anti-Markovnikov
addition of the Pt–H, followed by a cyclopropylmethyl to homoallyl rearrangement and
β-hydride elimination (Scheme 4.3). Allylidenecyclopropane would be produced in the
corresponding reaction from BCP, with only one addition product possible due to the two
identical ends of the double-bond (Scheme 4.4).
4.2.1 NMR Characterisation
For NMR spectra see Figures A.71–A.78. The peaks in the 13C{1H} NMR spectra
of 27a and 27b due to the cyclopropyl carbon directly bound to the metal had very
high 1JPt–C coupling constants (1160.6 and 1178.5 Hz), characteristic of a Pt–C σ-bond
(Table 4.2).93,139 These coupling constants were greater than those of the platinum-bound
carbon of the ethyl ligands in [PtEt2(COD)] and 27a (847.2 and 854.8 Hz respectively).
This indicated that the interaction with the metal was stronger for the cPr ring than for
the sp3 methylene, which has also been observed previously in this work for sp2 cyclopropyl
carbons (see Sections 2.1 and 3.2). The remaining 13C and 1H NMR data (Table 4.1) were
consistent with the assigned structures.
4.3 η2-Alkene Complexes
Platinum(II) η2-alkene complexes of BCP and MCP were synthesised by the displacement
of a neutral ligand from a precursor complex, as with the platinum(0) complexes previously
discussed (Chapter 2). For the Pt(0) complexes, it was an alkene ligand that was displaced.
This was usually ethene, but in the case of the P—S complexes, a norbornene precursor
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Pt Pt
H
Pt
H
Pt
H
+
C2H4+C6D6
RT
Scheme 4.3. Formation of butadiene from [PtEt2(COD)].
Pt Pt
H
Pt
H
Pt
H
+
C2H4+C6D6
RT
Scheme 4.4. Formation of ACP from [PtEt2(COD)].
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Table 4.1. Selected 1H NMR Data of [Pt(L)2(COD)].
a
Compound
δH
cPr CH
3
Et CH
2
Et CH
3
[PtEt
2
(COD)] 1.89 (90.2) 1.54 (79.5)
[PtEt(C(CH
2
)
2
CH
3
)(COD)] 27a 0.73 (66.2) 1.35 (55.9) 1.96 (91.8) 1.51 (74.4)
0.42 (46.5)
[Pt(C(CH
2
)
2
CH
3
)
2
(COD)] 27b 0.86 (66.2) 1.41 (53.5)
0.41 (44.4)
a δ values are given in ppm and J values in Hz. All spectra were measured in C
6
D
6
at room temperature with 40 mg/mL sample. Values in parentheses are platinum
couplings.
Table 4.2. Selected 13C{1H} NMR Data of [Pt(L)2(COD)].
a
Compound
δC
Pt−C cPr CH
3
Et CH
2
Et CH
3
[PtEt
2
(COD)] 20.4 (847.2) 16.6 (32.9)
[PtEt(C(CH
2
)
2
CH
3
)(COD)] 27a 17.4 (1160.6) 14.9 31.2 (27.2) 21.8 (854.8) 16.4 (35.2)
[Pt(C(CH
2
)
2
CH
3
)
2
(COD)] 27b 17.2 (1178.5) 15.9 31.5 (21.3)
a δ values are given in ppm and J values in Hz. All spectra were measured in C
6
D
6
at room
temperature with 40 mg/mL sample. Values in parentheses are platinum couplings.
was used (Section 3.1). It was found that both BCP and MCP were able to displace
ethene from the Pt(II) complex trans–[PtCl2(C2H4)(Py)] to form the η
2-alkene complexes
trans–[PtCl2(L)(Py)] (L = BCP (28), MCP (29)) (Scheme 4.5). The ethene complex
was synthesised in situ by the addition of two equivalents (one per Pt) of pyridine to
Zeise’s dimer ([Pt2Cl4(C2H4)2]). The formation of 28 and 29 occurred immediately upon
the addition of the appropriate alkene to trans–[PtCl2(C2H4)(Py)] at room temperature.
Both of these complexes were unstable, decomposing after approximately 1 hour.
When cis–[PtCl2(DMSO)2] was used, it was one of the DMSO ligands that was
displaced by the alkene to form cis–[PtCl2(L)(DMSO)] (L = BCP (30), MCP (31))
(Scheme 4.6). The reactions occurred over the course of several hours, and did not go to
completion. Unlike the pyridine complexes, these were stable for several days.
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Pt
Cl
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Cl
Cl
N
Cl
Pt
Cl
N
Cl
Pt
Cl
N
N
Cl
Pt
Cl
CDCl3
5 min, RT
28 29
Scheme 4.5. Synthesis of trans–[PtCl2(L)(Py)] (28 and 29) from
trans–[PtCl2(C2H4)(Py)].
Cl
Cl
Pt
S
O
Cl
Cl
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S
O
Cl
Cl
Pt
S
O
S
O
CDCl3
1 hr, RT
30
31
Scheme 4.6. Synthesis of cis–[PtCl2(L)(DMSO)] (30 and 31) from
cis–[PtCl2(DMSO)2].
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4.3.1 NMR Characterisation
For representative NMR spectra, see FIgures A.79–A.81. Compared to the platinum(0)
η2-alkene complexes, the alkene carbons in the Pt(II) complexes had significantly higher
chemical shifts in the 13C{1H} NMR spectra and therefore smaller changes in chemical
shift (∆δ) between the free and coordinated alkene (Tables 2.2 and 4.3). In the BCP
complexes 28 and 30, the chemical shifts of the double-bond carbons were 75.3 and
82.3 ppm respectively, representing ∆δs of 35.3 and 28.3 ppm. For [Pt(BCP)(P—P)]
(1), the chemical shifts were between 29–34 ppm, while in [Pt(BCP)(P—S)] (8), the two
double-bond carbons had shifts at 25.2 and 28.1 ppm, with an average ∆δ of 81 ppm. For
the Pt(II) MCP complexes 29 and 31, the cyclopropyl double-bond chemical shifts (91.6
and 97.34 ppm) were ∼30 ppm higher than the methylene double-bond carbons (59.8 and
67.5 ppm), twice the ∼15 ppm difference in [Pt(MCP)(P—P)] (2). The cPr carbons also
had a lower ∆δ (39.5 and 33.7 ppm) than the methylene carbons (43.7 and 36.0 ppm).
Again, the same resonances in the Pt(0) MCP complexes 2 and [Pt(MCP)(P—S)] (9)
appeared at significantly lower shifts, 33–43 ppm for the cPr double-bond carbon and
22–28 ppm for the methylene carbon (due to the low intensity of the signal, the NMR
data for the cPr carbon in 9 could not be obtained). The average ∆δ was therefore 93 ppm
for the cPr carbon and 78 ppm for the methylene carbon.
The magnitude of ∆δ gives a good estimate of the electron density around the alkene
carbons, with a larger upfield shift of the resonance upon coordination (larger ∆δ)
indicative of a greater electron density.140,149–151 A larger ∆δ also indicates that there
is a larger degree of pi back-bonding. Between the Pt(0) and Pt(II) complexes, there was
a ∼50 ppm difference in ∆δ for the cPr double-bond carbons and a ∼44 ppm difference
for the methylene double-bond carbons. This was consistent with there being a higher
metal electron density to be shared through back-donation in d10 Pt(0) complexes than
in d8 Pt(II) complexes.
There was a similar lowering of the magnitude of the 1JPt–C coupling constants in
the Pt(II) complexes compared the the Pt(0) complexes. In the BCP complexes 28 and
30, 1JPt–C of the cPr double-bond carbons were 248.5 and 251.8 Hz respectively. In 1,
101
Table 4.3. Selected NMR Data of [PtCl2(η
2-alkene)(L)].a
Compound
cPr =CH
2
=CR
2
δH δC δH δC
1
JPt–C δC
1
JPt–C
trans–[PtCl
2
(BCP)(Py)] 28 1.58 10.6 75.3 248.5
1.12
cis–[PtCl
2
(BCP)(DMSO)] 30 1.25 12.5 82.3 251.8
0.85 11.5
trans–[PtCl
2
(MCP)(Py)] 29 1.62 10.2 5.02 59.8 91.6
1.32
cis–[PtCl
2
(MCP)(DMSO)] 31 1.88 12.6 4.81 67.5 141.0 97.3 277.5
1.55 4.64
1.38
1.28
a δ values are given in ppm and J values in Hz. All spectra were measured in
CDCl
3
at room temperature with 40 mg/mL sample.
1JPt–C was 410–456 Hz, ∼200 Hz larger, while in 8 1JPt–C was even higher (579.0 and
656.6 Hz), a difference of as much as 400 Hz. For the cPr double-bond carbon in the MCP
complex 31, 1JPt–C was slightly higher than in the BCP complexes, 277.5 Hz, an average
of ∼220 Hz lower than 2. Due to the broadness of the spectra of 29, no coupling data
could be obtained. The 1JPt–C of the methylene carbon in 31 was also lower than those
of 2 at 141.0 Hz, a difference of ∼27 Hz, a smaller difference than for the cPr carbons.
4.4 β-Chloroalkyl Complexes
The polymerisation of halogenated monomers such as vinyl chloride typically occurs
through a radical mechanism.160–163 However, this method is problematic as it can lead
to a range of “defect sites”, which decrease the thermal stability of the resulting polymer.
An alternative pathway involves insertion of the alkene monomer into a metal alkyl
bond, forming a halogenated alkyl ligand. Chain propagation would then occur with
the coordination of another monomer molecule, followed by another insertion step. It is
thought that this mechanism would lead to a polymer that contains fewer defects, as well
as allowing greater control over polymer structure by using tailored catalysts.160,162
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When vinyl chloride was reacted with a variety of both early- and late-transition
metal catalysts, it was found that the insertion step was followed by a rapid β-chloride
elimination to form a M–Cl bond.160–163 There are two possible modes of insertion of
vinyl chloride into a M–R bond (Scheme 4.7). For 2,1-insertion, the R group attaches
to the methylene carbon, leading to an α-chloroalkyl ligand. For 1,2-insertion, the R
group attaches to the same carbon as the Cl, and a β-chloroalkyl ligand is produced.
While the 2,1-insertion is favoured theoretically, this product was never observed. Either
the 1,2-insertion product was the only one that formed, or the 2,1-product underwent a
facile isomerisation to form the 1,2-product.162,164,165 A very fast β-chloride elimination
reaction then occurred. The elimination proceeded more rapidly than the coordination
of a second monomer, preventing the propagation of the polymer chain. Complexes of
the early transition metals are more prone to β-halogen elimination than those of the
late transition metals due to the relative strengths of the M–X and M–C bonds.160,162
Calculations on a palladium phosphine species also showed that β-halide elimination is
both thermodynamically and kinetically more favourable than β-hydride elimination.166
LnM
R
LnM R
Cl
+
LnM
Cl
R
LnM
Cl
R
Cl
1,2-insertion2,1-insertion
Scheme 4.7. Vinyl chloride insertion into M–R.
Due to the facile nature of β-halide elimination, only a handful of complexes
that contain β-haloalkyl ligands have been synthesised.167 The majority were plat-
inum(IV) complexes, [PtCl5(CH2CH2Cl)]
2− 168 and a range of complexes of the formula
[PtX3(CH2CHRX)(2,9-Me2-phen)] (X = Cl, Br, 2,9-Me2-phen = 2,9-dimethyl-1,10-
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phenanthroline).169 An iridium complex, [IrBr2(CH2CH2Br)(CO)(PMe2Ph)2],
170 has also
been synthesised, as well as complexes with ligands that contain multiple halogens,171
particularly perfluorinated ligands.172–177 Except for the perfluorinated complexes, these
β-haloalkyl complexes were synthesised by the addition of X2 to an alkene complex.
4.4.1 Synthesis From Dichloro Complexes
It was found that when bicyclopropylidene was reacted with a range of platinum precursors
that contained chloride ligands, BCP inserted into the Pt–Cl bond to form complexes
with stable β-chloroalkyl ligands. The reactions with [PtCl2(SEt2)2] (a mixture of
isomers),178 trans–[PtCl2(NC
tBu)2] and trans–[PtCl2(Py)2] yielded the complexes trans–
[Pt(C(CH2)2C(CH2)2Cl)Cl(L)2] (L = SEt2 (32), NC
tBu (33), Py (34a)) respectively
(Scheme 4.8). The formation of 32 takes up to 5 days with an excess of BCP, while the
formation of 33 takes 2 days with 1 eq. BCP. The formation of 34a occurred over 2 days.
However, the reaction did not go to completion, with 34a making up 30% of the species
in solution by 1H NMR spectroscopy, and a large amount of undissolved solid remaining.
After two weeks, a second new complex formed from the trans–[PtCl2(Py)2] in a 1:3 ratio
relative to 34a. This complex could not be characterised.
When cis–[PtCl2(NC
tBu)2] and cis–[PtCl2(Py)2] were used, no reaction occurred.
Given this, it is likely that only the trans form of [PtCl2(SEt2)2] undergoes a reaction
with BCP. The cis and trans forms of [PtCl2(SEt2)2] can interconvert in the presence of
SEt2, forming an equilibrium mixture.
179 The need for the interconversion of the isomers
could explain the long reaction time with BCP.
When two equivalents of BCP (one per Pt) was reacted with Zeise’s dimer
([Pt2Cl4(C2H4)2]) and two equivalents pyridine (one per Pt), initially an η
2-alkene
complex, trans–[PtCl2(BCP)(Py)] (28) was formed (Section 4.3). This complex
was unstable, and decomposed after an hour. When a second equivalent of Py was
added after the formation of 28, the alkene complex reacted immediately formed the
β-chloroalkyl complex cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b). Complex 34b could
also be synthesised directly by the addition of two equivalents of BCP (one per Pt) and
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L
Cl
L
Cl
[PtCl2(L)2]
L = SEt2
   = NCtBu2
   = Py
TMPA
CDCl3
2-5 d, RT
32
33
34a
Scheme 4.8. Synthesis of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(L)2] from [PtCl2(L)2]
(32–34a).
four equivalents of Py (two per Pt) to Zeise’s dimer. This reaction occurred immediately
upon the mixing of the reagents (Scheme 4.9).
Comparable reactivity was observed with MCP. Again, when only two equivalents
of Py was used a η2-alkene complex formed, trans–[PtCl2(MCP)(Py)] (29). When a
further two equivalents of Py (one per Pt) was added, cis–[Pt(C(CH2)2CH2Cl)Cl(Py)2]
(34c) was formed (Scheme 4.10). The corresponding reaction of [Pt2Cl4(C2H4)2] with
two equivalents of MCP (one per Pt) and four equivalents of Py (two per Pt) also
produced 34c). The analogous reactions of MCP with [PtCl2(SEt2)2], cis– and trans–
[PtCl2(NC
tBu)2] and cis– and trans–[PtCl2(Py)2] did not occur.
Pt
Py
Py
Cl
Cl
0.5 [Pt2Cl4(C2H4)2]
Py
Cl
Pt
Cl
1 eq.
2 eq. Py
1 eq.
1 eq.
Py
1 eq.
Py
CDCl3
5 min, RT
CDCl3
5 min, RT
CDCl3
5 min, RT
34b
28
Scheme 4.9. Synthesis of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b) from
[Pt2Cl4(C2H4)2].
The ethene complex [PtCl2(C2H4)(Py)] in the presence of pyridine is in equilibrium
with the 5-coordinate complex [PtCl2(C2H4)(Py)2].
180 The availability of the 5-coordinate
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Scheme 4.10. Synthesis of cis–[Pt(C(CH2)2CH2Cl)Cl(Py)2] from [Pt2Cl4(C2H4)2]
(34c).
complex suggests that the mechanism for the formation of the β-chloroalkyl complexes
would be associative, rather than dissociative. Initially, BCP or MCP would coordinate
to form an intermediate η2-alkene complex (as with 28 and 29). This would be followed
by the addition of the second equivalent of pyridine and insertion of the alkene into
the Pt–Cl bond. The cis-pyridine complexes formed the most rapidly of the β-chloroalkyl
complexes (by several days), and had isolatable alkene complex intermediates, 28 and 29,
which were able to be converted to 34b and 34c by the addition of pyridine, supporting
this mechanism.
4.4.2 Synthesis of Phosphine Complexes
The synthesis of a phosphine complex containing a β-chloroalkyl ligand was considered
desirable due to the inclusion of another NMR-active nuclei, increasing the amount of
characterisation data available. However, no reaction occurred when either BCP or
MCP was combined with [PtCl2(PR3)2] complexes. Instead, phosphine complexes were
synthesised by the addition of the phosphine to a complex with a β-chloroalkyl ligand
already installed.
The thioether complex trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] (32) was treated
with a number of phosphines, both mono- and bi-dentate. When triphenylphosphine was
used, the SEt2 was successfully displaced by the PPh3. However, a β-chloride elimination
occurred, forming cis–[PtCl2(PPh3)2] as well as free BCP. The chelating phosphines
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1,3-bis(diphenylphosphino)propane (dppp) and 1,2-bis(diphenylphosphino)ethane (dppe)
were also used. In these reactions, there was again a β-chloride elimination, producing
the Pt(II) bis-diphosphine complexes [Pt(P—P)2]Cl2 (P—P = dppp (35a), dppe (35b))
and free BCP. The phosphine-chloride complexes were identified by 31P NMR data.181,182
Single crystals of 35a were grown by layering a frozen solution of 32 in CDCl3 with
a solution of dppp in CDCl3 and allowing to warm to room temperature, and an X-ray
crystal structure obtained (Figure 4.1, Table 4.4).183 The asymmetric unit contained only
half of the molecule, consisting of a complete dppp ligand as well as one of the chloride
counter ions and three of the six CDCl3 solvent molecules. The platinum coordination
geometry was close to square planar, with a P1–Pt–P2 angle of 87.23(3)◦. This is
smaller than the corresponding angle in the quasi-tetrahedral Pt(0) complex [Pt0(dppp)2]
(97.76(4)◦).90 The Pt–P bond lengths in 35a were 2.3647(8) and 2.3790(8) Å, longer
than those in [Pt0(dppp)2] (2.286(1) Å). The chelate ring had a ‘chair’ conformation,
typical for dppp complexes. In 35a, the two chelate rings were rotated by 180◦ relative
to each other, while in [Pt0(dppp)2] the rings were rotated by 87.20(2)
◦, according to the
P1–Pt–P2 planes. While 35a crystallised as a CDCl3 solvate in the orthorhombic Pccn
space group, [Pt0(dppp)2] crystallised solvent-free in the monoclinic C 2/c space group.
The Cl– counter ion was separated by 4.197 Å from the Pt, indicating that it was not
coordinated. The [PtII(dppp)2]
2+ ions were arranged in 2D layers, with the Cl– anions
and solvent between the layers (Figure 4.2).
When 1,3,5-triaza-7-phosphaadamantane (PTA) was added to 32, the SEt2 ligands
were again successfully displaced by the phosphine. As with the other phosphines,
cis–[PtCl2(PTA)2] and free BCP were formed.
184 However, in this case a short-lived
(approx. 1 hr) complex formed inititally. This complex is believed to be trans–
[Pt(C(CH2)2C(CH2)2Cl)Cl(PTA)2] (36a) (Scheme 4.11). The reaction of PTA with
trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(NC
tBu)2] (33) also resulted in the formation of 36a
and subsequently cis–[PtCl2(PTA)2].
The synthesis of cis–phosphine complexes proved to be more successful than trans–
phosphine complexes. When cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b) was treated
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Figure 4.1. ORTEP diagram of [Pt(dppp)2]Cl2 · 6CDCl3 (35a) showing 50%
probability thermal ellipsoids. H atoms and CDCl3 solvent molecules have been omitted
for clarity.
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Figure 4.2. Layered packing of [Pt(dppp)2]Cl2 · 6CDCl3 (35a).
Table 4.4. Crystallographic Data for [Pt(dppp)2]Cl2 · 6CDCl3 (35a).
Chemical formula C60H58Cl20P4Pt
Formula weight 1687.77
a, Å 26.2042(9)
b, Å 15.3120(5)
c, Å 16.7930(5)
α, deg 90.00
β, deg 90.00
γ, deg 90.00
V, Å3 6738.0(4)
Z 4
Space group Pccn
T, K 160
λ, Å 0.71073
Dcalcd, g cm−3 1.664
µ, mm−1 2.890
R1, [I> 2σ(I)]a 0.0373
wR2 (all data)a 0.0745
a Definition of R indices: R1
= Σ||Fo|−|Fc||/Σ|Fo|; wR2 =
[Σw(Fo
2
−Fc
2)2/Σw(Fo
2)2]
1/2
.
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+
CDCl3
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P
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32
33
36a
Scheme 4.11. Synthesis of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(PTA)2] (36a) from
trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(L)2] (32 and 33).
with either PTA, dppp or PPh3, the products were β-chloroalkyl complexes cis–
[Pt(C(CH2)2C(CH2)2Cl)Cl(P)2] ((P)2 = (PTA)2 (36b), dppp (37a), (PPh3)2 (38a))
which were stable in solution over several weeks (Scheme 4.12). The reactions also
generated a small amount of cis–[PtCl2(P)2]. The amount of cis–[PtCl2(PTA)2] produced
was significantly greater than for the other phosphines. As cis–[PtCl2(PTA)2] was
only partially soluble, the exact amount was not calculated, while there was 30% cis–
[PtCl2(PPh3)2] and 11% cis–[PtCl2(dppp)2].
Pt
Py
Py
Cl
Cl
Pt
P
P
Cl
Cl
= PTA
= dppp
= PPh3
P
P
CDCl3
5 min-4d, RT
34b 36b
37a
38a
Scheme 4.12. Synthesis of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(P)2] from
cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b).
In the reaction of 34a with PPh3, a complex with only one phosphine ligand was
formed initially (38b). The 31P{1H} and 13C{1H} NMR data (see below) indicated that
it was the pyridine trans to the chloride that was displaced. The bis(phosphine) complex
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38a began to form after an hour. The reaction did not reach completion; after 4 days there
was 53% 38a, 8.5% monophosphine complex, 8.5% PPh3 and 30% cis–[PtCl2(PPh3)2],
with the ratios remaining stable over several weeks. With dppp, 37a formed initially,
reaching 85% with 11% [PtCl2(dppp)] after 2 days.
The addition of phosphines to the β-chloroalkyl complex formed from MCP (cis–
[Pt(C(CH2)2CH2Cl)Cl(Py)2], 34c) also resulted in the formation of phosphine complexes
cis–[Pt(C(CH2)2CH2Cl)Cl(P)2] ((P)2 = (PTA)2 (36c), dppp (37b)), as well as cis–
[PtCl2(P)2] (Scheme 4.13). These complexes were all unstable, decomposing into the
dichloride complexes over 1 (dppp) to 5 (PTA) days. Again, due to the insolubility of
cis–[PtCl2(PTA)2], the exact amount formed was not calculated, with 36c comprising
approximately 50% of the species in solution after 24 hrs. With dppp, the solution
contained 58% 37b, 26% cis–[PtCl2(dppp)] and 16% [Pt(dppp)2]Cl2 after 10 min. There
was no bisphosphine β-chloroalkyl complex formed in the reaction with PPh3. Instead,
the monophosphine complex with the phosphine cis to the β-chloroalkyl ligand (38c) was
formed, decomposing to form cis–[PtCl2(PPh3)2] over 4 hours (Scheme 4.14).
Pt
Py
Py
Cl
Cl
Pt
P
P
Cl
Cl
P
cis-[PtCl2(P)2]
+
= PTA
= dppp
P
CDCl3
5 min, RT
1-5 d, RT
CDCl3
34c 36c
37b
Scheme 4.13. Synthesis of cis–[Pt(C(CH2)2CH2Cl)Cl(P)2] from
cis–[Pt(C(CH2)2CH2Cl)Cl(Py)2] (34b).
It appeared that the stability of the β-chloroalkyl complexes was dependent on the
cone angle, θ, of the phosphine ligand. Complexes of the smallest phosphine, PTA (θ
= 115◦)185 were the most stable. The trans complex 36a was the only β-chloroalkyl
complex with trans phosphines to be formed. For the complexes formed from MCP, the
PTA complex 36c was stable for several days longer than the dppp complex 37b (θ =
127◦),82 while no bisphosphine complex was observed with PPh3 (θ = 145
◦).82
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Scheme 4.14. Synthesis of [Pt(C(CH2)2CH2Cl)Cl(Py)(PPh3)] (38c) from
cis–[Pt(C(CH2)2CH2Cl)Cl(Py)2] (34b).
4.4.3 NMR Characterisation
For representative NMR spectra, see Figures A.83–A.105. The various NMR spectra of
the β-chloroalkyl complexes were distinctive. The 31P{1H} NMR spectra of 36b–38b
showed two doublets with 2JP–P couplings in the range of 14.9–25.9 Hz, typical for cis
couplings. The peak due to the phosphorus trans to the β-chloroalkyl ligand had a
low 1JPt–P coupling constant of 1522–1684 Hz, with those of the complexes from MCP
having values larger by ∼30 Hz. This low value was consistent with being trans to a
σ-bound cPr ring.93,139 The 1JPt–P coupling constant of the other peak was very large,
3884–4490 Hz, significantly larger than the 1JPt–P of the phosphines trans to Cl in cis–
[PtCl2(P)2] (3350–3674 Hz).
181,184 This difference can be ascribed to the difference in cis-
influence between Cl and cPr. While the cis-influence has not been reported for cPr, it
was found that a cis-influence series was approximately the reverse of the corresponding
trans-influence series.186 The 1JPt–P coupling constant for the phosphines cis to Cl in
[PtX(PPh3)3] was 444 Hz smaller than that of Me, which has a lower trans-influence
than cPr.139 It would therefore be expected that 1JPt–P would be significantly higher
in cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(P)2] and cis–[Pt(C(CH2)2CH2Cl)Cl(P)2] than in cis–
[PtCl2(P)2].
For the mono-phosphine complexes [Pt(C(CH2)2C(CH2)2Cl)Cl(Py)(PPh3)] and
[Pt(C(CH2)2CH2Cl)Cl(Py)(PPh3)],
1JPt–P were 4735 and 4661 Hz, respectively. As
these values were more similar to those trans to the chloride than those trans to the
β-chloroalkyl ligands in 36–38, it was therefore the pyridine trans to the Cl that was
displaced by the phosphine.
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Table 4.5. Selected NMR Data of [Pt(C(CH2)2CR2Cl)Cl(L)2].
a
Compound
Pt cPr Cl cPr Pt−C Cl−C
δP
1
JPt–P
δH δC δH δC δC
1
JPt–C δC
trans–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(SEt
2
)
2
] 32 0.36 (29.4) exo 16.4 0.83 14.3 −0.4 1011 57.1
0.21 (63.0) endo 0.77
trans–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(NCtBu)
2
] 33 0.30 14.7 1.03 15.8 0.0 953 55.2
0.73
trans–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(Py)
2
] 34a −0.03 (37.9) exo 13.1 0.41 12.9 1.1 1202 56.2
−0.15 (50.8) endo −0.25
cis–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(Py)
2
] 34b 0.50 endo 15.0 1.34 11.0 −11.1 970 65.9
0.36 exo 1.05
cis–[Pt(C(CH
2
)
2
CH
2
Cl)Cl(Py)
2
] b 34c 0.52 (29.6) endo 14.3 −15.6 c 76.8
0.32 (19.6) exo
trans–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(PTA)
2
] 36a 0.44 c 1.03 c c c c −59.2 3000
0.27 0.76
cis–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(PTA)
2
] 36b 0.92 13.4 1.69 16.7 15.5 [121.8, 8.6] 809 64.8 −57.9 [15.6] 3949
0.80 8.7 1.31 15.7 −65.8 [15.6] 1522
0.49 0.92
0.27 0.85
cis–[Pt(C(CH
2
)
2
CH
2
Cl)Cl(PTA)
2
] 36c c c c c −58.9 [14.9] 3884
−64.8 [14.9] 1530
cis–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(dppp)] 37a 0.48 13.3 1.05 17.1 15.6 [124.5, 6.8] 789 63.6 −1.8 [25.9] 1654
0.35 6.1 0.71 12.2 −2.7 [25.9] 4133
0.20 0.48
−1.22 −0.46
cis–[Pt(C(CH
2
)
2
CH
2
Cl)Cl(dppp)] 37b c c c c 0.4 [25.2] 4051
0.2 [25.2] 1684
cis–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(PPh
3
)
2
] 38a 0.77 13.3 1.34 19.2 15.7 [126.7, 8.0] 798 63.3 22.7 [15.6] 4490
0.57 8.1 0.85 15.8 16.7 [15.6] 1646
0.41 0.69
−0.85 −0.14
[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(Py)(PPh
3
)] 38b c c c c −8.7 [9.2] 940 c 10.8 4738
[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(Py)(PPh
3
)] 38c c c c c 13.5 4661
a δ values are given in ppm and J values in Hz. All spectra were measured in CDCl
3
at room temperature with 40 mg/mL sample unless otherwise
noted. Values in parentheses are 195Pt couplings, values in square brackets are 31P couplings. b Spectra collected in d6-acetone. c NMR data could
not be obtained.
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The 13C{1H} NMR data of the β-chloroalkyl ligands in 32–38 was characteristic of
these complexes (Table 4.5). Due to the short lifetimes, 13C{1H} NMR data could not
be obtained for 36a, 36c, 37b, 38b and 38c. The sp3 carbons directly bound to the
platinum in 32–38 had very large 1JPt–C coupling constants (1JPt–C = 989–1202 Hz),
indicative of Pt–C σ-bonds.93,139 The magnitude of these coupling constants reflected the
trans-influence of the trans ligand, with Cl and Py approximately the same while the
phosphines, with higher trans-influences, had lower 1JPt–C.93 The nature of the trans
ligand also had a significant effect on the chemical shift of the platinum-bound carbon.
When trans to P, the chemical shift appeared at 15 ppm. In contrast, when trans to Cl,
the chemical shift dropped by 15 ppm to 0 ppm and by about 25 ppm to approximately
−11 ppm when trans to Py. While the majority of the NMR data for 38b could not be
obtained due to the reactivity of this species, the use of carbon-13 enriched BCP enabled
the detection of the peak due to the carbon bound to the platinum. Both the chemical
shift (−8.7 ppm) and 1JPt–C (940 Hz) was consistent with the β-chloroalkyl ligand being
trans to Py rather than PPh3, as indicated by the
31P NMR data.
The carbons attached to the chlorines had resonances at δC = 55–66 ppm, except
for 34c, which had a resonance at 76.8 ppm. This was due to the fact that this was
a methylene rather than a cyclopropyl carbon. None of these resonances showed 2JPt–C
couplings. The cyclopropyl methylene carbons appeared at 6–19 ppm, within the typical
range for cPr carbons.
The 1H NMR resonances of the CH2 protons of the
cPr ring bound to the Pt in 32–38
appeared at low chemical shifts, between −1.22 and 0.92 ppm. The protons of the cPr
ring bound to the Cl appeared between −0.46 and 1.34 ppm, at shifts more typical of
organic cyclopropyl protons, except in 34a and the phosphine complexes. For 34a, all
of the shifts were lower than in the other complexes, with the Cl cPr protons appearing
at 0.41 and −0.25 ppm. In the phosphine complexes, the cPr peaks were spread over a
wider range than for the other complexes, although the range of the Pt cPr peaks was
lower than the Cl cPr peaks. Generally, the resonances appeared as four sharp peaks,
each integrating for two protons, corresponding to the exo and endo environments of
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(i)
(ii)
(iii)
Figure 4.3. 1H NMR spectra showing the cyclopropyl peaks for
(i) trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] (32) (500 MHz, RT, 100 mg/mL, CDCl3),
(ii) cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34a) (500 MHz, RT, 40 mg/mL, CDCl3) and
(iii) trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(PTA)2] (36a) (300 MHz, RT, 40 mg/mL, CDCl3).
* signifies peaks belonging to other species.
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the two rings (Figure 4.3). Again, the phosphine complexes were an exception due to
the JP–H couplings. The peaks of the Cl cPr ring protons did not have 195Pt satellites,
while Pt cPr ring protons showed 195Pt coupling, except in 33 (due to overlap of the
peaks), 34b and the phosphine complexes. The endo protons had higher JPt–H coupling
constants (50.8–63.0 Hz) than the exo (29.4–37.9 Hz). For 34c, the magnitudes of JPt–H
were smaller (29.6 and 19.6 Hz), although the endo coupling was still larger than the exo
coupling. In most cases, the endo/exo geometry of the rings was confirmed by NOESY
correlations (Figure 4.4).
Pt
L
L
L
Cl
Hendo
Hexo
Figure 4.4. Geometry of the endo/exo protons in β-haloalkyl complexes.
The NMR data of the β-chloroalkyl complex formed from MCP (34c) was used to
determine the mode of insertion into the Pt–Cl bond. The 1H NMR data showed a singlet
peak at 4.13 ppm with JPt–H = 24.6 Hz and two sharp peaks at 0.52 and 0.32 ppm, with a
similar lineshape to the cPr CH2 resonances in the complexes from BCP. The cyclopropyl
methylene peaks had JPt–H couplings, which were only present in the cyclopropyl ring
attached to the metal in the other complexes. The low shifts of the cyclopropyl peaks
also indicated that the cPr ring was attached to the metal, rather than the methylene.
This was supported by the 13C NMR data. There was a peak at −15.6 ppm, with the
high field shift indicating that this was the carbon attached to the platinum, although
no 1JPt–C coupling could be found even after running a 20 hr 13C experiment on the 600
MHz NMR instrument due to the low solubility of 34c. The corresponding resonance in
34b appeared at −11.09 ppm. There was also a resonance at 76.8 ppm which had an
HSQC correlation to the peak in the 1H NMR spectrum at 4.13 ppm due to the carbon
attached to the chlorine. The carbon peak was at significantly lower field than that in
34b, which appeared at 65.9 ppm. Typically, sp3-cyclopropyl peaks appear at higher field
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than sp3-methylene peaks, indicating that this peak was due to the methylene, and that
the cyclopropyl ring was therefore attached to the metal. This was further supported
by the 31P NMR spectra of 36c and 37b, formed by addition of the phosphines to 34c.
When trans to the cPr ring in the complexes formed from BCP, the 1JPt–P coupling
constant was 1522–1654 Hz. In the complexes formed from MCP, 1JPt–P was very similar,
1530–1680 Hz. Greater differences would be expected if the methylene was attached to
the metal.
Due to the short lifetime of 36a, 13C NMR data could not be obtained, even when
carbon-13 enriched BCP was used. The 1H NMR spectrum showed the same characteristic
sharp peaks as the other β-chloroalkyl complexes (Figure 4.3). The chemical shifts were
in good agreement with those of 32–34c, with peaks at 0.27, 0.44, 0.76 and 1.03 ppm
(Table 4.5). By analogy, the peaks at 0.27 and 0.44 ppm would correspond to those of
the cPr ring attached to the Pt, while those at 0.76 and 1.03 ppm would correspond to
those of the cPr ring attached to the Cl. In the 31P NMR spectrum, there was a singlet
peak with a 1JPt–P coupling constant of 3000 Hz. This indicated that the geometry of the
complex was trans , as the cis complexes had two phosphine environments. The coupling
constant was in the range expected for two trans phosphines.181 It was much smaller than
the 1JPt–P of phosphines trans to Cl in cis complexes, typically ∼3500 Hz, and 3350 Hz
for cis–[PtCl2(PTA)2] specifically.
181,184
4.4.4 Computational Studies
Computational models were used in order to determine what structural factors led to the
formation of a stable β-chloroalkyl complex. All structures were optimised and frequencies
calculated using density functional theory calculations (B3LYP),154–157 optimised using
the def2-TZVP basis set,158 of triple ζ quality. Complexes with β-chloroalkyl ligands
formed from bicyclopropylidene were determined to be stable experimentally, and a
number of these were formed (Section 4.4). Complexes were also formed experimentally
frommethylenecyclopropane, with the cyclopropyl ring directly bound to the metal. These
were unstable, decomposing via a β-chloride elimination.
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Figure 4.5. Structures of β-chloroalkyl complexes.
There were two potential structural factors that could contribute to the unusual
stability of the cyclopropyl β-chloroalkyl complexes. These were the degree of sub-
stitution (BCP is tetrasubstituted), and the presence of cPr rings. A number of
β-chloroalkyl complexes with varying substituents were optimised. These were trans–
[Pt(CH2CH2Cl)Cl(NC
tBu)2] (39), which had no carbon containing substituents on
the β-chloroalkyl ligand, trans–[Pt(CH2CMe2Cl)Cl(NC
tBu)2] (40a), disubstituted with
methyl groups on the β-carbon, trans–[Pt(CMe2CH2Cl)Cl(NC
tBu)2] (40b), disubstituted
with methyl groups on the α-carbon, trans–[Pt(CMe2CMe2Cl)Cl(NC
tBu)2] (41), tetra-
substituted with methyl groups, trans–[Pt(CH2C(CH2)2Cl)Cl(NC
tBu)2] (42a), substi-
tuted with a cPr ring on the β-carbon, trans–[Pt(C(CH2)2CH2Cl)Cl(NC
tBu)2] (42b), sub-
stituted with a cPr ring on the α-carbon, and trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(NC
tBu)2]
(33), substituted with two cPr rings (Figure 4.5). Structures were also optimised for
the respective cis– and trans–[PtCl2(L)(NC
tBu)] alkene complexes (L = C2H4 (43),
CH2CMe2 (44), C2Me4 (45), MCP (46), BCP (47), trans = a, cis = b), the free
alkenes, NCtBu and trans–[PtCl2(NC
tBu)2].
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Scheme 4.15. Formation of β-chloroalkyl complexes from trans–[PtCl2(NC
tBu)2].
Table 4.6. Reaction ∆H for the Formation of β-Chloroalkyl Complexes.
Compound ∆H (kJ mol−1)
trans–[Pt(CH2CH2Cl)Cl(NC
tBu)2] 39 85.1
trans–[Pt(CH2CMe2Cl)Cl(NC
tBu)2] 40a 111.8
trans–[Pt(CMe2CH2Cl)Cl(NC
tBu)2] 40b 138.1
trans–[Pt(CMe2CMe2Cl)Cl(NC
tBu)2] 41 165.4
trans–[Pt(CH2C(CH2)2Cl)Cl(NC
tBu)2] 42a 68.3
trans–[Pt(C(CH2)2CH2Cl)Cl(NC
tBu)2] 42b 67.0
trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(NC
tBu)2] 33 51.5
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Figure 4.6. Reaction ∆H for the formation of β-chloroalkyl complexes From
[PtCl2(NC
tBu)2].
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Scheme 4.16. Formation of [PtCl2(L)(NC
tBu)] via β-chloride elimination.
Table 4.7. Reaction ∆H for the Formation of [PtCl2(L)(NC
tBu)] Through β-Chloride
Elimination.
∆H (kJ mol−1)
Compound trans cis
trans–[Pt(CH2CH2Cl)Cl(NC
tBu)2] 39 −80.1 −70.3
trans–[Pt(CH2CMe2Cl)Cl(NC
tBu)2] 40a −88.3 −72.2
trans–[Pt(CMe2CH2Cl)Cl(NC
tBu)2] 40b −114.5 −98.5
trans–[Pt(CMe2CMe2Cl)Cl(NC
tBu)2] 41 −113.2 −106.0
trans–[Pt(CH2C(CH2)2Cl)Cl(NC
tBu)2] 42a −66.5 −51.2
trans–[Pt(C(CH2)2CH2Cl)Cl(NC
tBu)2] 42b −65.2 −49.9
trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(NC
tBu)2] 33 −49.4 −38.7
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Figure 4.7. Reaction ∆H for the formation of [PtCl2(L)(NC
tBu)] through β-chloride
elimination.
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Figure 4.8. Energy diagram for the formation of [PtCl2(L)(NC
tBu)] from
[PtCl2(NC
tBu)2] via β-chloroalkyl complexes.
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The reaction ∆H values for the formation of the β-chloroalkyl complexes from the ad-
dition of the appropriate alkene to trans–[PtCl2(NC
tBu)2] were calculated (Scheme 4.15,
Table 4.6, Figures 4.6 and 4.8). This reaction was observed experimentally for BCP, but
did not occur with MCP. The reaction ∆H for the decomposition of the β-chloroalkyl
complexs via β-chloride elimination, forming either the trans or cis alkene complex
[PtCl2(L)(NC
tBu)] (Scheme 4.16), was also calculated (Table 4.7, Figures 4.7 and 4.8).
The species used in the calculations were isolated molecules in the gas phase, so the
absolute values of ∆H thus obtained were not necessarily those for the experimental
systems. However, the calculated values of reaction ∆H were considered to be accurate
indicators of the trends in stability of the complexes, within the limits of the theoretical
description. Transition state structures were not calculated, so no kinetic information was
obtained.
The reaction ∆H for both the formation from trans–[PtCl2(NC
tBu)2] and the
β-chloride eliminations indicated that the complexes with cyclopropyl ring substituents
were the most stable. In the trans–[PtCl2(NC
tBu)2] reaction, the three
cPr complexes
(42a, 42b and 33) had the lowest ∆H values, 68.3, 67.0 and 51.5 kJ mol−1 respectively,
indicating that these reactions were the most likely to occur. The difference between
the two monosubstituted cPr complexes was small, in favour of the α-substituted
complex by 1.3 kJ mol−1. There was a greater difference between the mono- and di-
substituted complexes, with 33 15.5 kJ lower than 42b. With regard to the β-chloride
eliminations, the∆H values were the highest for the cPr substituted complexes (−66.4 and
−51.2 kJ mol−1 for 42a, −65.1 and −49.9 kJ mol−1 for 42b, −49.4 and −38.7 kJ mol−1
for 33), indicating that the reactions were less likely to occur and that the β-chloroalkyl
complexes were therefore the most stable. The formation of the trans alkene complexes
was more favourable than the cis, with differences of 10.7–15.3 kJ mol−1. Again, the
dicyclopropyl complex was more stable than either of the monocyclopropyl complexes
and the α-substituted complex was slightly more stable than the β-substituted.
The unsubstituted complex 39 was less stable than the cyclopropyl complexes but
more stable than the methyl complexes. For the trans–[PtCl2(NC
tBu)2] reaction, ∆H
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was 85.1 kJ mol−1, while for the β-Cl eliminations, ∆H was −80.1 and −70.2 kJ mol−1
for the trans and cis alkene complexes respectively. The methyl substituted β-chloroalkyl
complexes were the least stable in both the trans–[PtCl2(NC
tBu)2] reaction and the
β-chloride eliminations. The tetramethyl complex 41 had the highest ∆H for the trans–
[PtCl2(NC
tBu)2] reaction (165.4 kJ mol
−1), and the lowest for the β-Cl elimination
forming the cis alkene complex (−106.0 kJ mol−1), indicating that it was the least stable
of all the complexes studied. The α-substituted dimethyl complex 40b had a slightly
lower ∆H for the trans alkene reaction than 41 (−114.5 v.s. −113.2 kJ mol−1), but
had a higher ∆H for the cis alkene reaction (−98.5 kJ mol−1) and a lower ∆H for the
dichloride reaction (138.1 kJ mol−1). The β-substituted dimethyl complex 40a was more
stable than 40b, with ∆H values of 111.8 kJ mol−1 for the dichloride, −88.2 kJ mol−1
for the trans alkene and −72.2 kJ mol−1 for the cis alkene reactions. As with the cPr
substituted complexes, the formation of the trans alkene complex was more favourable
than the formation of the cis alkene complex for all three methyl substituted complexes,
with differences of 7.2–16.0 kJ mol−1.
It was evident from the above data that it was the presence of cPr rings rather than
simply the degree of substitution which determined the stability of the β-chloroalkyl
complexes. When substituted with methyl groups, the resulting β-haloalkyl complexes
were increasingly unstable with more substitution closer to the metal centre. The opposite
trend was observed for cPr substitution; it was the complexes with the higher degree of
substitution closer to the metal which were more stable. This was in agreement with the
experimental observation that complexes formed from BCP were the most stable, while
it was the complex with the cPr ring in the α-position that was formed from MCP.
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Chapter 5
Conclusion
Cyclopropyl rings are an important structural motif. They are found in many biologically
active molecules, such as the anti-depressant, tranylcypromine, the molecule responsible
for Jamaican vomiting sickness, hypoglycine A, and pyrethroids such as allethrin I, used
in RAID flyspray (Figure 5.1).
NH2
Tranylcypromine
NH2
COOHH
Hypoglycine A
O
O
O
Allethrin I
Figure 5.1. Biologically active molecules containing cyclopropyl rings.
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Bicyclopropylidene and methylenecyclopropane, alkenes which contain cyclopropyl
rings with exo-cyclic double-bonds, are useful synthetic precursors, enabling the incor-
poration of one or even two cyclopropyl rings into a carbon skeleton. Both are have
reliable syntheses which enable them to be made in appreciable quantities in a relatively
short time. Large amounts of work has been done investigating their reactivity and utility
as as reagents for organic chemistry. A significant portion of this has involved the use of
transition metal catalysts, particularly those of palladium. Two main modes of reactivity
with transition metals have been observed; these are additions across the double-bond, as
in reactions with Heck-type catalysts (for examples see Schemes 1.6 and 1.21), and ring-
opening, involving cleavage at either the proximal or the distal ring bonds (for examples
see Schemes 1.4 and 1.16). Reactions often involve a combination of the two reactivity
modes, such as in the domino-Heck-Diels-Alder reactions of BCP.63,74
The isolation of transition metal complexes analogous to the proposed intermediates
in these reactions has received comparatively little attention. There is one instance of
the isolation of an η3-allyl complex, which resulted from the addition of Pd–Ph across
the double bond in a Heck-type reaction.137 The coordination of MCP and BCP to form
η2-alkene complexes is a likely first step before any reaction takes place. A small handful
of such complexes have been isolated, with Ni,60 Pt,61 Co58,59 and Rh61 for MCP, and
Ti58 and Co58,59 for BCP.
The objective of this research was to investigate the reactivity of MCP and BCP
with platinum, with a particular focus on isolating complexes with ligands derived from
these alkenes. The majority of the transition metal chemistry done with these alkenes had
involved palladium, while very little work was done with platinum. However, catalytically
significant palladium species are transient and therefore difficult to characterise. In
contrast, platinum species tend to be more stable, making platinum a useful model
for palladium systems. Platinum also has an NMR-active isotope which assists with
characterisation.
Initial attempts were made to synthesise homoleptic alkene complexes in order to
determine the number of ligands that can coordinate. The typical number of alkene
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ligands in complexes such as [Pt(nb)3] is three;
16 in homoleptic alkyne complexes, the
typical number of ligands is two.187 In BCP, the presence of the cyclopropyl rings increases
the s-character of the double-bond carbon orbitals, making the carbons close to sp-
hybridised.29,32,68 This could mean that it would behave more like an alkyne in that only
two BCP ligands would coordinate in the homoleptic complex. However, the formation
of such complexes was not observed; instead ring-opening reactions occurred.
The synthesis of η2-alkene complexes was more successful when stabilising auxilliary
ligands were used. A range of η2-BCP and MCP Pt(0) complexes with both mono- and
di-phosphine ligands were synthesised, [Pt(L)(P—P)], [Pt(L)(P—S)], [Pt(C2H4)(L)(PR3)]
and [Pt(L)2(PR3)] (L = η
2-BCP, η2-MCP; P—P = dppp, dcyppe, dbpe, dbpx; P—S
= tBu2PCH2(o-C6H4)CH2S
tBu; PR3 = PPh3, PCy3), produced by the displacement of
an alkene ligand, either ethene or norbornene, from a precursor complex. Platinum(II)
complexes [PtCl2(L)(L
′)] (L = η2-BCP, η2-MCP; L′ = Py, DMSO) were also synthesised,
again by displacement of a ligand from a precursor, either ethene or DMSO. These
complexes are the first examples of late transition metal complexes of bicyclopropylidene
as well as the first bis-methylenecyclopropane complexes of platinum.79
The coordinated alkenes proved to be reactive, and both of the reactivity modes
observed with other transition metals, namely additions across the double-bond and ring-
opening, also occurred with platinum, supporting the formation of η2-alkene complexes as
a first step in TM-catalysed reactions. The alkene ligands underwent reactions with either
protons or in situ hydrides to produce η3-allyl complexes. Three different allyl structures
were observed in the protonation of [Pt(L)(P—P)] (P—P = dppp, dbpx) , with the
relative ratios dependent on both the phosphine auxiliary ligand and the solvent. These
allyl structures were the 2-substituted complexes [Pt(η3-CH2C
cPrCH2)(P—P)]
+ and
[Pt(η3-CH2CMeCH2)(P—P)]
+, the 1-methyl substituted complexes with the methyl in the
anti position [Pt(η3-C(CH2)2CHCHMe)(P—P)]
+ and [Pt(η3-CH2CHCHMe)(P—P)]
+,
and the 1-methyl substituted complexes with the methyl in the syn position.
Only one allyl structure was produced from the [Pt(L)(P—S)] complexes,
the 1-methyl substituted complexes with the methyl in the anti position
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[Pt(η3-C(CH2)2CHCHMe)(P—C)]
+ and [Pt(η3-CH2CHCHMe)(P—C)]
+. In this case,
the coordinated alkene reacted with a hydride generated by ortho-metallation of the P—S
ligand. Computational models were used to investigate the formation of these various
allyl complexes. It was determined that the activation energies for the various reactions
had a larger effect than the relative stabilities of the complexes on the final product.
The steric bulk of the auxiliary ligand was found to be more important in determining
product distributions than the electronic nature of the ligand.
The proposed mechanism for the formation of these allyl complexes involves the
addition of Pt–H across the double-bond, followed by cleavage of one of the ring bonds in
a cyclopropylmethyl to homoallyl rearrangement.135 Similar allyl complexes are likely
intermediates in other transition metal catalysed reactions, and undergo subsequent
reactions with nucleophiles.38,72,74,137,138 It is likely that the allyl complexes synthesised
in this work would also be reactive towards nucleophiles and therefore form the same
products observed with palladium systems.
The addition of Pt–H followed by ring-opening in a cyclopropylmethyl to homoallyl
rearrangement can also result in the formation of a 1,3-diene.38,74 With BCP, the diene
formed is allylidenecyclopropane, while with MCP it is 1,3-butadiene. Allylidenecyclo-
propane was produced from BCP with an number of Pt(0) and Pt(II) complexes, while
1,3-butadiene is only formed in the reaction of MCP with [PtEt2(COD)] as the minor anti-
Markovnikov product. The Markovnikov addition of Pt–H across the MCP double-bond
is not followed by ring opening. Instead, complexes with 1-methylcyclopropyl ligands are
produced, the first stable examples of such complexes.
As allylidenecyclopropane is itself an alkene with a cyclopropyl ring and an exo-
cyclic double-bond, its coordination chemistry was also explored. Diphosphine complexes
[Pt(ACP)(P—P)] (P—P = Ph2P(CH2)3PPh2, Cy2P(CH2)2PCy2,
tBu2P(CH2)2P
tBu2)
were synthesised in the same manor as the BCP and MCP analogues, and are the first
examples of coordinated ACP. Some of the ACP complexes underwent a rearrangement
reaction to form η2:σ2-metallacyclopentene complexes, the first instances of the formation
of η2:σ2-metallacyclopentene complexes from η2:pi-diene complexes, rather than from η4:pi-
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diene complexes. This work is the first exploration of the coordination chemistry of
allylidenecyclopropane.
Several instances of addition of Pt–Cl across the BCP double-bond were observed.
These were not followed by ring-opening. Instead, the addition products were stable
β-haloalkyl complexes, trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(L)2] (L = SEt2, NC
tBu, Py)
and cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2]. No trans complexes were produced from
MCP; only cis–[Pt(C(CH2)2CH2Cl)Cl(Py)2] was formed. Phosphine complexes were
synthesised addition of a phosphine to cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] and cis–
[Pt(C(CH2)2CH2Cl)Cl(Py)2]. The addition of a phosphine to trans β-chloroalkyl
complexes resulted in β-chloride elimination and the formation of either [PtCl2(PR3)2]
or [Pt(P—P)2]Cl2. A short-lived trans β-chloroalkyl complex formed with PTA, which
was the smallest of the phosphines used. The stability and formation rates of the other
phosphine complexes were dependent on the size of the phosphine ligand, with smaller
phosphines producing more stable complexes.
These β-chloroalkyl complexes are unusually stable, and are the only reported
instances of Pt(II) β-haloalkyl complexes. These are also the only β-haloalkyl complexes
formed by insertion into an Pt–X bond, rather than addition of X2 to an η
2-alkene
complex. Computational models of trans-[Pt(CR2CR2Cl)Cl(NC
tBu)2] (R = CH2, Me, H)
were used to investigate the stability of complexes with different substitution patterns.
When substituted with methyl groups, the resulting β-chloroalkyl complexes were
increasingly unstable with more substitution closer to the metal centre. The opposite
trend was observed for cyclopropyl substitution; it was the complexes with the higher
degree of substitution closer to the metal that were more stable. This was in agreement
with the experimental observations.
The β-haloalkyl complexes complexes are may have potential in the polymerisation
of halogenated monomers such as vinyl chloride.160–163 The polymerisation reactions
currently involve a radical mechanism, which offers limited control of over the polymer
structure and can lead to the formation of defects, affecting the stability of the resulting
polymer. A mechanism that involves a β-haloalkyl intermediate could lead to more control
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over the polymerisation process. However, previous work has been inhibited by very facile
β-chloride elimination reactions. This work has shown that the both the substitution of
the β-haloalkyl ligands and the nature of the auxiliary ligands affects the stability of such
complexes, potentially enabling the further development of these polymerisation reactions.
This work has explored the coordination chemistry of bicyclopropylidene and
methylenecyclopropane with platinum. Analogous reactivity to other transition metal
systems, particularly palladium, was observed. A number of complexes with ligands
derived from BCP and MCP were sythesised. These were η2-alkene, η3-allyl, 1-
cycloproylmethyl and β-chloroalkyl ligands. Such complexes are not only similar to
intermediates in various transition metal catalysed reactions, but are also interesting
species in their own rights.
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Chapter 6
Experimental
6.1 General Considerations
All reactions were carried out using de-oxygenated solvents and standard Schlenk
techniques under either a nitrogen or argon atmosphere, unless stated otherwise.
Starting materials were purchased from Sigma-Aldrich and used without further
purification unless stated otherwise. Bicyclopropylidene,67 methylenecyclopropane,28
[PtCl2(dppp)],
188 [Pt(C2H4)(dbpx)],
83 [Pt(C2H4)(dbpe)],
83 [Pt(C2H4)2(PPh3)],
119
[Pt(C2H4)2(PCy3)],
119 [Pt(nb)3],
20 [Pt(COD)2],
20 [Pt(C2H4)3],
20 [PtCl2(SEt2)2],
178
[PtCl2(Py)2],
189 [PtCl2(DMSO)2],
190 [PtCl2(NC
tBu)2],
191 [PtMe2(1,5-hexadiene)],
192
and [PtEt2(COD)]
83 were synthesized according to literature methods. The synthesis
of dbpx was via the deprotection of dbpx-borane193 using neat diethylamine, while
dcyppe was synthesized by the reaction of cyclopentylmagnesium bromide with 1,2-
bis(dichlorophosphino)ethane. Deuterated solvents were purchased from Sigma-Aldrich
and stored under a nitrogen atmosphere.
NMR spectra were measured on Varian Unity Inova 300 MHz (300 MHz for 1H,
121 MHz for 31P, 282 MHz for 19F), Varian Unity Inova 500 MHz (500 MHz for 1H,
125 MHz for 13C) and Varian DirectDrive 600 MHz (600 MHz for 1H, 150 MHz for
13C) NMR spectrometers, with chemical shift values δ referenced to the residual solvent
peaks for 1H and 13C{1H}, to 85% H3PO4 for
31P{1H} and CFCl3 for
19F. NMR yields
were reported for compounds unable to be isolated, and obtained by integration of
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the 31P{1H} or 1H NMR spectra against other species in solution. Elemental analyses
were performed by the Campbell Microanalytical Laboratory, University of Otago, New
Zealand. Electrospray ionization mass spectra were obtained using a Aglient 6530 Series
Q-TOF mass spectrometer or performed by the GlycoSyn QC laboratory at Industrial
Research Limited using a Waters Q-TOF Premier Tandem mass spectrometer. Calculated
NMR spectra were obtained from gNMR spectral simulation program, version 5.0.6.0,
written by P. H. M. Budzelaar, IvorySoft 2006. X-ray diffraction data were collected
by the X-ray Crystallograpy Laboratory at the University of Canterbury on a Bruker
SMART CCD diffractometer using Mo Kα radiation. Data were reduced using Bruker
SAINT software. Absorption correction was performed using the SADABS program.
The structures were solved using OLEX2 running SHELXS97 and SHELXL97.194,195 The
positions of all hydrogen atoms were calculated during refinement. Calculations were
performed using the Gaussian 09 Revision B.01 program196,197 and were performed on the
Victoria University of Wellington School of Chemical and Physical Sciences’ Heisenberg
cluster, consisting of eight processing nodes with two 2.53 GHz Xeon X3440 quad-core
processors per node and 1 GB of memory per core.
6.2 Chapter Two Experimental
Synthesis of Cyclopropanecarboxylic-carboxyl-13C{1H} Acid88
Magnesium turnings (1.7 g, 0.070 mol) was placed in a 2-neck 100 mL RB flask equipped
with a double surface condenser and a dropping funnel and dry stirred overnight.
THF (25 mL) was added and bromocyclopropane (5.0 g, 0.413 mol) placed in the
dropping funnel. The Mg was activated with 1,2-dibromoethane and heat, and the
bromocyclopropane slowly added and the solution stirred for 30 min. Barium carbonate
(7.1 g, 0.036 mol, 70% 13C) was placed in a 2-neck 100 mL RB flask equipt with a dropping
funnel and a drying tube filled with silica gel attached to a glass tube that vented into a
250 mL flask fitted with a balloon to regulate pressure. This flask was filled with 140 mL
of THF and cooled to –78 ◦C in a dry ice/acetone bath. H2SO4 (conc.) was slowly added
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onto the BaCO3 while stirring vigorously, with the mouth of the bubbling tube kept above
the level of the THF. The BaCO3 was heated to ensure complete reaction. The
cPrMgBr
solution was added to the solution of CO2, and the reaction allowed to warm to room
temperature. The reaction mixture was cooled in ice, quenched with H2SO4 (25 mL,
4 mol L−1), stirred overnight and filtered. The solution was reduced to ∼50 mL then
continuously extracted into Et2O for 48 hrs. The ether solution was distilled by heating
in an oil bath up to 110 ◦C, adding 5 mL CH2Cl2 and continuing until the temperature
started to drop. The residue was then distilled under water pump pressure, with the
product distilling at 80 ◦C (745 mg, 19%). 1H NMR (δ, C6D6, 500 MHz): 1.60(tt,
8.0, 4.4 Hz, 1H, CH), 1.06(m, 2H, CH2), 0.93(m, 2H, CH2).
13C{1H} NMR (δ, C6D6,
125 MHz): 181.5(s, COOH), 13.0(s, CH), 12.9(d, 1JC–C = 74.4 Hz, CH), 9.3(s, CH2).
Synthesis of [Pt(C2H4)(dppp)]
[PtCl2(dppp)] (0.455 g, 0.67 mmol) was suspended in ethanol (12.6 mL) under a nitrogen
atmosphere. The solution was saturated with ethene and a solution of NaBH4 (2.08 mmol,
10.4 mL, 2 M) in ethanol was added dropwise. The solution was stirred under a flow of
ethene for 2 hrs. The supernatant liquid was removed and the pale yellow precipitate
washed with water (3 × 6 mL) and ethanol (3 × 6 mL). Benzene (5 mL) was added
and the solution dried in vacuo to remove water. The product was a yellow crystalline
solid (368 mg, 0.58 mmol, 86%). 1H NMR (δ, C6D6, 500 MHz): 7.71(m, 8H, o-C6H5),
7.03(m, 12H, m- and p-C6H5), 2.68(d, 2.7, JPt–H = 60.0 Hz, 4H, =CH2), 2.19(m, 4H,
P−CH2), 1.68(m, 2H, CH2).
13C{1H} NMR (δ, C6D6, 125 MHz): 138.7(m, i -C6H5),
133.1(m, o-C6H5), 129.4(s, p-C6H5), 128.3(s, m-C6H5), 31.9(t, 25.5,
1JPt–C = 216.0 Hz,
=CH2), 28.9(dd, 14.5, 13.3 Hz, P−CH2), 21.0(t, 3.8 Hz, CH2).
31P{1H} NMR (δ, C6D6,
121 MHz): 13.8(s, 1JPt–P = 3340 Hz).
Synthesis of [PtCl2(dcyppe)]
1,2-Bis(dicyclopentylphosphino)ethane (278 mg, 0.76 mmol) was placed in a 50 mL 2-
necked round bottom flask fitted with a reflux condenser. K2[PtCl4] (314 mg, 0.76 mmol)
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was added, followed by EtOH (10 mL) and c. HCl (7 mL). The solution was refluxed
overnight, before filtration of the white solid and washing with H2O (2 × 5 mL) and
EtOH (2 × 5 mL). The isolated solid is [PtCl2(dcyppe)] (400 mg, 0.63 mmol, 83%).
1H
NMR (δ, CDCl3, 500 MHz): 2.64(m, 4H, P−CH), 2.15(m, 4H, CH2), 1.92(m, 8H, CH2),
1.82–1.59(m, 24H, P−CH2 and CH2, 125 MHz).
13C{1H} NMR (δ, CDCl3): 36.8(d,
37.8 Hz, P−CH), 29.7(d, 1.5 Hz, CH2), 29.4(s, CH2), 26.3(d, 10.1 Hz, CH2), 25.3(d,
11.6 Hz, CH2), 22.3(dd, 36.0, 7.8 Hz, P−CH2).
31P{1H} NMR (δ, CDCl3, 121 MHz):
59.2(s, 1JPt–P = 3570 Hz).
Synthesis of [Pt(C2H4)(dcyppe)]
Mercury (10.2 g, 0.051 mol) was placed in a Schlenk tube and small pieces of sodium
(88 mg, 3.8 mmol) slowly added. When the dissolution was complete, THF (10 mL) was
added and the liquid saturated with ethene. [PtCl2(dcyppe)] (248 mg, 0.39 mmol) was
added and the reaction stirred for 2 hr. The solution was run through a 1 cm Celite
column followed by a 1 cm alumina column and the amalgam was washed with THF (2 ×
10 mL ). The solvent was removed in vacuo yielding a brown solid (116 mg, 0.20 mmol,
51%). 1H NMR (δ, C6H6, 500 MHz): 2.38(t, 1.8, JPt–H = 58.0 Hz, 4H, =CH2), 1.97(m,
4H, P−CH), 1.80(m, 8H, CH2), 1.66–1.50(m, 12H, CH2), 1.50–1.32(m, 16H, P−CH2 and
CH2).
13C{1H} NMR (δ, C6H6, 125 MHz): 39.3(t, 12.9, JPt–C = 49.9 Hz, P−CH), 31.1(t,
4.6, JPt–C = 15.2 Hz, CH2), 30.5(t, 2.9, JPt–C = 22.1 Hz, CH2), 28.7(t, 21.1, JPt–C =
17.3 Hz, P−CH2), 26.4(t, 4.5 Hz, CH2), 23.2(t, 15.1,
1JPt–C = 227.4 Hz, =CH2).
31P{1H}
NMR (δ, C6H6, 121 MHz): 75.4(s,
1JPt–P = 3170 Hz).
Synthesis of [Pt(BCP)(dppp)] 1a
[Pt(C2H4)(dppp)] (0.162 g, 0.28 mmol) was dissolved in toluene (3.5 mL). Bicyclopropy-
lidene (0.052 mL, 0.56 mmol) was added, and the solution stirred for 30 min. The solvent
was removed in vacuo, yielding an off-white solid ([Pt(BCP)(dppp)], 158 mg, 0.23 mmol,
82%). Crystals of [Pt(BCP)(dppp)] were grown by slow recrystallization from hot toluene.
1H NMR (δ, C6D6, 500 MHz): 7.57(m, 8H, o-C6H5), 7.04(m, 8H, m-C6H5), 6.98(m, 4H, p-
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C6H5), 2.13(m, 4H, P−CH2), 1.51(m, 2H, CH2), 1.29(m, JPt–H= 66.0 Hz, 4H,
cPr-endo),
1.18(d, 4.4, JPt–H = 37.3 Hz, 4H, cPr-exo). 13C{1H} NMR (δ, C6D6, 150 MHz): 136.8(m,
i -C6H5), 132.9(m, o-C6H5), 129.5(s, p-C6H5), 128.4(s, m-C6H5), 34.3(m, JP–C = 73.3,
−9.1, JP–P = 24.5, 1JPt–C = 409.4Hz, =CR2), 28.5(m, P−CH2), 20.9(m, CH2), 8.8(s,
JPt–C = 23.1 Hz, cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 9.3(s,
1JPt–P = 2932 Hz).
m/z = [M + H]+ calcd for C33H35P
194
2 Pt 687.1841; found 687.1849. Anal. Calcd for
C33H34P2Pt: C 57.64; H 4.98. Found: C 57.76; H 4.96.
Synthesis of [Pt(BCP)(dcyppe)] 1b
[Pt(C2H4)(dcyppe)] (20 mg, 0.034 mmol) was dissolved in C6D6 (0.5 mL) and placed in an
NMR tube. BCP (3.2 µL, 0.034 mmol) was added and the reaction left overnight. Solution
contains 91% [Pt(BCP)(dcyppe)] by 31P{1H} NMR. 1H NMR (δ, C6D6, 500 MHz):
1.90(m, 4H, P−CH), 1.73(m, 4H, CH2), 1.63–1.53(m, 18H, CH2, P−CH2 and
cPr), 1.50–
1.40(m, 12H, CH2 and
cPr), 1.40–1.30(m, 10H, CH2 and P−CH2).
13C{1H} NMR (δ,
C6D6, 125 MHz): 39.1(dd, 14.5, 12.1, JPt–C = 63.0 Hz, P−CH), 33.8(m, JP–C = 66.8, 7.0,
JP–P = −59.7, 1JPt–C = 424.6 Hz, =CR2), 30.4(t, 2.3, JPt–C = 19.6 Hz, CH2), 30.0(t, 7.5,
JPt–C = 11.6 Hz, CH2), 28.0(t, 41.6, JPt–C = 14.8 Hz, P−CH2), 26.2(t, 4.6, CH2), 10.4(s,
JPt–C = 23.1 Hz, cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 70.8(s,
1JPt–P = 2731 Hz).
Synthesis of [Pt(BCP)(dbpe)] 1c
[Pt(C2H4)(dbpe)] (20 mg, 0.034 mmol) was dissolved in C6D6 (0.5 mL) and placed in an
NMR tube. BCP (3.2 µL, 0.034 mmol) was added and the reaction heated at 60 ◦C for
7 days. Solution contains 80% [Pt(BCP)(dbpe)] by 31P{1H} NMR. 1H NMR (δ, C6D6,
500 MHz): 1.57(m, 4H, cPr), 1.31(m, 8H, P−CH2 and
cPr), 1.06(d, 12.0 Hz, 36H, tBu).
13C{1H} NMR (δ, C6D6, 125 MHz): 35.1(t, 9.3, JPt–C = 49.7 Hz, P−CR3), 31.8(m, JP–C
= 70.5, 4.1, JP–P = 59.5, 1JPt–C = 428.91 Hz, =CR2), 29.9(t, 3.5, JPt–C = 15.9 Hz, CH3),
26.0(t, 5.1, JPt–C = 33.7 Hz, P−CH2), 9.9(s, JPt–C = 23.7 Hz,
cPr). 31P{1H} NMR (δ,
C6D6, 121 MHz): 97.4(s,
1JPt–P = 2798 Hz).
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Synthesis of [Pt(BCP)(dbpx)] 1d
[Pt(C2H4)(dbpx)] (51 mg, 0.083 mmol) was dissolved in C6D6 (0.5 mL) and placed in
an NMR tube. BCP (13 µL, 0.14 mmol) was added and the reaction heated at 60 ◦C
for 6 days. Solution contains 98% [Pt(BCP)(dbpx)] by 31P{1H} NMR. 1H NMR (δ,
C6D6, 500 MHz): 7.14(m, 2H, o-C6H4), 6.94(m, 2H, m-C6H4), 3.44(m, 4H, P−CH2),
1.34(m, JPt–H = 61.2 Hz, 4H, cPr-endo), 1.19(d, 12.5 Hz, 36H, tBu), 0.99(d, 4.0, JPt–H
= 32.0 Hz, 4H, cPr-exo). 13C{1H} NMR (δ, C6D6, 125 MHz): 138.3(s, i -C6H4), 133.1(s,
o-C6H4), 126.1(s, m-C6H4), 37.3(m, P−CR3), 32.0(m, P−CH2), 30.2(m, CH3), 29.3(m,
JP–C = 78.1, −4.2, JP–P = 21.6, 1JPt–C = 456.3 Hz, =CR2), 9.9(s, JPt–C = 22.5 Hz,
cPr).
31P{1H} NMR (δ, C6D6, 121 MHz): 43.3(s,
1JPt–P = 2983 Hz).
Synthesis of [Pt(MCP)(dppp)] 2a
Pt(C2H4)(dppp)] (87 mg, 0.14 mmol) was dissolved in toluene (1 mL). A large excess
of methylenecyclopropane was added, and the solution stirred for 30 min. The solvent
was removed in vacuo, yielding an off-white solid ([Pt(MCP)(dppp)], 79 mg, 0.13 mmol,
92%). 1H NMR (δ, C6D6, 500 MHz): 7.77(t, 9 Hz, 4H, o-C6H4−P1), 7.51(t, 8.5 Hz,
4H, o-C6H4−P2), 7.05(m, 8H, m-C6H5), 7.00(m, 4H, p-C6H4), 2.63(dd, JP–H = 7.7, 4.5,
2JPt–H = 65.3 Hz, 2H, =CH2), 2.17(m, 4H, P−CH2), 1.65(d, 6.5, JPt–H = 33.0 Hz, 2H,
cPr-exo), 1.59(m, 2H, CH2), 1.32(d, 9.5, JPt–H = 82.5 Hz, 2H,
cPr-endo). 13C{1H} NMR
(δ, C6D6, 125 MHz): 138.4(m, i -C6H4−P1), 136.9(m, i -C6H4−P2), 133.2(m, o-C6H4−P1),
132.8(m, o-C6H4−P2), 129.4(m, p-C6H4), 128.4(m, m-C6H5), 42.7(dd, JP–C = 57.3, 5.0,
1JPt–C = 455.4 Hz, =CR2), 28.8(m, P−CH2), 25.3(dd, JP–C = 36.4, 4.9,
1JPt–C = 173.4 Hz,
=CH2), 21.0(m, CH2), 10.1(d, JP–C = 3.8, JPt–C = 25.9 Hz,
cPr). 31P{1H} NMR (δ, C6D6,
121 MHz): 11.8(AB, 2JPt–P = 41.5, 1JPt–P = 3275 Hz, P2 trans =CH2), 11.4(AB,
2JPt–P
= 41.5, 1JPt–P = 2975 Hz, P1 trans =CR2). m/z = [M + H]
+ calcd for C31H33P
194
2 Pt
661.1684; found 661.1678. Anal. Calcd for C31H32P2Pt: C 56.28; H 4.87. Found: C 56.47;
H 4.86.
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Synthesis of [Pt(MCP)(dcyppe)] 2b
[Pt(C2H4)(dcyppe)] (20 mg, 0.034 mmol) was dissolved in C6D6 (0.5 mL) and placed in an
NMR tube. A large excess of MCP was added and the reaction left at room temperature
overnight. Solution contains 100% [Pt(MCP)(dcyppe)] by 31P{1H} NMR. 1H NMR (δ,
C6D6, 500 MHz): 2.40(dd, 8.5, 4.5,
2JPt–H = 60.5 Hz, 2H, =CH2), 1.99–1.89(m, 6H,
P−CH and cPr), 1.87–1.77(m, 6H, CH2 and
cPr), 1.75–1.68(m, 4H, CH2), 1.6–1.3(m,
28H, P−CH2 and CH2).
13C{1H} NMR (δ, C6D6, 125 MHz): 39.3(dd, 21.6, 4.2, JPt–C =
43.8 Hz, P−CH), 39.1(dd, 22.5, 4.5, JPt–C = 53.2 Hz, P−CH), 38.3(dd, 71.0, 8.7, 1JPt–C
= 501.0 Hz, =CR2), 31.0(d, 8.2, JPt–C = 15.7 Hz, CH2), 30.6(d, 5.4, JPt–C = 16.7 Hz,
CH2), 30.4(d, 5.2, JPt–C = 22.0 Hz, CH2), 30.0(d, 14.3, JPt–C = 10.3 Hz, CH2), 28.8(m,
P−CH2), 27.6(m, P−CH2), 26.3(m, CH2), 22.4(dd, 41.8, 5.6,
1JPt–C = 168.4 Hz, =CH2),
12.3(d, 3.9, JPt–C = 23.4 Hz, cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 75.0(AB,
2JPt–P
= 62.5, 1JPt–P = 2751 Hz, P trans =CR2), 70.8(AB,
2JPt–P = 62.5, 1JPt–P = 3107 Hz, P
trans =CH2).
Synthesis of [Pt(MCP)(dbpe)] 2c
[Pt(C2H4)(dbpe)] (20 mg, 0.034 mmol) was dissolved in C6D6 (0.5 mL) and placed in an
NMR tube. A large excess of MCP was added and the reaction heated at 40 ◦C overnight.
Solution contains 99% [Pt(MCP)(dbpe)] by 31P{1H} NMR. 1H NMR (δ, C6D6, 500 MHz):
2.39(dd, 8.4, 4.2, 2JPt–H = 60.6 Hz, 2H, =CH2), 1.89(d, 7.2, JPt–H = 33.6 Hz, 2H,
cPr-
exo), 1.79(m, JPt–H = 60.0 Hz, 2H, cPr-endo), 1.30(m, 4H, P−CH2), 1.10(d, 12.0 Hz,
18H, tBu), 1.02(d, 12.0 Hz, 18H, tBu). 13C{1H} NMR (δ, C6D6, 125 MHz): 36.8(dd,
71.9, 8.2, 1JPt–C = 511.4 Hz, =CR2), 35.0(dd, 12.2, 4.1 Hz, P−CR3), 34.9(dd, 13.4,
4.6 Hz, P−CR3), 30.3(d, 6.4, JPt–C = 17.7 Hz, CH3), 29.9(d, 7.0, JPt–C = 16.2 Hz, CH3),
26.8(dd, 18.1, 12.2, JPt–C = 10.4 Hz, P−CH2), 25.3(dd, 16.9, 14.6, JPt–C = 14.0 Hz,
P−CH2), 23.5(dd, 42.7, 4.7,
1JPt–C = 171.6 Hz, =CH2), 11.8(d, 4.1, JPt–C = 24.5 Hz,
cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 100.8(AB,
2JPt–P = 65.7, 1JPt–P = 2807 Hz, P
trans =CR2), 99.2(AB,
2JPt–P = 65.7, 1JPt–P = 3167 Hz, P trans =CH2).
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Synthesis of [Pt(MCP)(dbpx)] 2d
[Pt(C2H4)(dbpx)] (35 mg, 0.057 mmol) was dissolved in C6D6 (0.5 mL) and placed in an
NMR tube. A large excess of MCP was added and the reaction heated at 60 ◦C overnight.
Solution contains 96% [Pt(MCP)(dbpx)] by 31P{1H} NMR. 1H NMR (δ, C6D6, 500 MHz):
7.15(m, 2H, o-C6H4), 6.92(m, 2H, m-C6H4), 3.47(m, 4H, P−CH2), 2.12(t, 6.5,
2JPt–H =
56.5 Hz, 2H, =CH2), 1.60(m, 4H,
cPr), 1.26(d, 12.0 Hz, 18H, tBu), 1.17(d, 12.0 Hz, 18H,
tBu). 13C{1H} NMR (δ, C6D6, 125 MHz): 138.6(s, i -C6H4), 138.5(s, i -C6H4), 133.3(m, o-
C6H4), 126.0(m, m-C6H4), 37.8(m, P−CR3), 36.9(dd, 12.9, 3.9, JPt–C = 45.0 Hz, P−CR3),
33.6(dd, 72.5, 10.1, 1JPt–C = 537.6 Hz, =CR2), 32.5(d, 8.7 Hz, P−CH2), 32.3(d, 5.3 Hz,
P−CH2), 30.6(d, 5.3, JPt–C = 16.3 Hz, CH3), 30.2(d, 6.7, JPt–C = 15.3 Hz, CH3), 27.8(dd,
39.4, 5.3, 1JPt–C = 164.2 Hz, =CH2), 11.4(d, 2.9, JPt–C = 25.0 Hz,
cPr). 31P{1H} NMR
(δ, C6D6, 121 MHz): 49.3(AB,
2JPt–P = 29.7, 1JPt–P = 3362 Hz, P trans =CH2), 43.7(AB,
2JPt–P = 29.7, 1JPt–P = 3025 Hz, P trans =CR2).
Synthesis of [Pt(ACP)(dppp)] 3a and [Pt(CH2CH−CHC(CH2)2)(dppp)] 4a
A few crystals of [PtMe2(1,5-hexadiene)] were placed in an NMR tube and CDCl3 (0.5 mL)
added. BCP (0.2 mL, 18.7 mmol) was added and the reaction left for 3 days, after which all
of the BCP had reacted to form ACP. [Pt(C2H4)(dppp)] (30 mg, 0.047 mmol) was placed
in an NMR tube and C6D6 (0.5 mL) added. A solution of ACP (0.1 mL, 27 mol L
−1
solution in CDCl3) was added, resulting in the immediate formation of [Pt(ACP)(dppp)].
After several hours, the complex rearranges to form [Pt(CH2CH−CHC(CH2)2)(dppp)]
4a. Solution contains 91% [Pt(CH2CH−CHC(CH2)2)(dppp)] by
31P{1H} NMR after 24
hr. [Pt(ACP)(dppp)] 3a: 1H NMR (δ, C6D6, 500 MHz): 7.80(t, 8.7 Hz, 2H, o-C6H5),
7.69(t, 9.0 Hz, 2H, o-C6H5), 7.54(t, 6.9 Hz, 2H, o-C6H5), 7.38(t, 8.1 Hz, 2H, o-C6H5),
7.15–6.96(m, 12H, m- and p-C6H5), 6.47(m, 1H, =CHR), 5.04(m, 1H, =CH2), 4.69(m,
1H, =CH2), 3.78(td, 9.3, 3.6,
2JPt–H = 67.8 Hz, =CHR), 2.40–1.96(m, 4H, P−CH2), 1.5–
1.3(m, 2H, CH2), 1.3–0.8(m, 4H,
cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 10.3(AB,
2JPt–P = −39.4, 1JPt–P = 293 Hz, P trans =CHR), 9.7(AB, 2JPt–P = −39.4, 1JPt–P
= 3003 Hz, P trans =CR2). [Pt(CH2CH−CHC(CH2)2)(dppp)] 4a:
1H NMR (δ,
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C6D6, 500 MHz): 7.68(t, 8.0 Hz, 4H, o-C6H5), 7.58(t, 9.3 Hz, 4H, o-C6H5), 7.03(m,
12H, m- and p-C6H5), 6.07(dm, 12.0, JPt–H 97.0 Hz, 1H, =CHCH2), 5.29(t, 5.5, JPt–H
= 86.5 Hz, 1H, =CH−cPr), 2.85(m, 2JPt–H = 62.0 Hz, 2H, Pt−CH2), 2.05(m, 4H, P-
CH2), 1.30(m, 2H, CH2), 0.85(m, JPt–H = 25.0 Hz, 2H,
cPr-exo), 0.71(d, 7.5, JPt–H =
55.0 Hz, 2H, cPr-endo). 13C{1H} NMR (δ, C6D6, 125 MHz): 154.3(d, 9.6 Hz, JPt–C =
67.6 Hz, =CH−cPr), 134.2(m, o-C6H5), 133.8(m, o-C6H5), 133.5(m, i -C6H5), 132.5(m, i -
C6H5), 131.5(m, =CHCH2), 130.1(d, 1.9 Hz, m-C6H5), 129.9(d, 1.9 Hz, m-C6H5), 128.6(s,
p-C6H5), 128.4(s, p-C6H5), 39.3(dd, 83.9, 4.4,
1JPt–C= 450.3 Hz, Pt−CH2), 32.3(m,
Pt−CR3), 30.5(m, P−CH2), 27.4(m, P−CH2), 20.0(s, CH2), 16.9(s,
cPr). 31P{1H} NMR
(δ, C6D6, 121 MHz): 2.2(AB,
2JPt–P = 18.2, 1JPt–P = 1784 Hz), 1.7(AB, 2JPt–P = 18.2,
1JPt–P = 1856 Hz). m/z = [M + H]+ calcd for C33H35P
194
2 Pt 687.1841; found 687.1848.
Synthesis of [Pt(ACP)(dcyppe)] 3b and [Pt(CH2CH−CHC(CH2)2)(dcyppe)]
4b
[Pt(C2H4)(dcyppe)] (100 mg, 0.170 mmol) was placed in an NMR tube and C6D6 (0.5 mL)
added. A solution of ACP (0.1 mL, 27 mol L−1 solution in CDCl3) was added, resulting in
the immediate formation of [Pt(ACP)(dcyppe)] and [Pt(CH2CH−CHC(CH2)2)(dcyppe)].
After 3 hr, the only product is [Pt(CH2CH−CHC(CH2)2)(dcyppe)] 4b. Solution contains
93% [Pt(CH2CH−CHC(CH2)2)(dcyppe)] by
31P{1H} NMR. [Pt(ACP)(dcyppe)] 3b:
1H NMR (δ, C6D6, 500 MHz): 6.1(m, 1H, =CHR), 4.9(m, 1H, =CH2), 4.4(m, 1H,
=CH2), 3.4(m,
2JPt–H = 62.1 Hz, 1H, =CHR), 2.0–1.2(m, 44H, P−CH2, cyp and
cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 69.8(AB,
2JPt–P = −57.7, 1JPt–P =
3153 Hz, P trans =CHR), 68.3(AB, 2JPt–P = −57.7, 1JPt–P = 2771 Hz, P trans =CR2).
[Pt(CH2CH−CHC(CH2)2)(dcyppe)] 4b:
1H NMR (δ, C6D6, 500 MHz): 6.35(m,
JPt–H = 92.4 Hz, 1H, =CHCH2), 5.32(t, 6.0, JPt–H = 78.0 Hz, 1H, =CH−
cPr), 3.20(m,
2JPt–H= 73.2 Hz, 2H, Pt−CH2), 2.10(m, 2H, P−CH), 2.01(m, 4H, P−CH and CH2),
1.81(m, 4H, CH2), 1.6–1.3(m, 28H, CH2 and
cPr-endo), 1.24(m, 4H, P−CH2 and
cPr-
exo), 1.11(m, 2H, P−CH2).
13C{1H} NMR (δ, C6D6, 125 MHz): 154.0(d, 10.4, JPt–C =
130.6 Hz, =CH−cPr), 132.7(dd, 10.4, 4.6 Hz, =CHCH2), 37.2(d, 26.0, JPt–C = 26.0 Hz,
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P−CH), 36.7(d, 21.3, JPt–C = 19.2 Hz, P−CH), 33.1(dd, 117.9, 7.0, 1JPt–C = 959.0 Hz,
Pt−CR3), 31.0(d, 6.4, JPt–C = 11.4 Hz, CH2), 29.5(dd, 89.5, 6.3,
1JPt–C = 297.1 Hz,
Pt−CH2), 29.4(m, CH2), 26.6(d, 7.0 Hz, CH2), 26.4(d, 8.7 Hz, CH2), 25.8(d, 9.8 Hz,
CH2), 25.7(d, 9.3 Hz, CH2), 23.4(m, P−CH2), 22.6(m, P−CH2), 17.8(s,
cPr). 31P{1H}
NMR (δ, C6D6, 121 MHz): 55.4(s,
1JPt–P = 1801 Hz), 52.6(s, 1JPt–P = 1828 Hz).
Synthesis of [Pt(ACP)(dbpe)] 3c
[Pt(C2H4)(dbpe)] (100 mg, 0.185 mmol) was dissolved in C6D6 (0.5 mL) and placed in an
NMR tube. BCP (0.02 mL, 1.87 mmol) was added, and the solution heated at 40 ◦C for
13 days. Solution contains 88% Pt(ACP)(dbpe)] by 31P{1H} NMR. 1H NMR (δ, C6D6,
500 MHz): 6.20(dt, 16.2, 9.6 Hz, 1H, =CHR), 4.98(m, 1H, =CH2), 4.64(m, 1H, =CH2),
3.43(m, 2JPt–H = 62.0 Hz, 1H, =CHR), 1.9–1.5(m, 6H, P−CH2 and
cPr), 1.16(d, 12.5 Hz,
9H, tBu), 1.15(d, 12.5 Hz, 9H, tBu), 1.03(d, 12.0 Hz, 9H, tBu), 1.02(d, 12.5 Hz, 9H, tBu),
1.0(m, 2H, cPr). 13C{1H} NMR (δ, C6D6, 125 MHz): 147.5(t, JP–C = 4.6, JP–P = −34.3,
JPt–C = 56.4 Hz, =CHR), 102.7(t, JP–C = 8.6, JP–P = −25.3, JPt–C = 42.9 Hz, =CH2),
44.7(dd, JP–C = 38.1, 2.0, JP–P = −57.7, 1JPt–C = 165.5 Hz, =CHR), 41.4(m, JP–C =
70.3, 2.3, JP–P = 65.8, 1JPt–C = 533.1 Hz, =CR2), 36.5(dd, JP–C = 12.8, 4.6, JP–P =
−27.1, JPt–C = 46.8 Hz, P−CR3), 35.8(dd, JP–C = 11.5, 5.1, JP–P = −24.3, JPt–C =
44.0 Hz, P−CR3), 35.5(dd, JP–C = 13.2, 3.4, JP–P = −31.2, JPt–C = 53.8 Hz, P−CR3),
34.8(dd, JP–C = 14.5, 5.4, JP–P = −31.2, JPt–C = 60.0 Hz, P−CR3), 30.5–29.5(m, CH3),
26.4(t, 35.8, JPt–C = 12.7 Hz, P−CH2), 25.2(t, 18.0, JPt–C = 10.4 Hz, P−CH2), 10.6(t,
JP–C = 3.3, JP–P = −10.4, JPt–C = 17.7 Hz, cPr), 9.5(t, JP–C = 2.0, JP–P = −8.9, JPt–C
= 15.5 Hz, cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 96.4(AB,
2JPt–P = 62.2, 1JPt–P =
2848 Hz, P trans =CR2), 96.4(AB,
2JPt–P = 62.2, 1JPt–P = 3196 Hz, P trans =CHR).
m/z = [M + H]+ calcd for C24H49P
194
2 Pt 593.2936; found 593.2946.
Synthesis of [Pt(BCP)(C2H4)(PPh3)] 5a
[Pt(C2H4)2(PPh3)] (20 mg, 0.039 mmol) was dissolved in hexane (2 mL) under an ethene
atmosphere. BCP (3.6 µL, 0.34 mmol) was added, and the reaction stirred for 5 min.
139
The solution was cooled to −78 ◦C for an hour, after which the supernatant was decanted
off, leaving a white solid ([Pt(BCP)(C2H4)(PPh3)], 15 mg, 0.027 mmol, 70%).
1H NMR
(δ, C6D6, 500 MHz): 7.52(m, 6H, o-C6H5), 7.00(m, 9H, m- and p-C6H5), 2.71(s,
2JPt–H =
51.0 Hz, 4H, =CH2), 1.2–0.8(brs, 8H,
cPr). 13C{1H} NMR (δ, C6D6, 125 MHz): 134.6(d,
43.1, JPt–C = 25.5 Hz, i -C6H5), 134.2(d, 12.4, JPt–C = 18.2 Hz, o-C6H5), 129.9(d, 2.4 Hz,
m-C6H5), 128.4(s, p-C6H5), 54.8(d, 2.9,
1JPt–C = 102.2 Hz, =CH2), 30.2(d, 16.3,
1JPt–C
= 431.5 Hz, =CR2), 9.2–6.8(brs,
cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 23.2(s,
1JPt–P
= 3094 Hz).
Synthesis of [Pt(BCP)(C2H4)(PCy3)] 5b
[Pt(C2H4)2(PCy3)] (63 mg, 0.12 mmol) was dissolved in hexane (3 mL) under an ethene
atmosphere. An excess of BCP (0.02 mL, 1.9 mmol) was added, and the solution stirred for
30 min. The solution was reduced to approximately 0.5 mL and cooled to−78 ◦C. After an
hour, the supernatant was decanted, leaving a pale yellow solid ([Pt(BCP)(C2H4)(PCy3)],
53 mg, 0.091 mmol, 76%). 1H NMR (δ, C6D6, 500 MHz): 2.68(s,
2JPt–H = 50.0 Hz,
4H, =CH2), 2.03(d, 10.0, JPt–H = 23.0 Hz, 3H, P−CH) 1.86(d, 12.5 Hz, 6H, CH2),
1.64(d, 11.0 Hz, 6H, CH2), 1.54(d, 12.5 Hz, 3H, CH2), 1.35(qm, 13.0 Hz, 6H, CH2),
1.17–1.05(m, 11H, CH2 and
cPr), 1.02(quintt, 13.0, 3.0 Hz, 6H, CH2).
13C{1H} NMR (δ,
C6D6, 125 MHz): 50.7(d, 1.9,
1JPt–C = 101.8 Hz, =CH2), 36.5(d, 20.6, JPt–C = 26.0 Hz,
P−CH), 30.3(s, JPt–C = 17.8 Hz, CH2), 29.1(s,
1JPt–C = 482.9 Hz, =CR2), 27.9(d, 10.1 Hz,
CH2), 26.8(s, CH2), 8.3(brs, JPt–C = 23.8 Hz,
cPr). 31P{1H} NMR (δ, C6D6, 121 MHz):
25.3(s, 1JPt–P = 2976 Hz).
Synthesis of [Pt(MCP)(C2H4)(PPh3)] 6a
[Pt(C2H4)2(PPh3)] (10 mg, 0.019 mmol) was dissolved in hexane (1.5 mL) under an ethene
atmosphere. An excess of MCP was added, and the solution flushed with C2H4 for 5 min.
The volume was reduced to ∼0.5 mL, and the solution cooled to −78 ◦C for an hour.
The supernatant was decanted off, leaving pale white crystals. Solution contains 47%
[Pt(MCP)(C2H4)(PPh3)] by
31P{1H} NMR. 1H NMR (δ, C6D6, 500 MHz): 7.52(m, 6H,
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o-C6H5), 7.01(m, 9H, m- and p-C6H5), 2.61(s,
2JPt–H = 56.0 Hz, 4H, C2H4 =CH2), 2.58(d,
6.5, 2JPt–H = 61.5 Hz, 2H, MCP =CH2), 1.64(brd, 7.5, JPt–H = 60.0 Hz, 2H,
cPr), 1.55(d,
5.5, JPt–H = 34.0 Hz, 2H, cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 23.6(s,
1JPt–P =
3085 Hz).
Synthesis of [Pt(MCP)(C2H4)(PCy3)] 6b
[Pt(C2H4)2(PCy3)] (12 mg, 0.023 mmol) was placed in an NMR tube under an ethene
atmosphere, and C6D6 (0.5 mL) added. An excess of MCP was added, and the solution
flushed with C2H4 for 5 min. Solution contains 94% [Pt(MCP)(C2H4)(PCy3)] by
31P{1H}
NMR. In the presence of excess MCP, [Pt(MCP)2(PCy3)] forms overnight.
1H NMR (δ,
C6D6, 500 MHz): 2.52(d, 6.3,
2JPt–H = 61.2 Hz, 2H, MCP =CH2), 2.49(s,
2JPt–H =
48.1 Hz, 4H, C2H4 =CH2), 2.20(m, 3H, P−CH), 1.90(d, 12.0 Hz, 6H, CH2), 1.7–1.5(m,
9H, CH2), 1.5–0.9(m, 19H, CH2 and
cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 28.0(s,
1JPt–P = 2978 Hz).
Synthesis of [Pt(MCP)2(PPh3)] 7a
[Pt(C2H4)2(PPh3)] (70 mg, 0.14 mmol) was suspended in hexane (5 mL). An excess of
MCP was added, and the reaction stirred for 15 min. Hexane was added to dissolve
the remaining solid. The solution was cooled to −78 ◦C for an hour, after which the
supernatant was decanted off, leaving an off-white solid. Solid was 90% [Pt(MCP)2(PPh3)]
7a, 10% [Pt(MCP)(C2H4)(PPh3)] 6a. X-ray quality crystals of [Pt(MCP)2(PPh3)] were
grown by recrystallization from hexane containing a few drops of MCP. 1H NMR (δ,
C6D6, 500 MHz): 7.52(m, 6H, o-C6H5), 7.00(m, 9H, m- and p-C6H5), 2.39(d, 4.0,
2JPt–H
= 55.0 Hz, 4H, =CH2), 1.31(m, 4H,
cPr). 13C{1H} NMR (δ, C6D6, 125 MHz): 138.8(d,
39.1, JPt–C = 26.9 Hz, i -C6H5), 134.2(m, o-C6H5), 129.8(d, 2.4Hz, m-C6H5), 128.4(s, p-
C6H5), 54.1(d, 16.3,
1JPt–C = 352.9 Hz, =CR2), 38.9(s,
1JPt–C = 100.3 Hz, =CH2), 7.8(s,
JPt–C = 24.5 Hz, cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 22.3(s,
1JPt–P = 2932 Hz).
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Synthesis of [Pt(MCP)2(PCy3)] 7b
[Pt(C2H4)2(PCy3)] (12mg, 0.023 mmol) was placed in an NMR tube under an ethene
atmosphere, and C6D6 (0.5 mL) added. A large excess of MCP was added, and Ar
bubbled through the solution for 5 min. Solution contains 99% [Pt(MCP)2(PCy3)] by
31P{1H} NMR. 1H NMR (δ, C6D6, 500 MHz): 2.27(d, 6.0,
2JPt–H = 50.0 Hz, 4H, =CH2),
2.21(d, 8.5, JPt–H = 24.0 Hz, 3H, P−CH), 1.88(d, 12.0 Hz, 6H, CH2), 1.65(dd, 13.0,
2.0 Hz, 6H, CH2), 1.55(d, 12.0 Hz, 3H, CH2), 1.47–1.29(m, 11H, CH2 and
cPr), 1.13(m,
6H, CH2), 1.03(m, 6H, CH2).
13C{1H} NMR (δ, C6D6, 125 MHz): 48.5(brd, 28.3,
1JPt–C
= 385.6 Hz, =CR2), 36.7(d, 21.1, JPt–C= 26.9 Hz, P−CH), 32.0(m, =CH2), 30.3(s, JPt–C
= 18.2 Hz, CH2), 28.0(d, 10.2 Hz, CH2), 26.9(s, CH2), 7.2(s, JPt–C = 25.0 Hz,
cPr).
31P{1H} NMR (δ, C6D6): 23.2(s,
1JPt–P= 2695 Hz).
6.3 Chapter Three Experimental
Synthesis of [Pt(BCP)(tBu2PCH2(o-C6H4)CH2S
tBu)] 8 and
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P trans cPr)
11a and (P trans Me) 11b
[Pt(nb)(tBu2PCH2(o-C6H4)CH2S
tBu)] (30 mg, 0.048 mmol) was placed in a
NMR tube and C6D6 (0.5 mL) added. Carbon-13 enriched BCP (0.08 mL of a
0.62 mmol/mL sln in C6D6, 0.050 mmol, 1.03 eq.) was added, resulting in the
immediate formation of [Pt(BCP)(tBu2PCH2(o-C6H4)CH2S
tBu)] 8. After an hour,
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P trans cPr) 11a and
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P trans Me) 11b begin to
form, reaching 98% completion by 31P{1H} NMR after 8 days (85% 11a, 15% 11b).
[Pt(BCP)(tBu2PCH2(o-C6H4)CH2S
tBu)] 8: 1H NMR (δ, C6D6, 600 MHz): 7.10(d,
7.6 Hz, 1H, o-C6H4), 7.06(d, 7.3 Hz, 1H, o-C6H4), 7.01(t, 7.4 Hz, 1H, m-C6H4), 6.95((t,
7.3 Hz, 1H, m-C6H4), 4.11(s, JPt–H = 28.5 Hz, 2H, S−CH2), 3.23(d, 8.5, JPt–H = 17.0 Hz,
2H, P−CH2), 1.22(s, 9H, S
tBu), 1.16(d, 12.7 Hz, 18 H, P tBu). Data for cPr protons
could not be obtained. 13C{1H} NMR (δ, C6D6, 150 MHz): 138.5(s, S i -C6H4), 136.1(d,
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2.9 Hz, P i -C6H4), 131.9(d, 2.3 Hz, P o-C6H4), 131.2(d, 3.5 Hz, S o-C6H4), 127.2(d,
1.8 Hz, P m-C6H4), 127.0(d, 2.3 Hz, S m-C6H4), 49.6(d, 4.0 Hz, S−CR3), 38.5(d, 2.9,
JPt–C = 32.3 Hz, S−CH2), 36.2(d, 14.4, JPt–C = 55.5 Hz, P−CR3), 29.9(d, 6.4 Hz, P
CH3), 29.8(s, JPt–C = 12.8 Hz, S CH3), 28.4(d, 4.6 Hz, P−CH2), 28.2(d, 78.0,
1JPt–C
= 579.0 Hz, =CR2 trans P), 25.2(d, 5.2,
1JPt–C = 656.6 Hz, =CR2 trans S), 9.0(brs,
cPr), 8.7(brs, cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 54.9(s,
1JPt–P = 3383 Hz).
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P trans cPr)
11a: 1H NMR (δ, C6D6, 500 MHz): 7.52(t, 4.5, JPt–H = 59.5 Hz, 1H, Ar-H), 7.10(d,
4.5 Hz, 2H, Ar-H), 4.85(t, 13.5, JPt–H = 13.0 Hz, 1H, CHMe), 4.54(d, 8.0, JPt–H =
39.0 Hz, 1H, CH), 3.80(d, 12.5, JPt–H = 22.0 Hz, 2H, S−CH2), 3.55(dd, 17.0, 10.0, JPt–H
= 29.0 Hz, 1H, P−CH2), 3.26(dd, 17.0, 8.0, JPt–H = 8.0 Hz, 1H, P−CH2), 1.63(d, 6.5 Hz,
3H, CH3), 1.56(m, 2H,
cPr), 1.29(s, 9H, S tBu), 1.26(m, 2H, cPr), 1.15(d, 13.0 Hz, 9H,
P tBu), 1.08(d, 13.0 Hz, 9H, P tBu). 13C{1H} NMR (δ, C6D6, 125 MHz): 153.9(d,
2.4, 1JPt–C = 1192.1, Pt−C), 151.4(d, 15.3, JPt–C = 72.0 Hz, P i -C6H4), 136.9(d, 2.9,
JPt–C = 48.9 Hz, Ar), 131.7(d, 12.4, JPt–C = 59.5 Hz, S i -C6H4), 126.6(s, JPt–C =
9.3 Hz, Ar), 126.3(s, Ar), 98.6(d, 4.3, 1JPt–C = 21.1 Hz, CH), 74.1(s, 1JPt–C = 32.6 Hz,
CHMe), 53.5(d, 76.3, 1JPt–C = 447.4 Hz, C(CH2)2), 42.4(s, S−CR3), 35.7(s, JPt–C =
13.8 Hz, S−CH2), 35.4(d, 18.2, JPt–C = 31.7 Hz, P−CR3), 34.3(d, 21.1, JPt–C = 52.3 Hz,
P−CR3), 31.4(d, 33.6, JPt–C = 89.4 Hz, P−CH2), 30.9(s, S CH3), 29.4(d, 4.7, P CH3),
29.3(d, 5.2, P CH3), 17.3(s, JPt–C = 27.9 Hz, CH3), 7.7(d, 4.3, JPt–H = 25.9 Hz,
cPr),
3.7(brs, JPt–H = 18.0 Hz, cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 82.0(s,
1JPt–P =
3141 Hz). [Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P
trans Me) 11b: 1H NMR (δ, C6D6, 600 MHz): 8.45(dd, 6.4, 2.3 JPt–H = 46.7 Hz,
1H, Ar-H), 7.10(d, 4.7 Hz, 2H, Ar-H), 4.82(d, 7.5, JPt–H = 41.6 Hz, 1H, CH), 4.57(m,
1H, CHMe), 3.82(d, 19.3, JPt–H = 30.7 Hz, 2H, S−CH2), 3.66(dd, 17.0, 9.6 Hz, 1H,
P−CH2), 3.33(dd, 17.0, 8.8 Hz, 1H, P−CH2), 1.65(dd, 6.4, 4.7 Hz, 3H, CH3), 1.38(m,
2H, cPr), 1.29(s, 9H, S tBu), 1.26(m, 1H, cPr), 1.16(d, 13.6 Hz, 9H, P tBu), 1.12(d,
13.6 Hz, 9H, P tBu), 1.1(m, 1H, cPr). 13C{1H} NMR (δ, C6D6, 150 MHz): 159.9(d, 2.8,
1JPt–C = 1043.3, Pt−C), 150.5(d, 13.3, P i -C6H4), 142.7(d, 2.8, JPt–C = 41.7 Hz, Ar),
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131.8(d, 17.3, JPt–C = 60.0 Hz, S i -C6H4), 126.2(s, JPt–C = 7.1 Hz, Ar), 126.1(s, Ar),
102.8(brs, 1JPt–C = 7.1 Hz, CH), 84.3(d, 30.1, 1JPt–C = 130.6 Hz, CHMe), 48.1(s, 1JPt–C
= 202.3 Hz, C(CH2)2), 42.3(s, S−CR3), 36.1(d, 23.2, JPt–C = 63.9 Hz, P−CR3), 35.9(s,
JPt–C = 12.2 Hz, S−CH2), 34.3(d, 23.7, JPt–C = 54.8 Hz, P−CR3), 33.0(d, 35.3, JPt–C
= 80.8 Hz, P−CH2), 30.9(s, S CH3), 29.2(d, 4.1, JPt–C = 14.0 Hz, P CH3), 28.7(d, 4.6,
JPt–C = 19.6 Hz, P CH3), 16.8(d, 4.6, JPt–C = 41.6 Hz, CH3), 9.0(s, JPt–H = 15.0 Hz,
cPr) 6.6(s, cPr). 31P{1H} NMR (δ, C6D6, 121 MHz): 80.1(s,
1JPt–P = 3893 Hz). m/z =
[M+ calcd for C26H43P
194PtS 613.2468; found 613.2473.
Synthesis of [Pt(MCP)(tBu2PCH2(o-C6H4)CH2S
tBu)] 9 and
[Pt(η3-CH2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P trans Me) 12a
and (P trans CH2) 12b
[Pt(nb)(tBu2PCH2(o-C6H4)CH2S
tBu)] (35 mg, 0.056 mmol) was placed in a NMR
tube and C6D6 (0.5 mL) added. MCP (0.16 mL of a 0.37 mmol/mL sln in
C6D6, 0.059 mmol, 1.06 eq.) was added, resulting in the immediate formation of
[Pt(MCP)(tBu2PCH2(o-C6H4)CH2S
tBu)] (S trans cPr) 9a and [Pt(MCP)(tBu2PCH2(o-
C6H4)CH2S
tBu)] (P trans cPr) 9b (62% 9a, 38% 9b, 80% completion by 31P{1H} NMR).
Overnight, [Pt(η3-CH2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P trans Me) 12a
and [Pt(η3-CH2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P trans CH2) 12b began
to form, reaching 95% completion by 31P{1H} NMR after 21 days (63% 12a, 37% 12b).
[Pt(MCP)(tBu2PCH2(o-C6H4)CH2S
tBu)] (S trans cPr) 9a: 1H NMR (δ, C6D6,
600 MHz): 7.12(d, 7.3 Hz, 2H, o-C6H4), 7.03(t, 7.3 Hz, 1H, m-C6H4), 6.97((t, 6.1 Hz,
1H, m-C6H4), 4.19(s, JPt–H = 26.8 Hz, 2H, S−CH2), 3.27(d, 8.4, JPt–H = 14.4 Hz, 2H,
P−CH2), 2.05(d, 8.2, JPt–H = 52.7 Hz, 2H, =CH2), 1.45(brs, 2H,
cPr), 1.37(brs, 2H,
cPr), 1.34(s, 9H, S tBu), 1.25(d, 12.3 Hz, 9H, P tBu), 1.17(d, 12.6 Hz, 9H, P tBu).
13C{1H} NMR (δ, C6D6, 150 MHz): 138.9(s, S i -C6H4), 136.6(d, 3.5 Hz, P i -C6H4),
132.0(d, 2.3 Hz, P o-C6H4), 131.4(d, 4.1 Hz, S o-C6H4), 127.1(d, 1.2 Hz, m-C6H4),
126.9(d, 2.3 Hz, m-C6H4), 50.5(d, 4.0 Hz, S−CR3), 38.8(d, 2.3, JPt–C = 31.1 Hz,
S−CH2), 37.2(d, 13.9, JPt–C = 52.6 Hz, P−CR3), 30.1(s, JPt–C = 14.5 Hz, S CH3),
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29.8(brd, 6.9, JPt–C = 29.6 Hz, P CH3), 28.9(d, 5.2 Hz, P−CH2), 26.3(d, 38.7,
1JPt–C
= 145.1 Hz, =CH2), 10.5(d, 1.7, JPt–C = 30.1 Hz,
cPr). Data for MCP =CR2 carbon
could not be obtained. 31P{1H} NMR (δ, C6D6, 121 MHz): 58.8(s,
1JPt–P = 3870 Hz).
[Pt(MCP)(tBu2PCH2(o-C6H4)CH2S
tBu)] (P trans cPr) 9b: 1H NMR (δ, C6D6,
600 MHz): 7.14(d, 7.5 Hz, 1H, o-C6H4), 7.10(d, 7.5 Hz, 1H, o-C6H4), 7.01(t, 6.6 Hz,
1H, m-C6H4), 6.96((t, 6.1 Hz, 1H, m-C6H4), 4.20(s, JPt–H = 31.4 Hz, 2H, S−CH2),
3.27(d, 8.4, JPt–H = 18.8 Hz, 2H, P−CH2), 2.38(d, 4.2, JPt–H = 82.1 Hz, 2H, =CH2),
1.59(m, 2H, cPr), 1.50(m, 2H, cPr), 1.29(d, 12.3 Hz, 9H, P tBu), 1.26(d, 12.0 Hz, 9H,
P tBu), 1.21(s, 9H, S tBu). 13C{1H} NMR (δ, C6D6, 150 MHz): 138.9(s, S i -C6H4),
136.5(d, 2.9 Hz, P i -C6H4), 132.2(d, 1.7 Hz, P o-C6H4), 131.4(d, 4.0 Hz, S o-C6H4),
127.0(brs, m-C6H4), 127.0(d, 2.3 Hz, m-C6H4), 49.2(d, 4.7 Hz, S−CR3), 39.5(d, 4.1,
JPt–C = 34.1 Hz, S−CH2), 36.1(d, 15.1, JPt–C = 63.0 Hz, P−CR3), 30.3(brd, 5.2 Hz,
JPt–C = 16.3 Hz, P CH3), 29.4(s, JPt–C = 13.8 Hz, S CH3), 28.9(d, 1.5 Hz, P−CH2),
25.7(d, 5.7, 1JPt–C = 270.6 Hz, =CH2), 10.0(s, JPt–C = 24.8 Hz,
cPr). Data for MCP
=CR2 carbon could not be obtained.
31P{1H} NMR (δ, C6D6, 121 MHz): 55.3(s,
1JPt–P
= 3483 Hz). [Pt(η3-CH2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P trans
Me) 12a: 1H NMR (δ, C6D6, 600 MHz): 8.49(t, 7.3, JPt–H = 55.2 Hz, 1H, Ar-H), 7.1(m,
2H, Ar-H), 4.61(dt, 13.3, 7.7, JPt–H = 41.9 Hz, 1H, CH), 4.34(m, 1H, CHMe), 3.83(m,
2H, S−CH2), 3.58(dt, 7.6, 1.2 Hz, 1H, CH2 syn), 3.57(dd, 16.7, 9.1, JPt–H = 42.5 Hz,
1H, P−CH2), 3.42(d, 9.1, JPt–H = 15.4 Hz, 1H, P−CH2), 2.27(d, 13.2, JPt–H = 38.1 Hz,
1H, CH2 anti), 1.39(dd, 6.4, 5.6 Hz, 3H, CH3), 1.29(s, 9H, S
tBu), 1.16(d, 13.5 Hz, 9H,
P tBu), 1.09(d, 13.5 Hz, 9H, P tBu). 13C{1H} NMR (δ, C6D6, 150 MHz): 158.4(d, 2.3,
1JPt–C = 1142.7, Pt−C), 151.0(d, 14.4, JPt–C = 80.3 Hz, P i -C6H4), 142.7(d, 3.2, JPt–C
= 52.1 Hz, Ar), 131.9(d, 12.7, JPt–C = 56.0 Hz, S i -C6H4), 126.5(s, Ar), 126.2(s, JPt–C =
8.7 Hz, Ar), 108.2(d, 2.4, 1JPt–C = 8.4 Hz, CH), 73.4(d, 37.0, 1JPt–C = 173.4 Hz, CHMe),
42.5(s, 1JPt–C = 52.0 Hz, CH2), 42.3(s, S−CR3), 35.9(s, JPt–C = 13.8 Hz, S−CH2),
34.6(d, 22.5, JPt–C = 54.3 Hz, P−CR3), 34.1(d, 23.2, JPt–C = 43.8 Hz, P−CR3), 32.0(d,
34.7, JPt–C = 82.6 Hz, P−CH2), 30.9(s, S CH3), 29.3(d, 1.7, P CH3), 29.3(d, 1.7, P CH3),
15.3(d, 5.2, JPt–C = 39.9 Hz, CH3).
31P{1H} NMR (δ, C6D6, 121 MHz): 84.1(s,
1JPt–P
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= 3560 Hz). [Pt(η3-CH2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (P trans
CH2) 12b:
1H NMR (δ, C6D6, 600 MHz): 8.51(d, 7.0, JPt–H = 58.3 Hz, 1H, Ar-H),
7.1(m, 2H, Ar-H), 4.61(dt, 13.3, 7.7, JPt–H = 41.9 Hz, 1H, CH), 4.39(quint, 5.1 Hz, 1H,
CHMe), 3.83(m, 2H, S−CH2), 3.6(m, 1H, CH2 syn), 3.51(dd, 9.1, 2.1, JPt–H = 20.0 Hz,
1H, P−CH2), 3.39(d, 9.1, JPt–H = 14.6 Hz, 1H, P−CH2), 2.92(ddd, 12.9, 9.7, 2.1 Hz, 1H,
CH2 anti), 1.29(d, 11.8 Hz, 3H, CH3), 1.29(s, 9H, S
tBu), 1.15(d, 13.5 Hz, 9H, P tBu),
1.07(d, 13.5 Hz, 9H, P tBu). 13C{1H} NMR (δ, C6D6, 150 MHz): 155.5(d, 2.4,
1JPt–C =
1132.8, Pt−C), 151.1(d, 14.5, JPt–C = 81.0 Hz, P i -C6H4), 144.5(d, 4.0, JPt–C = 58.4 Hz,
Ar), 131.8(d, 12.8, JPt–C = 55.3 Hz, S i -C6H4), 126.3(s, JPt–C = 7.5 Hz, Ar), 126.0(s,
Ar), 108.7(d, 3.4, 1JPt–C = 11.0 Hz, CH), 62.5(s, 1JPt–C = 48.6 Hz, CHMe), 53.1(d, 40.4,
1JPt–C = 182.6 Hz, CH2), 42.4(s, S−CR3), 35.8(s, JPt–C = 13.8 Hz, S−CH2), 34.8(d, 13.8,
JPt–C = 40.6 Hz, P−CR3), 34.7(d, 16.1, JPt–C = 59.0 Hz, P−CR3), 32.2(d, 34.6, JPt–C =
82.0 Hz, P−CH2), 30.9(s, S CH3), 29.4(d, 5.2, P CH3), 29.4(d, 4.6, P CH3), 15.6(s, JPt–C
= 26.6 Hz, CH3).
31P{1H} NMR (δ, C6D6, 121 MHz): 82.0(s,
1JPt–P = 3590 Hz). m/z
= [M + H]+ calcd for C24H42P
194PtS 583.2299; found 583.2344.
Synthesis of [Pt(MCP)2(
tBu2PCH2(o-C6H4)CH2S
tBu)] 10
[Pt(nb)(tBu2PCH2(o-C6H4)CH2S
tBu)] (12 mg, 0.019 mmol) was placed in a NMR tube
and C6D6 (0.5 mL) added. A large excess of MCP was added, resulting in the immediate
formation of 9a, 9b and [Pt(MCP)2(
tBu2PCH2(o-C6H4)CH2S
tBu)] 10 (40% 9a, 24% 9b,
36% 10, quantitative by 31P{1H} NMR). After an hour, 12a and 12b began to form.
All of the 10 had reacted after 13 days, and the formation of 12a and 12b had reached
91% completion by 31P{1H} NMR after 21 days (63% 12a, 37% 12b). 1H NMR (δ,
C6D6, 600 MHz): 7.1(m, 2H, o-C6H4), 6.89(t, 7.4 Hz, 1H, m-C6H4), 6.79((t, 7.5 Hz, 1H,
m-C6H4), 4.29(dd, 10.9, 5.3 Hz, 2H, P−CH2), 4.24(m, 2H, P−CH2), 3.96(d, 9.4, JPt–H
= 32.6 Hz, 2H, S−CH2), 2.49(d, 6.4, JPt–H = 48.1 Hz, 4H, =CH2), 1.26(s, 9H, S
tBu),
1.23(d, 12.3 Hz, 18 H, P tBu). Data for cPr protons could not be obtained. 13C{1H} NMR
(δ, C6D6, 150 MHz): 142.0(s, S i -C6H4), 136.4(d, 5.8 Hz, P i -C6H4), 131.9(d, 7.5 Hz, Ar),
130.9(s, Ar), 126.8(s, Ar), 48.7(brd, 25.7 Hz, 1JPt–C = 381.9 Hz, =CR2), 42.6(s, S−CR3),
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37.8(d, 14.5, JPt–C = 28.8 Hz, S−CH2), 35.7(brs,
1JPt–C = 100.6 Hz, =CH2), 30.9(s, S
CH3), 30.5(d, 4.0 Hz, P CH3), 26.5(d, 18.5 Hz, JPt–C = 30.0 Hz, P−CH2), 7.2(s, JPt–C =
25.4 Hz, cPr). Data for P−CR3 carbons could not be obtained.
31P{1H} NMR (δ, C6D6,
121 MHz): 40.6(s, 1JPt–P = 2661 Hz).
Synthesis of [Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (anti Me)
13a[HC(SO2CF3)2] and [Pt(η
3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2]
(syn Me) 13b[HC(SO2CF3)2]
[Pt(C2H4)(dppp)] (30 mg, 0.047 mmol) was placed in an NMR tube and C6D6 (0.5 mL)
added. Carbon-13 enriched BCP (0.08 mL of a 0.62 mmol/mL sln in C6D6, 0.050 mmol,
1.06 eq.) was added, resulting in the immediate formation of [Pt(13BCP)(dppp)]. After 30
min, the solution was dried in vacuo and a solution of H2C(SO2CF3)2 (13 mg, 0.047 mmol)
in d6-acetone (0.5 mL) added. Two new complexes, 13a[HC(SO2CF3)2] and 14a were
formed immediately in a 75:25 ratio by 31P{1H} NMR. Overnight, 14a converted com-
pletely to 14b, while 13a[HC(SO2CF3)2] began to form 13b[HC(SO2CF3)2], stabilising at
27:73 anti :syn after 2 months. [Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2]
(anti Me) 13a[HC(SO2CF3)2]:
1H NMR (δ, d6-acetone, 600 MHz): 7.9–7.3(m, 20H,
Ar-H), 5.40(d, 8.2, JPt–H = 54.0 Hz, 1H, CH), 4.93(m, 1H, CHMe), 3.80(s, 1H, CHS2),
3.3–2.9(m, 4H, P−CH2), 2.3(m, 2H, CH2), 1.21(m, 1H,
cPr), 0.88(m, 3H, CH3), 0.86(m,
1H, cPr), 0.37(m, 2H, cPr). 13C{1H} NMR (δ, d6-acetone, 150 MHz): 134–129(m, Ar),
122.1(q, 1JF–C = 325.4 Hz, CF3), 104.2(dd, 3.4, 1.7, CH), 91.2(d, 22.6,
1JPt–C = 65.9 Hz,
CHMe), 66.7(d, 54.3, 1JPt–C = 252.6 Hz, C(CH2)2), 55.4(m, CHS2), 26.3(dd, 37.0, 4.1,
JPt–C = 35.8 Hz, P−CH2), 25.4(dd, 34.7, 2.3, JPt–C = 17.2 Hz, P−CH2), 19.4(s, JPt–C =
17.3 Hz, CH2), 15.5(d, 4.1, JPt–C = 33.2, CH3), 8.1(d, 4.0, JPt–C = 16.8 Hz,
cPr), 4.4(s,
JPt–C = 15.6 Hz, cPr). 31P{1H} NMR (δ, d6-acetone, 121 MHz): 1.4(d, 21.2, 1JPt–P =
3852 Hz, P trans CHMe), −2.8(d, 21.2, 1JPt–P = 3259 Hz, P trans cPr). 19F NMR (δ, d6-
acetone, 282 MHz): −81.5(brs). [Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2]
(syn Me) 13b[HC(SO2CF3)2]:
1H NMR (δ, d6-acetone, 600 MHz): 7.9–7.3(m, 20H,
Ar-H), 5.39(d, 12.5, JPt–H = 51.0 Hz, 1H, CH), 4.14(m, 1H, CHMe), 3.80(s, 1H, CHS2),
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3.3–2.9(m, 4H, P−CH2), 2.3(m, 2H, CH2), 1.38(m, 3H, CH3), 1.22(m, 1H,
cPr), 0.65(m,
1H, cPr), 0.39(m, 1H, cPr), 0.14(m, 1H, cPr). 13C{1H} NMR (δ, d6-acetone, 150 MHz):
134–129(m, Ar), 122.1(q, 1JF–C = 325.4 Hz, CF3), 11.6(dd, 4.1, 1.8, CH), 92.6(d, 21.9,
1JPt–C = 29.0 Hz, CHMe), 67.1(d, 53.2, 1JPt–C = 269.3 Hz, C(CH2)2), 55.4(m, CHS2),
27.2(dd, 34.7, 2.9, P−CH2), 25.9(dd, 37.0, 3.5, P−CH2), 19.7(s, JPt–C = 13.8 Hz, CH2),
15.9(d, 2.4, CH3), 8.6(d, 4.0, JPt–C = 20.8 Hz,
cPr), 5.7(s, cPr). 31P{1H} NMR (δ, d6-
acetone, 121 MHz): 1.0(d, 20.8, 1JPt–P = 4042 Hz, P trans CHMe), −0.41(d, 20.8, 1JPt–P
= 3267 Hz, P trans cPr). 19F NMR (δ, d6-acetone, 282 MHz): −81.5(brs). m/z = [M+
calcd for C33H35P
194
2 Pt 683.1767; found 683.1813.
Synthesis of [Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
15[PhC(SO2CF3)2], [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me)
16a[PhC(SO2CF3)2] and [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn
Me) 16b[PhC(SO2CF3)2]
[Pt(C2H4)(dppp)] (30 mg, 0.047 mmol) was placed in an NMR tube and C6D6
(0.25 mL) added. MCP (0.25 mL of a 0.37 mmol/mL sln in C6D6, 0.093 mmol,
2 eq.) was added, resulting in the immediate formation of [Pt(MCP)(dppp)]. After
30 min, the solution was dried in vacuo and a solution of H2C(SO2CF3)2 (13 mg,
0.047 mmol) in d6-acetone (0.5 mL) added. Two new complexes, 15[PhC(SO2CF3)2]
and 16a[PhC(SO2CF3)2] were formed immediately in a 68:32 ratio by
31P{1H}
NMR. Overnight, 16a[PhC(SO2CF3)2] began to form 16b[PhC(SO2CF3)2], stabilising
at 16:84 anti :syn after 8 days. Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
15[PhC(SO2CF3)2]:
1H NMR (δ, d6-acetone, 600 MHz): 7.7–7.1(m, 25H, Ar-H),
3.56(brs, 2H, CH2 syn), 3.2–2.9(m, 6H, P−CH2 and CH2), 2.96(d, 8.5, JPt–H = 32.0 Hz,
2H, CH2 anti), 1.96(s, JPt–H = 58.4 Hz, 3H, CH3).
13C{1H} NMR (δ, d6-acetone,
150 MHz): 136.1(s, Ph), 135.9(t, 3.2, 1JPt–C = 24.8 Hz, CR2Me), 134–129(m, Ar),
127.8(s, Ph), 127.7(s, Ph), 123.0(q, 1JF–C = 328.9 Hz, CF3), 66.4(m, JP–C = 27.5, 1.8,
JP–P = 24.6, 1JPt–C = 85.0 Hz, CH2), 71.5(sept, JF–C = 3.2, CS2), 25.6(m, P−CH2),
24.8(s, JPt–C = 30.0, CH3), 20.1(s, JPt–C = 15.0 Hz, CH2).
31P{1H} NMR (δ, d6-acetone,
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121 MHz): 0.1(s, 1JPt–P = 3521 Hz). 19F NMR (δ, d6-acetone, 282 MHz): −78.72(s).
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me) 16a[PhC(SO2CF3)2]:
1H NMR (δ, d6-acetone, 600 MHz): 7.7–7.1(m, 25H, Ar-H), 5.32(dt, 14.1, 7.6, JPt–H =
53.4 Hz, 1H, CH), 4.62(t, 6.2, 1H, CHMe), 3.94(m, 1H, CH2 syn), 3.2–2.9(m, 5H, P−CH2
and CH2 anti), 2.3–2.2(m, 2H, CH2), 0.80(m, 3H, CH3).
13C{1H} NMR (δ, d6-acetone,
150 MHz): 136.1(s, Ph), 134.4-129.5(m, Ar), 127.8(s, Ph), 127.7(s, Ph), 123.0(q, 1JF–C
= 328.9 Hz, CF3), 113.9(t, 3.2,
1JPt–C = 16.5 Hz, CH), 83.4(m, 1JPt–C = 83.7 Hz,
CHMe), 60.2(m, 1JPt–C = 88.0 Hz, CH2), 71.5(sept, JF–C = 3.2, CS2), 25.6(m, P−CH2),
19.7(s, JPt–C = 16.8 Hz, CH2), 14.1(dd, 2.8, 1.1, JPt–C = 23.1, CH3).
31P{1H} NMR
(δ, d6-acetone, 121 MHz): −1.2(AB, 2JPt–P = 23.0, 1JPt–P = 3569 Hz, P trans CH2),
−1.2(AB, 2JPt–P = 23.0, 1JPt–P = 3625 Hz, P trans CHMe). 19F NMR (δ, d6-acetone,
282 MHz): −78.72(s). [Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me)
16b[PhC(SO2CF3)2]:
1H NMR (δ, d6-acetone, 600 MHz): 7.7–7.1(m, 25H, Ar-H),
5.23(td, 12.7, 7.3, JPt–H = 51.5 Hz, 1H, CH), 3.68(m, 1H, CHMe), 3.59(m, 1H, CH2 syn),
3.2–2.9(m, 4H, P−CH2), 2.54(ddd, 12.7, 10.0, 2.7, 1H, CH2 anti), 2.3-2.1(m, 2H, CH2),
1.29(m, 3H, CH3).
13C{1H} NMR (δ, d6-acetone, 150 MHz): 136.1(s, Ph), 134-129(m,
Ar), 127.8(s, Ph), 127.7(s, Ph), 123.0(q, 1JF–C = 328.9 Hz, CF3), 119.3(t, 3.5,
1JPt–C =
26.6 Hz, CH), 84.3(d, 27.2, 1JPt–C = 54.4 Hz, CHMe), 62.3(d, 27.8, 1JPt–C = 100.1 Hz,
CH2), 71.5(sept, JF–C = 3.2, CS2), 26.9(dd, 35.8, 3.5, JPt–C = 19.6 Hz, P−CH2), 25.6(m,
P−CH2), 19.9(s, JPt–C = 13.8 Hz, CH2), 15.9(d, 2.9, JPt–C = 3.8, CH3).
31P{1H} NMR
(δ, d6-acetone, 121 MHz): 1.4(AB, 2JPt–P = 22.0, 1JPt–P = 3670 Hz, P trans CH2),
−1.8(AB, 2JPt–P = 22.0, 1JPt–P = 3693 Hz, P trans CHMe). 19F NMR (δ, d6-acetone,
282 MHz): −78.72(s).
Synthesis of [Pt(η3-CH2C
cPrCH2)(dbpx)][HC(SO2CF3)2] 17[HC(SO2CF3)2]
[Pt(C2H4)(dbpx)] (30 mg, 0.049 mmol) was placed in an NMR tube and C6D6 (0.5 mL)
added. Carbon-13 enriched BCP (0.24 mL of a 0.62 mmol/mL sln in C6D6, 0.14 mmol,
3 eq.) was added, and the solution heated at 60 ◦C for 3 days, forming [Pt(13BCP)(dbpx)]
in an 90% yield by 31P{1H} NMR. The solution was dried in vacuo and a solution of
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H2C(SO2CF3)2 (14 mg, 0.049 mmol) in d6-acetone (0.5 mL) added, resulting in the
immediate formation of [Pt(η3-CH2C
cPrCH2)(dbpx)][HC(SO2CF3)2].
1H NMR (δ, d6-
acetone, 600 MHz): 7.60(brs, 2H, o-C6H4), 7.28(brs, 2H, m-C6H4), 4.81(brs, 2H, CH2
syn), 4.2(br, 4H, P−CH2), 3.86(brs, 1H, CHS2), 2.74(d, 8.1, JPt–H = 41.3 Hz, CH2 anti),
1.44(brm, 37H, tBu and CH), 0.93(brm, 2H, cPr), 0.87(brm, 2H, cPr). 13C{1H} NMR
(δ, d6-acetone, 125 MHz): 136.4(brs, i -C6H4), 134.2(brs, o-C6H4), 128.0(s, m-C6H4),
126.4(s, 1JPt–C = 44.5 Hz, CR2
cPr), 122.2(q, 1JF–C = 325.4 Hz, CF3), 59.1(m, JP–C =
30.2, −2.1, JP–P = 11.2, 1JPt–C = 79.8 Hz, CH2), 55.3(sept, JF–C = 1.2 Hz, CS2), 40.2(brs,
P−CH2), 39.4(brs, P−CR3), 30.8(brs, CH3), 15.6(s, JPt–C = 24.9 Hz, CH), 8.9(brs,
cPr).
31P{1H} NMR (δ, d6-acetone, 121 MHz): 33.9(brs, 1JPt–P = 3632 Hz), 32.1(brs, 1JPt–P
= 3647 Hz). 19F NMR (δ, d6-acetone, 282 MHz): −81.6(brs). m/z = [M+ calcd for
C30H53P
194
2 Pt 670.3268; found 670.3256.
Synthesis of [Pt(η3-CH2CMeCH2)(dbpx)][HC(SO2CF3)2]
18a[HC(SO
2
CF3)2] and [Pt(η
3-CH2CHCHMe)(dbpx)][HC(SO2CF3)2]
18b[HC(SO2CF3)2]
[Pt(C2H4)(dbpx)] (30 mg, 0.049 mmol) was placed in an NMR tube and C6D6 (0.5 mL)
added. MCP (0.08 mL of a 1.85 mmol/mL sln in C6D6, 0.14 mmol, 3 eq.) was
added, and the solution heated at 60 ◦C for 4 days, forming [Pt(MCP)(dbpx)]
in an 83% yield by 31P{1H} NMR. The solution was dried in vacuo and a
solution of H2C(SO2CF3)2 (14 mg, 0.049 mmol) in d6-acetone (0.5 mL) added,
resulting in the immediate formation of [Pt(η3-CH2CMeCH2)(dbpx)][HC(SO2CF3)2]
and [Pt(η3-CH2CHCHMe)(dbpx)][HC(SO2CF3)2] in a 58:42 ratio. [Pt(η
3-
CH2CMeCH2)(dbpx)][HC(SO2CF3)2] 18a[HC(SO2CF3)2]:
1H NMR (δ, d6-
acetone, 600 MHz): 7.60(brs, 2H, o-C6H4), 7.28(brs, 2H, m-C6H4), 4.88(brs, 2H, CH2
syn), 4.2(br, 4H, P−CH2), 3.77(s, 1H, CHS2), 2.80(d, 8.4, JPt–H = 39.4 Hz, CH2 anti),
1.45(brm, 39H, tBu and CH3).
13C{1H} NMR (δ, d6-acetone, 150 MHz): 136.4(brs,
i -C6H4), 134.2(brs, o-C6H4), 128.1(s, m-C6H4), 127.9(m,
1JPt–C = 56.7 Hz, CR2Me),
122.2(q, 1JF–C = 326.0 Hz, CF3), 63.3(m, CH2), 55.3(m, CS2), 40.7(brs, P−CR3),
150
40.2(brs, P−CH2), 30.8(brs, CH3), 21.6(s, JPt–C = 28.4 Hz, CH).
31P{1H} NMR (δ, d6-
acetone, 121 MHz): 33.9(brs, 1JPt–P = 3572 Hz), 32.4(brs, 1JPt–P = 3641 Hz). 19F NMR
(δ, d6-acetone, 282 MHz): −81.81(s). [Pt(η3-CH2CHCHMe)(dbpx)][HC(SO2CF3)2]
18b[HC(SO2CF3)2]:
1H NMR (δ, d6-acetone, 600 MHz): 7.60(m, 2H, o-C6H4), 7.28(m,
2H, m-C6H4), 6.28(brs, 1H, CHMe), 5.04(dt, 12.2, 7.5 Hz, JPt–H = 51.9 Hz, 1H, CH),
4.53(m, 1H, CH2 syn), 4.2(br, 4H, P−CH2), 3.77(brs, 1H, CHS2), 2.86(ddd, 11.1, 10.0,
2.2, JPt–H = 34.4 Hz, CH2 anti), 1.45(brm, 39H,
tBu and CH3).
13C{1H} NMR (δ, d6-
acetone, 150 MHz): 136.4(brs, i -C6H4), 134.1(brs, o-C6H4), 128.1(s, m-C6H4), 122.2(q,
1JF–C = 326.0 Hz, CF3), 106.8(brs, CH), 84.6(brd, 22.0,
1JPt–C = 63.7 Hz, CHMe),
55.3(m, CS2), 51.7(brd, 32.4,
1JPt–C = 106.9 Hz, CH2), 40.1(brs, P−CH2), 39.4(brs,
P−CR3), 30.9(dd, 13.9, 3.5 Hz, CH3), 30.3(d, 2.9, JPt–C = 15 Hz, CH3), 16.5(brs, JPt–C
= 14.5 Hz, CH). 31P{1H} NMR (δ, d6-acetone, 121 MHz): 36.9(d, 1JPt–P = 3844 Hz).
19F NMR (δ, d6-acetone, 282 MHz): −81.81(s). m/z = [M+ calcd for C28H51P
194
2 Pt
643.3093; found 643.3089.
6.4 Chapter Four Experimental
Synthesis of [PtEt(C(CH2)2CH3)(COD)] 27a and
[Pt(C(CH2)2CH3)2(COD)] 27b
[PtEt2(COD)] (20 mg, 0.055 mmol) was placed in an NMR tube and MCP (0.51 mL of
a 1.85 mmol/mL solution in C6D6, 11 eq.) was added. [PtEt(C(CH2)2CH3)(COD)] and
[Pt(C(CH2)2CH3)2(COD)] began to form after two hours, ending in a 15:85 ratio by
1H
NMR after 30 days. [PtEt(C(CH2)2CH3)(COD)] 27a:
1H NMR (δ, C6D6, 600 MHz):
4.82(brs, JPt–H = 33.8 Hz, 2H, =CH), 4.64(brs, JPt–H = 34.4 Hz, 2H, =CH), 1.96(q, 7.8,
JPt–H = 91.8 Hz, 2H, Et CH2), 1.85–1.75(m, 8H, COD CH2), 1.51(t, 7.7, JPt–H = 74.4 Hz,
3H, Et CH3), 1.35(s, JPt–H = 55.9 Hz, 3H, MCP CH3), 0.73(m, JPt–H = 66.2 Hz, 2H,
cPr), 0.42(m, JPt–H = 46.5 Hz, 2H, cPr). 13C{1H} NMR (δ, C6D6/d6-acetone, 150 MHz):
101.8(s, JPt–C = 46.7 Hz, =CH), 98.9(s, JPt–C = 54.2 Hz, =CH), 31.2(s, JPt–C = 21.3 Hz,
MCP CH3), 29.8(s, COD CH2), 29.3(s, COD CH2), 21.8(s, JPt–C = 854.8 Hz, Et CH2),
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17.4(s, JPt–C = 1160.6 Hz, MCP Pt−C), 16.4(s, JPt–C = 35.2 Hz, Et CH3), 14.9(s,
cPr).
[Pt(C(CH2)2CH3)2(COD)] 27b:
1H NMR (δ, C6D6, 600 MHz): 4.82(brs, JPt–H =
33.8 Hz, 4H, =CH), 1.85–1.75(m, 8H, COD CH2), 1.41(s, JPt–H = 53.5 Hz, 3H, MCP
CH3), 0.86(t, 4.2, JPt–H = 66.2 Hz, 2H,
cPr), 0.41(m, JPt–H = 44.4 Hz, 2H, cPr). 13C{1H}
NMR (δ, C6D6/d6-acetone, 150 MHz): 102.0(s, JPt–C = 43.7 Hz, =CH), 31.5(s, JPt–C =
21.3 Hz, MCP CH3), 29.3(s, COD CH2), 17.2(s, JPt–C = 1178.5 Hz, MCP Pt−C), 15.9(s,
cPr).
Synthesis of trans–[PtCl2(BCP)(Py)] 28
[Pt2Cl4(C2H4)2] (50 mg, 0.085 mmol) was placed in an NMR tube and CDCl3 (0.5 mL)
added. Pyridine (14 µL, 0.085 mmol) and carbon-13 enriched BCP (0.14 mL of a
0.62 mmol/mL sln in C6D6, 0.085 mmol, 1 eq.) were added, resulting in the immediate
formation of trans–[PtCl2(BCP)(Py)]. Reaction is quantitative by
1H NMR. 1H NMR (δ,
CDCl3, 300 MHz): 8.92(dd, 6.6, 1.3, 2H, o-H Py), 7.89(tt, 7.8, 1.5, 1H, p-H Py), 7.47(td,
6.6, 1.5, 2H, m-H Py), 1.58(t, 7.0, JPt–H = 45.8 Hz, 4H, cPr-endo), 1.12(t, 7.5, JPt–H
= 29.9 Hz, 4H, cPr-exo). 13C{1H} NMR (δ, C6D6/CDCl3, 150 MHz): 151.6(s, o-C Py),
140.1(s, p-C Py), 125.5(s, m-C Py), 75.3(s, 1JPt–C = 248.5 Hz, =CR2), 10.6(s,
cPr). m/z
= [M + H]+ calcd for C11H14Cl2N
194Pt 424.0130; found 424.0136.
Synthesis of trans–[PtCl2(MCP)(Py)] 29
[Pt2Cl4(C2H4)2] (50 mg, 0.085 mmol) was placed in an NMR tube and CDCl3 (0.5 mL)
added. Pyridine (14 µL, 0.085 mmol) and MCP (0.09 mL of a 0.92 mmol/mL sln in
CDCl3, 0.085 mmol, 1 eq.) were added, resulting in the immediate formation of trans–
[PtCl2(MCP)(Py)]. Reaction is quantitative by
1H NMR. 1H NMR (δ, CDCl3, 300 MHz):
8.92(d, 5.2, JPt–H = 33.6 Hz, 2H, o-H Py), 7.93(t, 7.6, 1H, p-H Py), 7.51(t, 7.0, 2H,
m-H Py), 5.02(brs, 2H, =CH2), 1.63(brs, 2H,
cPr), 1.32(brs, 2H, cPr). 13C{1H} NMR (δ,
CDCl3, 150 MHz): 151.6(s, o-C Py), 140.2(s, p-C Py), 125.5(s, m-C Py), 91.6(brs, =CR2),
59.8(brs, =CH2), 10.2(s,
cPr). m/z = [M − Cl]+ calcd for C9H11ClN
194Pt 358.0185;
found 358.0179.
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Synthesis of cis–[PtCl2(BCP)(DMSO)] 30
cis–[PtCl2(DMSO)2] (10 mg, 0.024 mmol) was placed in an NMR tube and CDCl3
(0.5 mL) added. BCP (0.04 mL of a 0.62 mmol/mL solution in C6D6, 0.024 mmol)
was added, resulting in the formation of cis–[PtCl2(BCP)(DMSO)] after 1 hr. Due to the
limited solubility of cis–[PtCl2(DMSO)2] in CDCl3, a yield could not be obtained.
1H
NMR (δ, CDCl3, 600 MHz): 3.53(s, JPt–H = 21.2 Hz, 3H, S−CH3), 1.25(m, 4H,
cPr),
0.85(m, 4H, cPr). 13C{1H} NMR (δ, C6D6/CDCl3, 150 MHz): 82.2(s,
1JPt–C = 251.8 Hz,
=CR2), 44.6(s, S−CH3), 12.5(s,
cPr), 11.5(s, cPr).
Synthesis of cis–[PtCl2(MCP)(DMSO)] 31
cis–[PtCl2(DMSO)2] (20 mg, 0.047 mmol) was placed in an NMR tube and CDCl3
(0.5 mL) added. MCP (0.05 mL of a 0.92 mmol/mL solution in CDCl3, 0.046 mmol)
was added, resulting in the immediate formation of cis–[PtCl2(MCP)(DMSO)]. Due to
the limited solubility of cis–[PtCl2(DMSO)2] in CDCl3, a yield could not be obtained.
1H NMR (δ, CDCl3, 600 MHz): 4.81(s, JPt–H = 67.5 Hz, 1H, =CH2), 4.64(s, JPt–H =
63.1 Hz, 1H, =CH2), 3.59(s, JPt–H = 16.5 Hz, 3H, S−CH3), 3.45(s, JPt–H = 14.8 Hz, 3H,
S−CH3), 1.88(dt, 12.0, 8.3, 1H,
cPr), 1.55(dt, 12.0, 8.3, 1H, cPr), 1.38(dt, 9.4, 8.0, 1H,
cPr), 1.28(td, 9.4, 8.0, 1H, cPr). 13C{1H} NMR (δ, CDCl3, 150 MHz): 97.3(s,
1JPt–C =
277.5 Hz, =CR2), 67.5(s,
1JPt–C = 141.0 Hz, =CH2), 45.5(s,
1JPt–C = 47.9 Hz, S−CH3),
44.2(s, 1JPt–C = 44.0 Hz, S−CH3), 12.6(s,
cPr), 11.0(s, cPr).
Synthesis of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] 32
[PtCl2(SEt2)2] (50 mg, 0.11 mmol) was placed in an NMR tube and CDCl3
(0.5 mL) added. BCP (0.05 mL, 0.53 mmol) was added. After 2 days, trans–
Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] formed. Reaction is quantitative by
1H NMR.1H
NMR (δ, CDCl3, 500 MHz): 3.3-2.9(brs, 8H, S−CH2), 1.37(t, 15 Hz, 12H, CH3), 0.83(t,
7.0 Hz, 2H, Cl cPr), 0.77(t, 7.0 Hz, 2H, Cl cPr), 0.36(t, 5.0, JPt–H = 29.4 Hz, 2H, Pt
cPr-exo), 0.21(t, 5.0, JPt–H = 63.0 Hz, 2H, Pt cPr-endo). 13C{1H} NMR (δ, CDCl3,
125 MHz): 57.1(s, Cl−C), 32.2(s, JPt–C = 17.7 Hz, S−CH2), 16.4(s, Pt
cPr), 14.3(s, Cl
153
cPr), 13.4(s, JPt–C = 32.9 Hz, CH3), −0.4(s, JPt–C = 1011 Hz, Pt−C). m/z = [M − Cl]
+
calcd for C14H28Cl
194PtS2 489.0948; found 489.0949.
Synthesis of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(NC
tBu)2] 33
trans–[PtCl2(NC
tBu)2] (10 mg, 0.026 mmol) was was placed in an NMR tube and CDCl3
(0.5 mL) added. BCP (2.4 µL, 0.026 mmol) was added, resulting in the formation of
trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(NC
tBu)2] after 2 days. Reaction is quantitative by
1H
NMR. 1H NMR (δ, CDCl3, 500 MHz): 1.44(s, 18H,
tBu), 1.03(t, 6.3 Hz, 2H, Cl cPr),
0.73(t, 6.3 Hz, 2H, Cl cPr), 0.30(m, 4H, Pt cPr). 13C{1H} NMR (δ, CDCl3, 125 MHz):
122.1(s, JPt–C = 349 Hz, N−−C), 55.2(s, Cl−C), 30.2(s, CR3), 27.9(s, Me), 15.8(s, Cl
cPr),
14.7(s, Pt cPr), 0.0(s, JPt–C = 953 Hz, Pt−C).
Synthesis of trans–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(Py)
2
] 34a
trans–[PtCl2(Py)2] (20 mg, 0.047 mmol) was placed in an NMR tube and CDCl3
(0.5 mL) added. BCP (4.4 µL, 0.047 mmol) was added. Overnight, trans–
[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] forms, ending up as 30% of the species in solution.
1H NMR (δ, CDCl3, 600 MHz): 9.04(dd, 6.6, 1.2, JPt–H = 39.7 Hz, 4H, o-Py), 7.41(tt,
7.9, 1.6 Hz, 2H, p-Py), 6.98(td, 6.6, 0.9 Hz, 4H, m-Py), 0.41(t, 6.4 Hz, 2H, Cl cPr-
exo), −0.03(td, 4.1, 1.2, JPt–H = 37.9 Hz, 2H, Pt cPr-exo), −0.15(t, 4.1, 1.2, JPt–H =
50.8 Hz, 2H, Pt cPr-endo), −0.25(t, 6.4 Hz, 2H, Cl cPr-endo). 13C{1H} NMR (δ, CDCl3,
150 MHz): 153.7(s, o-Py), 136.7(s, p-Py), 124.9(s, m-Py), 56.2(s, Cl−C), 13.1(s, Pt cPr),
12.9(s, Cl cPr), 1.1(s, JPt–C = 1202 Hz, Pt−C).
Synthesis of cis–[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(Py)
2
] 34b
[Pt2Cl4(C2H4)2] (20 mg, 0.034 mmol) was placed in an NMR tube and CDCl3 (0.5 mL)
added. Pyridine (11 µL, 0.137 mmol, 4 eq.) and BCP (6.4 µL, 0.068 mmol, 2 eq.)
were added, resulting in the immediate formation of paritally soluble yellow cis–
[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2]. Reaction is quantitative by
1H NMR. 1H NMR (δ,
CDCl3, 500 MHz): 9.46(d, 6.0 Hz, 2H, o-H cis-Py), 8.87(d, 5.0 Hz, 2H, o-H trans-Py),
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8.28(t, 8.0 Hz, 1H, p-H cis-Py), 7.83(t, 7.5 Hz, 2H, m-H cis-Py), 7.62(t, 8.0 Hz, 1H, p-H
trans-Py), 7.18(t, 6.5 Hz, 2H, m-H trans-Py), 1.34(t, 6.5 Hz, 2H, Cl cPr-endo), 1.05(t,
6.5 Hz, 2H, Cl cPr-exo), 0.50(t, 4.8 Hz, 2H, Pt cPr-endo), 0.36(t, 4.8 Hz, 2H, Pt cPr-
exo). 13C{1H} NMR (δ, CDCl3, 125 MHz): 151.3(s, o-C trans-Py), 146.5(s, o-C cis-Py),
144.4(s, p-C cis-Py), 136.5(s, p-C trans-Py), 126.1(s, m-C cis-Py), 124.5(s, m-C trans-
Py), 65.9(s, Cl−C), 15.0(s, Pt cPr), 11.1(s, Cl cPr), −11.1(s, JPt–C = 970 Hz, Pt−C).
m/z = [M − Cl]+ calcd for C16H18ClN
194
2 Pt 467.0785; found 467.0791.
Synthesis of cis–[Pt(C(CH2)2CH2Cl)Cl(Py)2] 34c
[Pt2Cl4(C2H4)2] (20 mg, 0.034 mmol) was placed in an NMR tube and d6-acetone(0.5 mL)
added. Pyridine (11 µL, 0.137 mmol, 4 eq.) and MCP (0.07 mL of a 0.92 mmol/mL
solution in CDCl3, 0.068 mmol, 2 eq.) were added, resulting in the immediate formation
of sparingly soluble yellow cis–[Pt(C(CH2)2CH2Cl)Cl(Py)2]. Reaction is quantitative by
1H NMR. 1H NMR (δ, d6-acetone, 600 MHz): 9.50(d, 5.6, JPt–H = 81.9 Hz, 2H, o-H
cis-Py), 8.91(dt, 4.7, 1.8 Hz, 2H, o-H trans-Py), 8.54(td, 7.7, 1.4 Hz, 1H, p-H cis-Py),
8.08(t, 6.9 Hz, 2H, m-H cis-Py), 7.82(tt, 7.6, 1.8 Hz, 1H, p-H trans-Py), 7.31(ddd, 7.6,
5.0, 1.4 Hz, 2H, m-H trans-Py), 4.13(s, JPt–H = 24.6 Hz, 2H, Cl−CH2), 0.52(td, 5.0,
1.5, JPt–H = 29.6 Hz, 2H, Pt cPr-endo), 0.32(td, 5.0, 1.5, JPt–H = 19.6 Hz, 2H, Pt cPr-
exo). 13C{1H} NMR (δ, d6-acetone, 150 MHz): 153.5(s, o-C trans-Py), 151.1(s, o-C
cis-Py), 138.8(s, p-C trans-Py), 136.3(s, p-C cis-Py), 126.4(s, m-C trans-Py), 124.0(s,
m-C cis-Py), 76.8(s, Cl−C), 14.3(s, Pt cPr), −15.6(s, Pt−C). m/z = [M − Cl]+ calcd
for C14H16ClN
194
2 Pt 437.0597; found 437.0601.
Synthesis of [Pt(dppp)2]Cl2 35a
[PtCl2(SEt2)2] (50 mg, 0.11 mmol) was placed in an NMR tube and CDCl3 (0.5 mL)
added. BCP (0.05 mL, 0.54 mmol) was added, resulting in the formation of trans–
[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] (32) after 5 days. The solution was frozen in liquid
N2, and a solution of dppp (90 mg, 0.22 mmol) in CDCl3 (0.5 mL) added. X-ray quality
crystals of [Pt(dppp)2]Cl2 formed as the solution warmed to RT.
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Synthesis of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(PTA)2] 36a
[PtCl2(SEt2)2] (50 mg, 0.11 mmol) was placed in an NMR tube and CDCl3
(0.5 mL) added. BCP (0.05 mL, 0.53 mmol) was added. After 2 days, trans–
Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] formed and the solvent was removed in vacuo.
PTA (40 mg, 0.25 mmol) was dissolved in CDCl3 (0.5 mL) and added to the NMR
tube., resulting in the immediate formation of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(PTA)2].
After ∼1 hr, the complex had decomposed to form cis–[PtCl2(PTA)2] and BCP. Due
to the insolubility of cis–[PtCl2(PTA)2], a yield was not obtained.
1H NMR (δ, CDCl3,
600 MHz): 4.45(m, 12H, N−CH2), 4.31(dd, 47.4, 14.4, 12H, P−CH2), 1.03(t, 6.0 Hz, 2H,
Cl cPr), 0.76(t, 6.0 Hz, 2H, Cl cPr), 0.44(s, 2H, Pt cPr), 0.27(s, 2H, Pt cPr). 31P{1H}
NMR (δ, CDCl3, 121 MHz): −59.2(s,
1JPt–P = 3000 Hz).
Synthesis of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(PTA)2] 36b
[Pt2Cl4(C2H4)2] (30 mg, 0.051 mmol) was placed in an NMR tube and CDCl3 (0.3 mL)
added. Pyridine (16.5 µL, 0.21 mmol, 4 eq.) and BCP (0.25 mL of a 0.62 mmol/mL
solution in C6D6, 0.153 mmol, 3 eq.) were added, resulting in the immediate formation of
cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2]. The solvent was removed in vacuo and PTA (48 mg
of a sample containing 10% PTA oxide, ∼6 eq.) in CDCl3 (0.5 mL) added. A large amount
of cis–[PtCl2(PTA)2] was formed, as well as cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(PTA)2].
Relative amounts could not be calculated due to the insolubility of cis–[PtCl2(PTA)2]..
1H
NMR (δ, CDCl3, 600 MHz): 4.7–4.1(m, 24H, N−CH2 and P−CH2), 1.69(dt, 11.2, 6.7 Hz,
1H, Cl cPr), 1.31(dt, 10.2, 7.1 Hz, 1H, Cl cPr), 0.92(m, 2H, Cl cPr and Pt cPr), 0.85(dt,
10.9, 6.2 Hz, 1H, Cl cPr), 0.80(m, 1H, Pt cPr), 0.49(m, 1H, Pt cPr), 0.27(m, 1H, Pt cPr).
13C{1H} NMR (δ, CDCl3, 150 MHz): 72.8(m, N−CH2), 72.2(d, 9.2 Hz, N−CH2), 64.8(s,
Cl−C), 53.5(dd, 23.3, 2.4 Hz, P−CH2), 51.9(d, 14.7 Hz, P−CH2), 16.7(s, Cl
cPr), 15.7(s,
Cl cPr), 15.5(dd, 121.8, 8.6, 1JPt–C = 809.1 Hz, Pt−C), 13.4(s, Pt cPr), 8.7(d, 3.7 Hz, Pt
cPr). 31P{1H} NMR (δ, CDCl3, 121 MHz): −57.9(d, 15.6,
1JPt–P = 3949 Hz, trans Cl),
−65.8(d, 15.6, 1JPt–P = 1522 Hz, JP–C = 121.5 Hz, trans cPr). m/z = [M + K]+ calcd
for C18H32Cl2KN6P
194
2 Pt 699.0804; found 699.0784.
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Synthesis of cis–[Pt(C(CH2)2CH2Cl)Cl(PTA)2] 36c
[Pt2Cl4(C2H4)2] (30 mg, 0.051 mmol) was placed in an NMR tube and MCP (0.17 mL of a
0.92 mmol/mL solution in CDCl3, 0.153 mmol, 3 eq.) and pyridine (16.5 µL, 0.21 mmol,
4 eq.) added, resulting in the immediate formation of cis–[Pt(C(CH2)2CH2Cl)Cl(Py)2].
PTA (48 mg of a sample containing 10% PTA oxide, ∼6 eq.) in CDCl3 (0.3 mL)
was added. A large amount of cis–[PtCl2(PTA)2] was formed, as well as cis–
[Pt(C(CH2)2CH2Cl)Cl(PTA)2] (50% of species in solution). After 5 days, all of the
cis–[Pt(C(CH2)2CH2Cl)Cl(PTA)2] had decomposed to form cis–[PtCl2(PTA)2].
31P{1H}
NMR (δ, CDCl3, 121 MHz): −58.9(d, 14.9,
1JPt–P = 3884 Hz, trans Cl), −65.8(d, 14.9,
1JPt–P = 1530 Hz, trans cPr).
Synthesis of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)] 37a
[Pt2Cl4(C2H4)2] (30 mg, 0.051 mmol) was placed in an NMR tube and CDCl3 (0.3 mL)
added. Pyridine (16.5 µL, 0.21 mmol, 4 eq.) and BCP (0.25 mL of a 0.62 mmol/mL
solution in C6D6, 0.153 mmol, 3 eq.) were added, resulting in the immediate formation
of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2]. The solvent was removed in vacuo and dppp
(42 mg, 0.102 mmol) in CDCl3 (0.5 mL) added. cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)]
(85%) and cis–[PtCl2(dppp)] (11%) formed immediately.
1H NMR (δ, CDCl3, 600 MHz):
7.86(t, 8.4 Hz, 4H, Ar), 7.53(t, 9.0 Hz, 4H, Ar), 7.37(m, 4H, Ar), 7.2(m, 8H, Ar), 4.47(brs,
1H, P−CH2), 3.41(t, 13.8 Hz, 1H, P−CH2), 2.51(m, 2H, P−CH2), 2.28(m, 1H, CH2),
1.05(m, 2H, CH2 and Cl
cPr), 0.71(m, 1H, Cl cPr), 0.48(m, 2H, Cl cPr and Pt cPr),
0.35(m, 1H, Pt cPr), 0.20(m, 1H, Pt cPr), −0.46(m, 1H, Cl cPr), −1.22(m, 1H, Pt
cPr). 13C{1H} NMR (δ, CDCl3, 150 MHz): 134.3(d, 10.0 Hz, Ar), 133.5(d, 9.6 Hz, Ar),
132.9(d, 10.0 Hz, Ar), 130.6(d, 13.8 Hz, Ar), 128.8(m, Ar), 128.5(d, 9.5 Hz, Ar), 128.1(d,
11.2 Hz, Ar), 127.0(d, 10.6 Hz, Ar), 63.6(s, Cl−C), 28.5(dd, 39.3, 5.9 Hz, P−CH2), 22.8(d,
29.2 Hz, P−CH2), 18.8(m, CH2), 17.1(s, Cl
cPr), 15.6(dd, 124.5, 6.8, 1JPt–C = 789.4 Hz,
Pt−C), 13.3(s, Pt cPr), 12.2(s, Cl cPr), 6.1(d, 3.2 Hz, Pt cPr). 31P{1H} NMR (δ, CDCl3,
121 MHz): −1.8(d, 25.9, 1JPt–P = 1654 Hz, trans cPr), −2.7(d, 25.9, 1JPt–P = 4133 Hz,
trans Cl).
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Synthesis of cis–[Pt(C(CH2)2CH2Cl)Cl(dppp)] 37b
[Pt2Cl4(C2H4)2] (30 mg, 0.051 mmol) was placed in an NMR tube and MCP
(0.17 mL of a 0.92 mmol/mL solution in CDCl3, 0.153 mmol, 3 eq.) and pyridine
(16.5 µL, 0.21 mmol, 4 eq.) added, resulting in the immediate formation of cis–
[Pt(C(CH2)2CH2Cl)Cl(Py)2]. Dppp (42 mg, 0.102 mmol) in CDCl3 (0.3 mL) was added.
cis–[Pt(C(CH2)2CH2Cl)Cl(dppp)] (58%), cis–[PtCl2(dppp)] (26%) and [Pt(dppp)2]Cl2
(16%) formed immediately. The cis–[Pt(C(CH2)2CH2Cl)Cl(dppp)] decomposed to form
cis–[PtCl2(dppp)] overnight.
31P{1H} NMR (δ, CDCl3, 121 MHz): 0.4(d, 25.2,
1JPt–P =
4051 Hz, trans Cl), 0.2(d, 25.2, 1JPt–P = 1684 Hz, trans cPr).
Synthesis of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(PPh3)2] 38a
[Pt2Cl4(C2H4)2] (30 mg, 0.051 mmol) was placed in an NMR tube and CDCl3
(0.3 mL) added. Pyridine (16.5 µL, 0.21 mmol, 4 eq.) and BCP (0.25 mL of
a 0.62 mmol/mL solution in C6D6, 0.153 mmol, 3 eq.) were added, resulting
in the immediate formation of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2]. The solvent
was removed in vacuo and PPh3 (54 mg, 0.204 mmol) in CDCl3 (0.5 mL)
added. [Pt(C(CH2)2C(CH2)2Cl)Cl(Py)(PPh3)] (70%) and cis–[PtCl2(PPh3)2]
(30%) formed immediately. After an hour, cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(PPh3)2]
began to form, ending up as 53% cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(PPh3)2], 8.5%
[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)(PPh3)] (70%) and 30% cis–[PtCl2(PPh3)2] after 4 days.
[Pt(C(CH
2
)
2
C(CH
2
)
2
Cl)Cl(Py)(PPh
3
)] 38b: 31P{1H} NMR (δ, CDCl3, 121 MHz):
10.8(s, 1JPt–P = 4738 Hz). cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(PPh3)2] 38a:
1H NMR
(δ, CDCl3, 600 MHz): 8–7(m, 8H, Ar), 1.34(m, 1H, Cl
cPr), 0.85(m, 1H, Cl cPr), 0.77(m,
1H, Pt cPr), 0.69(m, 1H, Cl cPr), 0.57(m, 1H, Pt cPr), −0.41(m, 1H, Cl cPr), −0.85(m,
1H, Pt cPr). 13C{1H} NMR (δ, CDCl3, 150 MHz): 134.7(m, Ar), 133.6(d, 18.4 Hz, Ar),
128.9–127.6(m, Ar), 63.3(s, Cl−C), 19.2(s, Cl cPr), 15.8(d, 4.3 Cl cPr), 15.7(dd, 126.7,
8.0, 1JPt–C = 797.7 Hz, Pt−C), 13.3(s, Pt cPr), 8.1(d, 3.7 Hz, Pt cPr). 31P{1H} NMR
(δ, CDCl3, 121 MHz): 22.7(d, 15.6,
1JPt–P = 1646 Hz, trans cPr), 16.7(d, 15.6, 1JPt–P
= 4490 Hz, trans Cl). m/z = [M − Cl]+ calcd for C42H38ClP
194
2 Pt 835.1783; found
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838.1785.
Synthesis of cis–[Pt(C(CH2)2CH2Cl)Cl(Py)(PPh3)] 38c
[Pt2Cl4(C2H4)2] (30 mg, 0.051 mmol) was placed in an NMR tube and MCP
(0.17 mL of a 0.92 mmol/mL solution in CDCl3, 0.153 mmol, 3 eq.) and pyridine
(16.5 µL, 0.21 mmol, 4 eq.) added, resulting in the immediate formation of cis–
[Pt(C(CH2)2CH2Cl)Cl(Py)2]. PPh3 (54 mg, 0.204 mmol) in CDCl3 (0.3 mL) was
added. [Pt(C(CH2)2CH2Cl)Cl(Py)(PPh3)] (32%) and cis–[PtCl2(PPh3)2] (30%) formed
immediately, with the [Pt(C(CH2)2CH2Cl)Cl(Py)(PPh3)] decomposing to form cis–
[PtCl2(PPh3)2] over 4 hours.
31P{1H} NMR (δ, CDCl3, 121 MHz): 13.5(s,
1JPt–P =
4661 Hz).
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Appendix A
NMR Spectra
A.1 Chapter Two
[Pt(BCP)(dppp)] (1a)
1H NMR spectrum – Figures A.1 and A.2, pages 162 and 163
13C{1H} NMR spectrum – Figures A.4 and A.5, pages 164 and 165
31P{1H} NMR spectrum – Figure A.3, page 163
[Pt(MCP)(dppp)] (2a)
1H NMR spectrum – Figures A.6 and A.7, pages 166 and 167
13C{1H} NMR spectrum – Figures A.8–A.10, pages 168–170
31P{1H} NMR spectrum – Figure A.11, page 170
[Pt(CH2CH−CHC(CH2)2)(dppp)] (4a)
1H NMR spectrum – Figures A.12–A.14, pages 171–173
13C{1H} NMR spectrum – Figures A.16–A.19, pages 174–177
31P{1H} NMR spectrum – Figure A.15, page 173
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[Pt(MCP)2(PPh3)] (7a)
1H NMR spectrum – Figures A.20 and A.21, pages 178 and 179
13C{1H} NMR spectrum – Figures A.22–A.24, pages 180–182
31P{1H} NMR spectrum – Figure A.25, page 182
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Figure A.1. 1H NMR spectrum of [Pt(BCP)(dppp)] (1a) (600 MHz, RT, 40 mg/mL,
C6D6).
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Figure A.2. Expanded 1H NMR spectrum of [Pt(BCP)(dppp)] (1a) (600 MHz, RT,
40 mg/mL, C6D6).
Figure A.3. 31P{1H} NMR spectrum of [Pt(BCP)(dppp)] (1a) (121 MHz, RT,
40 mg/mL, C6D6).
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Figure A.4. 13C{1H} NMR spectrum of [Pt(BCP)(dppp)] (1a) (150 MHz, RT,
40 mg/mL, C6D6).
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Figure A.5. Expanded 13C{1H} NMR spectrum of [Pt(BCP)(dppp)] (1a) (150 MHz,
RT, 40 mg/mL, C6D6).
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Figure A.6. 1H NMR spectrum of [Pt(MCP)(dppp)] (2a) (500 MHz, RT, 40 mg/mL,
C6D6).
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Figure A.7. Expanded 1H NMR spectrum of [Pt(MCP)(dppp)] (2a) (500 MHz, RT,
40 mg/mL, C6D6).
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Figure A.8. 13C{1H} NMR spectrum of [Pt(MCP)(dppp)] (2a) (125 MHz, RT,
40 mg/mL, C6D6).
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Figure A.9. Expanded 13C{1H} NMR spectrum of [Pt(MCP)(dppp)] (2a) (125 MHz,
RT, 40 mg/mL, C6D6).
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Figure A.10. Expanded 13C{1H} NMR spectrum of [Pt(MCP)(dppp)] (2a) (125 MHz,
RT, 40 mg/mL, C6D6).
Figure A.11. 31P{1H} NMR spectrum of [Pt(MCP)(dppp)] (2a) (121 MHz, RT,
40 mg/mL, C6D6).
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Figure A.12. 1H NMR spectrum of [Pt(CH2CH−CHC(CH2)2)(dppp)] (4a) (500 MHz,
RT, 40 mg/mL, C6D6).
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Figure A.13. Expanded 1H NMR spectrum of [Pt(CH2CH−CHC(CH2)2)(dppp)] (4a)
(500 MHz, RT, 40 mg/mL, C6D6).
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Figure A.14. Expanded 1H NMR spectrum of [Pt(CH2CH−CHC(CH2)2)(dppp)] (4a)
(500 MHz, RT, 40 mg/mL, C6D6).
*
Figure A.15. 31P{1H} NMR spectrum of [Pt(CH2CH−CHC(CH2)2)(dppp)] (4a)
(121 MHz, RT, 40 mg/mL, C6D6). * signifies peaks belonging to other species.
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Figure A.16. 13C{1H} NMR spectrum of [Pt(CH2CH−CHC(CH2)2)(dppp)] (4a)
(125 MHz, RT, 40 mg/mL, C6D6).
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Figure A.17. Expanded 13C{1H} NMR spectrum of [Pt(CH2CH−CHC(CH2)2)(dppp)]
(4a) (125 MHz, RT, 40 mg/mL, C6D6).
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Figure A.18. Expanded 13C{1H} NMR spectrum of [Pt(CH2CH−CHC(CH2)2)(dppp)]
(4a) (125 MHz, RT, 40 mg/mL, C6D6).* signifies peaks belonging to other species
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Figure A.19. Expanded 13C{1H} NMR spectrum of [Pt(CH2CH−CHC(CH2)2)(dppp)]
(4a) (125 MHz, RT, 40 mg/mL, C6D6).
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Figure A.20. 1H NMR spectrum of [Pt(MCP)2(PPh3)] (7a) (500 MHz, RT,
40 mg/mL, C6D6).
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Figure A.21. Expanded 1H NMR spectrum of [Pt(MCP)2(PPh3)] (7a) (500 MHz, RT,
40 mg/mL, C6D6).
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Figure A.22. 13C{1H} NMR spectrum of [Pt(MCP)2(PPh3)] (7a) (125 MHz, RT,
40 mg/mL, C6D6).
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Figure A.23. Expanded 13C{1H} NMR spectrum of [Pt(MCP)2(PPh3)] (7a)
(125 MHz, RT, 40 mg/mL, C6D6).
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Figure A.24. Expanded 13C{1H} NMR spectrum of [Pt(MCP)2(PPh3)] (7a)
(125 MHz, RT, 40 mg/mL, C6D6).
*
Figure A.25. 31P{1H} NMR spectrum of [Pt(MCP)2(PPh3)] (7a) (121 MHz, RT,
40 mg/mL, C6D6). * signifies peaks belonging to other species.
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A.2 Chapter Three
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a
and 11b)
1H NMR spectrum – Figures A.26 and A.27, pages 185 and 186
13C{1H} NMR spectrum – Figures A.28–A.31, pages 187–190
HMBC spectrum – Figures A.32 and A.33, pages 191 and 192
COSY spectrum – Figure A.34, page 192
31P{1H} NMR spectrum – Figure A.35, page 193
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (anti Me)
(13a[HC(SO2CF3)2]) and
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (syn Me)
(13b[HC(SO2CF3)2])
1H NMR spectra – Figures A.36–A.39, pages 194–197
13C{1H} NMR spectrum – Figures A.40–A.43, pages 198–201
HMBC spectrum – Figures A.44 and A.45, pages 202 and 203
COSY spectrum – Figure A.46, page 203
31P{1H} NMR spectra – Figures A.47 and A.48, pages 204 and 205
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[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]),
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2]
(anti Me) (16a[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me)
(16b[PhC(SO2CF3)2])
1H NMR spectra – Figures A.49–A.54, pages 206–211
13C{1H} NMR spectrum – Figures A.55–A.62, pages 212–219
HMBC spectrum – Figures A.63, A.64, A.66 and A.67, pages 220– 223
COSY spectrum – Figures A.65 and A.68, pages 221 and 223
31P{1H} NMR spectra – Figures A.69 and A.70, pages 224 and 225
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Figure A.26. 1H NMR spectrum of
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a) (600 MHz, RT,
40 mg/mL, C6D6).
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Figure A.27. Expanded 1H NMR spectrum of
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a) (600 MHz, RT,
40 mg/mL, C6D6).
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Figure A.28. 13C{1H} NMR spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a and 11b) (150 MHz,
RT, 40 mg/mL, C6D6).
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Figure A.29. Expanded 13C{1H} NMR spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a and 11b) (150 MHz,
RT, 40 mg/mL, C6D6).
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Figure A.30. Expanded 13C{1H} NMR spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a and 11b) (150 MHz,
RT, 40 mg/mL, C6D6).
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Figure A.31. Expanded 13C{1H} NMR spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a and 11b) (150 MHz,
RT, 40 mg/mL, C6D6).
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Figure A.32. HMBC spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a and 11b)
(600/150 MHz, RT, 40 mg/mL, C6D6). Some residual one bond coupling is present.
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Figure A.33. Expanded HMBC spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a and 11b)
(600/150 MHz, RT, 40 mg/mL, C6D6). Some residual one bond coupling is present.
Figure A.34. COSY spectrum of
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a and 11b) (600 MHz,
RT, 40 mg/mL, C6D6).
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Figure A.35. 31P{1H} NMR spectrum of
[Pt(η3-C(CH2)2CHCHMe)(C6H3-o-CH2P
tBu2-m-CH2S
tBu)] (11a and 11b) (121 MHz,
RT, 40 mg/mL, C6D6).
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Figure A.36. 1H NMR spectrum of [Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2]
(anti Me) (13a[HC(SO2CF3)2]) (600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.37. Expanded 1H NMR spectrum of
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (anti Me) (13a[HC(SO2CF3)2])
(600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.38. 1H NMR spectrum of [Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2]
(syn Me) (13b[HC(SO2CF3)2]) (600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.39. Expanded 1H NMR spectrum of
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (syn Me) (13b[HC(SO2CF3)2])
(600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.40. 13C{1H} NMR spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (13a[HC(SO2CF3)2] and
13b[HC(SO2CF3)2]) (150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.41. Expanded 13C{1H} NMR spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (13a[HC(SO2CF3)2] and
13b[HC(SO2CF3)2]) (150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.42. Expanded 13C{1H} NMR spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (13a[HC(SO2CF3)2] and
13b[HC(SO2CF3)2]) (150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.43. Expanded 13C{1H} NMR spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (13a[HC(SO2CF3)2] and
13b[HC(SO2CF3)2]) (150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.44. HMBC spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (13a[HC(SO2CF3)2] and
13b[HC(SO2CF3)2]) (600/150 MHz, RT, 40 mg/mL, d6-acetone). Some residual one
bond coupling is present.
202
Figure A.45. Expanded HMBC spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (13a[HC(SO2CF3)2] and
13b[HC(SO2CF3)2]) (600/150 MHz, RT, 40 mg/mL, d6-acetone). Some residual one
bond coupling is present.
Figure A.46. COSY spectrum of carbon-13 enriched
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (13a[HC(SO2CF3)2]) (150 MHz, RT,
40 mg/mL, d6-acetone).
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Figure A.47. 31P{1H} NMR spectrum of
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (13a[HC(SO2CF3)2]) (121 MHz, RT,
40 mg/mL, d6-acetone).
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Figure A.48. 31P{1H} NMR spectrum of
[Pt(η3-C(CH2)2CHCHMe)(dppp)][HC(SO2CF3)2] (13a[HC(SO2CF3)2] and
13b[HC(SO2CF3)2]) (121 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.49. 1H NMR spectrum of [Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
(15[PhC(SO2CF3)2]) and [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me)
(16a[PhC(SO2CF3)2]). (600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.50. Expanded 1H NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me) (16a[PhC(SO2CF3)2]).
(600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.51. Expanded 1H NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me) (16a[PhC(SO2CF3)2]).
(600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.52. 1H NMR spectrum of [Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
(15[PhC(SO2CF3)2]) and [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me)
(16b[PhC(SO2CF3)2]). (600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.53. Expanded 1H NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me) (16b[PhC(SO2CF3)2]).
(600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.54. Expanded 1H NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me) (16b[PhC(SO2CF3)2]).
(600 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.55. 13C{1H} NMR spectrum of [Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
(15[PhC(SO2CF3)2]) and [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me)
(16a[PhC(SO2CF3)2]). (150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.56. Expanded 13C{1H} NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me) (16a[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.57. Expanded 13C{1H} NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me) (16a[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.58. Expanded 13C{1H} NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me) (16a[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.59. Expanded 13C{1H} NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me) (16a[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.60. 13C{1H} NMR spectrum of [Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
(15[PhC(SO2CF3)2]) and [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me)
(16b[PhC(SO2CF3)2]). (150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.61. Expanded 13C{1H} NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me) (16b[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.62. Expanded 13C{1H} NMR spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me) (16b[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.63. HMBC spectrum of [Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
(15[PhC(SO2CF3)2]) and [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me)
(16a[PhC(SO2CF3)2]). (600/150 MHz, RT, 40 mg/mL, d6-acetone). Some residual one
bond coupling is present.
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Figure A.64. Expanded HMBC spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me) (16a[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone). Some residual one bond coupling is present.
Figure A.65. COSY spectrum of carbon-13
enriched[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me) (16a[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.66. HMBC spectrum of [Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
(15[PhC(SO2CF3)2]) and [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me)
(16b[PhC(SO2CF3)2]). (600/150 MHz, RT, 40 mg/mL, d6-acetone). Some residual one
bond coupling is present.
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Figure A.67. Expanded HMBC spectrum of
[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me) (16b[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone). Some residual one bond coupling is present.
Figure A.68. COSY spectrum of carbon-13
enriched[Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2] (15[PhC(SO2CF3)2]) and
[Pt(η3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me) (16b[PhC(SO2CF3)2]).
(150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.69. 31P{1H} NMR spectrum of [Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
(15[PhC(SO2CF3)2]) and [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (anti Me)
(16a[PhC(SO2CF3)2]). (150 MHz, RT, 40 mg/mL, d6-acetone).
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Figure A.70. 31P{1H} NMR spectrum of [Pt(η3-CH2CMeCH2)(dppp)][PhC(SO2CF3)2]
(15[PhC(SO2CF3)2]) and [Pt(η
3-CH2CHCHMe)(dppp)][PhC(SO2CF3)2] (syn Me)
(16b[PhC(SO2CF3)2]). (150 MHz, RT, 40 mg/mL, d6-acetone).
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A.3 Chapter Four
[PtEt(C(CH2)2CH3)(COD)] (27a) and [Pt(C(CH2)2CH3)2(COD)]
(27b)
1H NMR spectrum – Figures A.71 and A.72, pages 228 and 229
13C{1H} NMR spectrum – Figures A.73–A.75, pages 230–232
HMBC spectrum – Figures A.76 and A.77, pages 233 and 234
COSY spectrum – Figure A.78, pages 234
Trans–[PtCl2(BCP)(Py)] (28)
1H NMR spectrum – Figures A.79 and A.80, pages 235 and 236
13C{1H} NMR spectrum – Figures A.81 and A.82, pages 237 and 238
Trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] (32)
1H NMR spectrum – Figures A.83 and A.84, pages 239 and 240
13C{1H} NMR spectrum – Figures A.85 and A.86, pages 241 and 242
HMBC spectrum – Figures A.87 and A.88, pages 243 and 244
COSY spectrum – Figure A.89, pages 244
Cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b)
1H NMR spectrum – Figures A.90 and A.91, pages 245 and 246
13C{1H} NMR spectrum – Figures A.92 and A.93, pages 247 and 248
HMBC spectrum – Figures A.94 and A.95, pages 249 and 250
COSY spectrum – Figure A.96, pages 250
226

Cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)] (37a)
1H NMR spectrum – Figures A.97 and A.98, pages 251 and 252
13C{1H} NMR spectrum – Figures A.99–A.101, pages 253–255
HMBC spectrum – Figures A.102 and A.103, pages 256 and 257
COSY spectrum – Figure A.104, pages 257
31P{1H} NMR spectrum – Figure A.105, page 258
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Figure A.71. 1H NMR spectrum of [PtEt(C(CH2)2CH3)(COD)] (27a) and
[Pt(C(CH2)2CH3)2(COD)] (27b) (600 MHz, RT, 40 mg/mL, C6D6).
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Figure A.72. Expanded 1H NMR spectrum of [PtEt(C(CH2)2CH3)(COD)] (27a) and
[Pt(C(CH2)2CH3)2(COD)] (27b) (600 MHz, RT, 40 mg/mL, C6D6).
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Figure A.73. 13C{1H} NMR spectrum of [PtEt(C(CH2)2CH3)(COD)] (27a) and
[Pt(C(CH2)2CH3)2(COD)] (27b) (150 MHz, RT, 40 mg/mL, C6D6).
230
Pt Pt
Pt
Pt
Figure A.74. Expanded 13C{1H} NMR spectrum of [PtEt(C(CH2)2CH3)(COD)] (27a)
and [Pt(C(CH2)2CH3)2(COD)] (27b) (150 MHz, RT, 40 mg/mL, C6D6).
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Figure A.75. Expanded 13C{1H} NMR spectrum of [PtEt(C(CH2)2CH3)(COD)] (27a)
and [Pt(C(CH2)2CH3)2(COD)] (27b) (150 MHz, RT, 40 mg/mL, C6D6).
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Figure A.76. HMBC spectrum of [PtEt(C(CH2)2CH3)(COD)] (27a) and
[Pt(C(CH2)2CH3)2(COD)] (27b) (600/150 MHz, RT, 40 mg/mL, C6D6). Some residual
one bond coupling is present.
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Figure A.77. Expanded HMBC spectrum of [PtEt(C(CH2)2CH3)(COD)] (27a) and
[Pt(C(CH2)2CH3)2(COD)] (27b) (600/150 MHz, RT, 40 mg/mL, C6D6). Some residual
one bond coupling is present.
Figure A.78. COSY spectrum of [PtEt(C(CH2)2CH3)(COD)] (27a) and
[Pt(C(CH2)2CH3)2(COD)] (27b) (600 MHz, RT, 40 mg/mL, C6D6).
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Figure A.79. 1H NMR spectrum of trans–[PtCl2(BCP)(Py)] (28) (300 MHz, RT,
100 mg/mL, CDCl3).
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Figure A.80. Expanded 1H NMR spectrum of trans–[PtCl2(BCP)(Py)] (28)
(300 MHz, RT, 100 mg/mL, CDCl3).
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Figure A.81. 13C{1H} NMR spectrum of carbon-13 enriched trans–[PtCl2(BCP)(Py)]
(28) (150 MHz, RT, 100 mg/mL, CDCl3).
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Figure A.82. Expanded 13C{1H} NMR spectrum of carbon-13 enriched
trans–[PtCl2(BCP)(Py)] (28) (150 MHz, RT, 100 mg/mL, CDCl3).
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Figure A.83. 1H NMR spectrum of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] (32)
(500 MHz, RT, 100 mg/mL, CDCl3).
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Figure A.84. Expanded 1H NMR spectrum of
trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] (32) (500 MHz, RT, 100 mg/mL, CDCl3).
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Figure A.85. 13C{1H} NMR spectrum of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2]
(32) (125 MHz, RT, 100 mg/mL, CDCl3).
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Figure A.86. Expanded 13C{1H} NMR spectrum of
trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] (32) (125 MHz, RT, 100 mg/mL, CDCl3).
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Figure A.87. HMBC spectrum of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] (32)
(500/125 MHz, RT, 100 mg/mL, CDCl3).
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Figure A.88. Expanded HMBC spectrum of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2]
(32) (500/125 MHz, RT, 100 mg/mL, CDCl3).
Figure A.89. COSY spectrum of trans–[Pt(C(CH2)2C(CH2)2Cl)Cl(SEt2)2] (32)
(500 MHz, RT, 100 mg/mL, CDCl3).
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Figure A.90. 1H NMR spectrum of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b)
(500 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.91. Expanded 1H NMR spectrum of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2]
(34b) (500 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.92. 13C{1H} NMR spectrum of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b)
(125 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.93. Expanded 13C{1H} NMR spectrum of
cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b) (125 MHz, RT, 40 mg/mL,
CDCl3).* signifies peaks belonging to other species.
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Figure A.94. HMBC spectrum of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b)
(500/125 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.95. Expanded HMBC spectrum of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2]
(34b) (500/125 MHz, RT, 40 mg/mL, CDCl3).
Figure A.96. COSY spectrum of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(Py)2] (34b)
(500 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.97. 1H NMR spectrum of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)] (37a)
(600 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.98. Expanded 1H NMR spectrum of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)]
(37a) (600 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.99. 13C{1H} NMR spectrum of carbon-13 enriched
cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)] (37a) (150 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.100. Expanded 13C{1H} NMR spectrum of carbon-13 enriched
cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)] (37a) (150 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.101. Expanded 13C{1H} NMR spectrum of carbon-13 enriched
cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)] (37a) (150 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.102. HMBC spectrum of carbon-13 enriched
cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)] (37a) (600/150 MHz, RT, 40 mg/mL, CDCl3).
Some residual one bond coupling is present.
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Figure A.103. Expanded HMBC spectrum of carbon-13 enriched
cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)] (37a) (600/150 MHz, RT, 40 mg/mL, CDCl3).
Some residual one bond coupling is present.
Figure A.104. COSY spectrum of carbon-13 enriched
cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)] (37a) (600 MHz, RT, 40 mg/mL, CDCl3).
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Figure A.105. 31P{1H} NMR spectrum of cis–[Pt(C(CH2)2C(CH2)2Cl)Cl(dppp)]
(37a) (150 MHz, RT, 40 mg/mL, CDCl3).
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